
    
<!DOCTYPE html>




<html lang="en" >
<head >
    <meta charset="UTF-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">

    <!-- Mobile properties -->
    <meta name="HandheldFriendly" content="True">
    <meta name="MobileOptimized" content="320">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">

  
    <!-- Stylesheets -->
    <link rel="stylesheet" href="/pmc/static/CACHE/css/output.cc84172e9e16.css" type="text/css">
  
  <link rel="stylesheet" href="/pmc/static/CACHE/css/output.b634933a977d.css" type="text/css"><link rel="stylesheet" href="/pmc/static/CACHE/css/output.913c7dcab8ff.css" type="text/css"><link rel="stylesheet" href="/pmc/static/CACHE/css/output.3766d7ad0d2d.css" type="text/css"><link rel="stylesheet" href="/pmc/static/CACHE/css/output.e3c3c2c84eb3.css" type="text/css">

  
    <link rel="stylesheet" href="https://maxcdn.bootstrapcdn.com/font-awesome/4.7.0/css/font-awesome.min.css"/>
  
<link type="text/css" href="/pmc/static/bundles/base/base.a2ef7ca69e4b20dff539.css" rel="stylesheet" />


    <link rel="stylesheet" href="/corehtml/pmc/css/fonts/stix/stixfonts.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/3.18/pmcrefs1.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/pmc2020_1.1/ncbi_web.min.css?_=a" type="text/css" /><style type="text/css">.pmc-wm {background:transparent repeat-y top left;background-image:url(/corehtml/pmc/pmcgifs/wm-journal.gif);background-size: auto, contain}</style><style type="text/css">.print-view{display:block}</style>

    <link type="text/css" href="/pmc/static/bundles/article/article.3c5d12ff2e4beea20136.css" rel="stylesheet" />
    <link type="text/css" href="/pmc/static/django_pmc_cite_box/lib/cite-box.css" rel="stylesheet" />


    <title>Gene therapy for neurodegenerative disorders: advances, insights and prospects - PMC</title>

  
  <!-- Favicons -->
  <link rel="shortcut icon" type="image/ico" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon.ico" />
  <link rel="icon" type="image/png" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon.png" />

  <!-- 192x192, as recommended for Android
  http://updates.html5rocks.com/2014/11/Support-for-theme-color-in-Chrome-39-for-Android
  -->
  <link rel="icon" type="image/png" sizes="192x192" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-192.png" />

  <!-- 57x57 (precomposed) for iPhone 3GS, pre-2011 iPod Touch and older Android devices -->
  <link rel="apple-touch-icon-precomposed" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-57.png">
  <!-- 72x72 (precomposed) for 1st generation iPad, iPad 2 and iPad mini -->
  <link rel="apple-touch-icon-precomposed" sizes="72x72" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-72.png">
  <!-- 114x114 (precomposed) for iPhone 4, 4S, 5 and post-2011 iPod Touch -->
  <link rel="apple-touch-icon-precomposed" sizes="114x114" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-114.png">
  <!-- 144x144 (precomposed) for iPad 3rd and 4th generation -->
  <link rel="apple-touch-icon-precomposed" sizes="144x144" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-144.png">



    
        <!-- Logging params: Pinger defaults -->

<meta name="ncbi_app" content="pmc-frontend" />

<meta name="ncbi_db" content="pmc" />

<meta name="ncbi_phid" content="939BE807DB0F4BC500003B673C9D880A.1.m_2" />


        <!-- Logging params: Pinger custom -->

<meta name="ncbi_pdid" content="article" />

<meta name="ncbi_op" content="retrieved" />

<meta name="ncbi_app_version" content="0.0" />

<meta name="ncbi_domain" content="apsb" />

<meta name="ncbi_type" content="fulltext" />

<meta name="ncbi_pcid" content="/articles/PMC7488363/" />


    


    <script>
        
            var ncbiBaseUrl = "https://www.ncbi.nlm.nih.gov";
        
        var useOfficialGovtHeader = true;
    </script>


    <meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7488363/" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="citation_journal_title" content="Acta Pharmaceutica Sinica. B" /><meta name="citation_title" content="Gene therapy for neurodegenerative disorders: advances, insights and prospects" /><meta name="citation_author" content="Wei Chen" /><meta name="citation_author_institution" content="Department of Biological Medicines, Fudan University School of Pharmacy, Shanghai 201203, China" /><meta name="citation_author_institution" content="Department of Ophthalmology, Stanford University School of Medicine, Palo Alto, CA 94304, USA" /><meta name="citation_author" content="Yang Hu" /><meta name="citation_author_institution" content="Department of Ophthalmology, Stanford University School of Medicine, Palo Alto, CA 94304, USA" /><meta name="citation_author" content="Dianwen Ju" /><meta name="citation_author_institution" content="Department of Biological Medicines, Fudan University School of Pharmacy, Shanghai 201203, China" /><meta name="citation_publication_date" content="2020/08" /><meta name="citation_issue" content="8" /><meta name="citation_volume" content="10" /><meta name="citation_firstpage" content="1347" /><meta name="citation_doi" content="10.1016/j.apsb.2020.01.015" /><meta name="citation_abstract_html_url" content="/pmc/articles/PMC7488363/?report=abstract" /><meta name="citation_fulltext_html_url" content="/pmc/articles/PMC7488363/" /><meta name="citation_pmid" content="32963936" /><meta name="DC.Title" content="Gene therapy for neurodegenerative disorders: advances, insights and prospects" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="Elsevier" /><meta name="DC.Contributor" content="Wei Chen" /><meta name="DC.Contributor" content="Yang Hu" /><meta name="DC.Contributor" content="Dianwen Ju" /><meta name="DC.Date" content="2020 Aug" /><meta name="DC.Identifier" content="10.1016/j.apsb.2020.01.015" /><meta name="DC.Language" content="en" /><meta property="og:title" content="Gene therapy for neurodegenerative disorders: advances, insights and prospects" /><meta property="og:type" content="article" /><meta property="og:description" content="Gene therapy is rapidly emerging as a powerful therapeutic strategy for a wide range of neurodegenerative disorders, including Alzheimer's disease (AD), Parkinson's disease (PD) and Huntington's disease (HD). Some early clinical trials have failed to ..." /><meta property="og:url" content="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7488363/" /><meta property="og:site_name" content="PubMed Central (PMC)" /><meta property="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/pmc-card-share.jpg?_=0" /><meta name="twitter:card" content="summary_large_image" /><meta name="twitter:site" content="@ncbi" />


</head>
<body >

   
    
        <button
          class="back-to-top back-to-top--bottom"
          data-ga-category="pagination"
          data-ga-action="back_to_top">
          Back to Top
        </button>
    

    <a class="usa-skipnav" href="#main-content">Skip to main content</a>
    <!-- ========== BEGIN HEADER ========== -->
<section class="usa-banner" style="display: none;">
  <div class="usa-accordion">
    <header class="usa-banner-header">
      <div class="usa-grid usa-banner-inner">
        <img src="https://www.ncbi.nlm.nih.gov/coreutils/uswds/img/favicons/favicon-57.png" alt="U.S. flag" />
        <p>An official website of the United States government</p>
        <button
          class="usa-accordion-button usa-banner-button"
          aria-expanded="false"
          aria-controls="gov-banner-top"
        >
          <span class="usa-banner-button-text">Here's how you know</span>
        </button>
      </div>
    </header>
    <div
      class="usa-banner-content usa-grid usa-accordion-content"
      id="gov-banner-top"
    >
      <div class="usa-banner-guidance-gov usa-width-one-half">
        <img
          class="usa-banner-icon usa-media_block-img"
          src="https://www.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-dot-gov.svg"
          alt="Dot gov"
        />
        <div class="usa-media_block-body">
          <p>
            <strong>The .gov means it’s official.</strong>
            <br />
            Federal government websites often end in .gov or .mil. Before
            sharing sensitive information, make sure you’re on a federal
            government site.
          </p>
        </div>
      </div>
      <div class="usa-banner-guidance-ssl usa-width-one-half">
        <img
          class="usa-banner-icon usa-media_block-img"
          src="https://www.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-https.svg"
          alt="Https"
        />
        <div class="usa-media_block-body">
          <p>
            <strong>The site is secure.</strong>
            <br />
            The <strong>https://</strong> ensures that you are connecting to the
            official website and that any information you provide is encrypted
            and transmitted securely.
          </p>
        </div>
      </div>
    </div>
  </div>
</section>
<div class="usa-overlay"></div>
<header class="ncbi-header" role="banner" data-section="Header">

	<div class="usa-grid">
		<div class="usa-width-one-whole">

            <div class="ncbi-header__logo">
                <a href="https://www.ncbi.nlm.nih.gov/" class="logo" aria-label="NCBI Logo" data-ga-action="click_image" data-ga-label="NIH NLM Logo">
                  <img src="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/logos/AgencyLogo.svg" alt="NIH NLM Logo" />
                </a>
            </div>

			<div class="ncbi-header__account">
				<a id="account_login" href="https://account.ncbi.nlm.nih.gov" class="usa-button header-button" style="display:none" data-ga-action="open_menu" data-ga-label="account_menu">Log in</a>
				<button id="account_info" class="header-button" style="display:none"
						aria-controls="account_popup">
					<span class="fa fa-user" aria-hidden="true"></span>
					<span class="username desktop-only" aria-hidden="true" id="uname_short"></span>
					<span class="sr-only">Show account info</span>
				</button>
			</div>

			<div class="ncbi-popup-anchor">
				<div class="ncbi-popup account-popup" id="account_popup" aria-hidden="true">
					<div class="ncbi-popup-head">
						<button class="ncbi-close-button" data-ga-action="close_menu" data-ga-label="account_menu"><span class="fa fa-times"></span><span class="usa-sr-only">Close</span></button>
						<h4>Account</h4>
					</div>
					<div class="account-user-info">
						Logged in as:<br/>
						<b><span class="username" id="uname_long">username</span></b>
					</div>
					<div class="account-links">
						<ul class="usa-unstyled-list">
							<li><a id="account_myncbi" href="/myncbi/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_myncbi">Dashboard</a></li>
							<li><a id="account_pubs" href="/myncbi/collections/bibliography/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_pubs">Publications</a></li>
							<li><a id="account_settings" href="/account/settings/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_settings">Account settings</a></li>
							<li><a id="account_logout" href="/account/signout/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_logout">Log out</a></li>
						</ul>
					</div>
				</div>
			</div>

		</div>
	</div>
</header>
<div role="navigation" aria-label="access keys">
<a id="nws_header_accesskey_0" href="https://www.ncbi.nlm.nih.gov/guide/browsers/#ncbi_accesskeys" class="usa-sr-only" accesskey="0" tabindex="-1">Access keys</a>
<a id="nws_header_accesskey_1" href="https://www.ncbi.nlm.nih.gov" class="usa-sr-only" accesskey="1" tabindex="-1">NCBI Homepage</a>
<a id="nws_header_accesskey_2" href="/myncbi/" class="set-base-url usa-sr-only" accesskey="2" tabindex="-1">MyNCBI Homepage</a>
<a id="nws_header_accesskey_3" href="#maincontent" class="usa-sr-only" accesskey="3" tabindex="-1">Main Content</a>
<a id="nws_header_accesskey_4" href="#" class="usa-sr-only" accesskey="4" tabindex="-1">Main Navigation</a>
</div>
<section data-section="Alerts">
	<div class="ncbi-alerts-placeholder"></div>
</section>
<!-- ========== END HEADER ========== -->

    
    


    
        

<section class="pmc-alerts">
    
    <div role="alert" class="pmc-alert pmc-alert--info" role="region" aria-label="Alert" aria-hidden="false"  data-key="pmc-alert-welcome">
        <div class="pmc-alert__body pmc-alert--ncbi-icon">
            <div class="pmc-alert__content">
                <p>
                    <strong>
                        Preview improvements coming to the PMC website in October 2024.
                        <a href="https://ncbiinsights.ncbi.nlm.nih.gov/2024/03/14/preview-pmc-improvements/" data-ga-category="cloud_beta_banner" data-ga-label="learn_more" data-ga-action="on_pmc2020">Learn More</a> or
                        <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC7488363/" data-ga-category="cloud_beta_banner" data-ga-action="on_pmc2020" data-ga-label="go_to_cloud">Try it out now</a>.
                    </strong>
                </p>
            </div>
        </div>
    </div>
    
</section>
    

    
    
        
        <header class="pmc-header usa-header-extended" role="banner">
    <div class="pmc-header__bar">
        <div class="pmc-header__control usa-accordion">
            
                <button class="usa-menu-btn pmc-header--button pmc-header--left">
                    <i class="fa fa-ellipsis-v" aria-hidden="true"></i>
                </button>
            

            <div class="usa-logo pmc-header__logo pmc-header--stretch
                
               " id="extended-mega-logo">
                <div class="usa-logo-text">
                    <a href="/pmc/" title="Home" aria-label="Home" ></a>
                </div>
            </div>
            <button class="usa-accordion-button pmc-header--right pmc-header--button pmc-header__search--control pmc-header--right" aria-expanded="false" aria-controls="a1">
                <i class="fa fa-search" aria-hidden="true"></i>
                <i class="fa fa-times" aria-hidden="true"></i>
            </button>
        </div>
        <div class="pmc-header__search usa-accordion-content" id="a1">
            <div role="search"  class="pmc-header--stretch"  >
    <form class="usa-search " autocomplete="off">
        <div>
              <label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
              <span class="clearable">
                <input
                  required="required"
                  autocomplete-url="/pmc/autocomplete/pmc/"
                  placeholder="Search PMC Full-Text Archive"
                  id="pmc-search" type="search" name="term"/>
                  <i class="clear-btn" ></i>
              </span>
              <button type="submit" formaction="/pmc/">
                <span class="usa-search-submit-text">Search in PMC</span>
              </button>
        </div>
    </form>
</div>


            <ul class="usa-unstyled-list usa-nav-secondary-links pmc-header--offset-two">
                    <li>
                        <a href="https://www.ncbi.nlm.nih.gov/pmc/advanced" data-ga-action="featured_link" data-ga-label="advanced_search">
                            Advanced Search
                        </a>
                    </li>
                    <li>
                        <a  href="/pmc/about/userguide/" data-ga-action="featured_link"
                        data-ga-label="user guide">
                            User Guide
                        </a>
                    </li>
            </ul>
        </div>
    </div>
     <nav role="navigation" class="usa-nav ">
        <button class="usa-nav-close">
            <i class="fa fa-times" aria-hidden="true"></i>
        </button>
        <div class="usa-breadcrumb usa-breadcrumb--wrap usa-breadcrumb--hack">
             
    <ul class="usa-breadcrumb__list">
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a href="/pmc/journals/" class="navlink">Journal List</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a class="navlink" href="/pmc/journals/2814/">Acta Pharm Sin B</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a class="navlink" href="/pmc/issues/365107/">v.10(8); 2020 Aug</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                     aria-current="page" >
                    PMC7488363
                </li>
            
    </ul>
 

        </div>
        
        
            <div class="pmc-sidebar pmc-sidebar-hack">
                

<div class="scroller">

    
        <section>
                <h6>Other Formats</h6>
                <ul class="pmc-sidebar__formats">
                  <li class="pdf-link other_item"><a href="/pmc/articles/PMC7488363/pdf/main.pdf" class="int-view">PDF (1.0M)</a></li>
                </ul>
        </section>
    
    <section>
        <h6>Actions</h6>
        <ul class="pmc-sidebar__actions">
            <li>
                <button role="button" class="citation-button citation-dialog-trigger ctxp"
                        aria-label="Open dialog with citation text in different styles" data-ga-category="save_share" data-ga-action="cite" data-ga-label="open"
                        data-all-citations-url="/pmc/resources/citations/7488363/"
                        data-citation-style="nlm"
                        data-download-format-link="/pmc/resources/citations/7488363/export/"
                >
                    <span class="button-label">Cite</span>
                </button>
            </li>
            <li>
                
                    

<link type="text/css" href="ncbi-overlay-block/src/overlay-block.css">
<div class="collections-button-container" data-article-id="7488363" data-article-db="pmc">
  <button class="collections-button collections-dialog-trigger"
          aria-label="Save article in MyNCBI collections."
          data-ga-category="collections_button"
          data-ga-action="click"
          data-ga-label="collections_button"
          data-collections-open-dialog-enabled="false"
          data-collections-open-dialog-url="https://www.ncbi.nlm.nih.gov/account?back_url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7488363%2F%23open-collections-dialog"
          data-in-collections="false">
      <span class="button-label">Collections</span>
  </button>
  <div class="overlay" role="dialog">
  <div id="collections-action-dialog"
       class="dialog collections-dialog"
       aria-hidden="true">
    <div class="title">Add to Collections</div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/pmc/list-existing-collections/"
      data-add-to-existing-collection-url="/pmc/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/pmc/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

  <input type="hidden" name="csrfmiddlewaretoken" value="wRGGwkdqjTdJZ0IdWxpInHoMEdTTIL6ZpXMZ3quXvJTueZHBknczgrcZStlpcFOZ">

  

  <div class="choice-group" role="radiogroup">
    <ul class="radio-group-items">
      <li>
        <input type="radio"
               id="collections-action-dialog-new-header "
               class="collections-new"
               name="collections"
               value="new"
               data-ga-category="collections_button"
               data-ga-action="click"
               data-ga-label="collections_radio_new">
        <label for="collections-action-dialog-new-header ">Create a new collection</label>
      </li>
      <li>
        <input type="radio"
               id="collections-action-dialog-existing-header "
               class="collections-existing"
               name="collections"
               value="existing"
               checked="true"
               data-ga-category="collections_button"
               data-ga-action="click"
               data-ga-label="collections_radio_existing">
        <label for="collections-action-dialog-existing-header ">Add to an existing collection</label>
      </li>
    </ul>
  </div>

  <div class="controls-wrapper">
    <div class="action-panel-control-wrap new-collections-controls">
      <label for="collections-action-dialog-add-to-new" class="action-panel-label required-field-asterisk">
        Name your collection:
      </label>
      <input
        type="text"
        name="add-to-new-collection"
        id="collections-action-dialog-add-to-new"
        class="collections-action-add-to-new"
        pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
        maxlength=""
        data-ga-category="collections_button"
        data-ga-action="create_collection"
        data-ga-label="non_favorties_collection">
      <div class="collections-new-name-too-long usa-input-error-message selection-validation-message">
        Name must be less than  characters
      </div>
    </div>
    <div class="action-panel-control-wrap existing-collections-controls">
      <label for="collections-action-dialog-add-to-existing" class="action-panel-label">
        Choose a collection:
      </label>
      <select id="collections-action-dialog-add-to-existing"
              class="action-panel-selector collections-action-add-to-existing"
              data-ga-category="collections_button"
              data-ga-action="select_collection"
              data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
      </select>
      <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
        Unable to load your collection due to an error<br>
        <a href="#">Please try again</a>
      </div>
    </div>
  </div>

  <div class="action-panel-actions">
    <button class="action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
      Add
    </button>
    <button class="action-panel-cancel"
            aria-label="Close 'Add to Collections' panel"
            ref="linksrc=close_collections_panel"
            aria-controls="collections-action-panel"
            aria-expanded="false"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="cancel">
      Cancel
    </button>
  </div>
</form>
    </div>
  </div>
</div>
</div>
                
            </li>

        </ul>
    </section>
    
        <section class="social-sharing">
            <h6>Share</h6>
            <ul class="pmc-sidebar__share">
                <li><a class="fa-stack fa-lg" target="_blank" rel="noopener noreferrer" role="button" href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7488363%2F&amp;text=Gene%20therapy%20for%20neurodegenerative%20disorders%3A%20advances%2C%20insights%20and%20prospects" alt="Share on Twitter"><i class="fa fa-twitter fa-stack-1x">&#160;</i></a></li> 
<li><a class="fa-stack fa-lg" target="_blank" rel="noopener noreferrer" role="button" href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7488363%2F" alt="Share on Facebook"><i class="fa fa-facebook fa-stack-1x">&#160;</i></a></li>
                <li>
                    <div class="share-permalink">
                        <button class="trigger"  alt="Show article permalink" aria-expanded="false" aria-haspopup="true">
                            <i class="fa-stack fa-lg" >
                                <i class="fa fa-link fa-stack-1x">&nbsp;</i>
                            </i>
                        </button>
                        <div class="dropdown dropdown-container" hidden>
                              <div class="title">
                                Permalink
                              </div>
                              <div class="content">
                                  <input type="text" class="permalink-text" value="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7488363/" aria-label="Article permalink"><button class="permalink-copy-button usa-button-primary" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                                      <span class="button-title">Copy</span>
                                  </button>
                              </div>
                        </div>
                    </div>
                </li>
            </ul>
        </section>
    
    <section>
        <h6>RESOURCES</h6>
        <ul class="pmc-sidebar__resources">
        
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_similar_articles"
                            data-ga-label="/pmc/articles/PMC7488363/"
                            class="usa-accordion-button"
                            aria-controls="similar-articles-accordion-header"
                            aria-expanded="false"
                            data-action-open="open_similar_articles"
                            data-action-close="close_similar_articles"
                    >
                        Similar articles
                    </button>
                    <div
                            
                                data-source-url="/pmc/resources/similar-article-links/32963936/"
                            

                         class="usa-accordion-content pmc-sidebar__resources--citations" id="similar-articles-accordion-header" aria-hidden="true">
                        
                    </div>
                </div>
            </li>
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_cited_by"
                            data-ga-label="/pmc/articles/PMC7488363/"
                            class="usa-accordion-button"
                            aria-controls="cited-by-accordion-header"
                            aria-expanded="false"
                            data-action-open="open_cited_by"
                            data-action-close="close_cited_by"
                    >
                        Cited by other articles
                    </button>
                    <div
                            
                                data-source-url="/pmc/resources/cited-by-links/32963936/"
                            
                            class="usa-accordion-content pmc-sidebar__resources--citations"
                            id="cited-by-accordion-header"
                            aria-hidden="true"
                    >
                        
                    </div>
                </div>
            </li>
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/pmc/articles/PMC7488363/"
                            class="usa-accordion-button"
                            aria-controls="links-accordion-header"
                            aria-expanded="false"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                    >
                        Links to NCBI Databases
                    </button>
                    <div data-source-url="/pmc/resources/db-links/7488363/" class="usa-accordion-content" id="links-accordion-header" aria-hidden="true"></div>
                </div>
            </li>

            
        
        </ul>
    </section>

 </div>
            </div>
        

    </nav>

</header>

    
    

    <div class="usa-overlay"></div>
    
<main id="main-content" class="usa-grid usa-layout-docs pmc-main">
    <article class="usa-width-three-fourths usa-layout-docs-main_content pmc-article">
        <section class="usa-breadcrumb usa-breadcrumb--wrap">
         
    <ul class="usa-breadcrumb__list">
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a href="/pmc/journals/" class="navlink">Journal List</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a class="navlink" href="/pmc/journals/2814/">Acta Pharm Sin B</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a class="navlink" href="/pmc/issues/365107/">v.10(8); 2020 Aug</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                     aria-current="page" >
                    PMC7488363
                </li>
            
    </ul>
 

        </section>
        
  <div class="pmc-article__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/pmc/about/disclaimer/">PMC Disclaimer</a>
    |
    <a data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/pmc/about/copyright/">
        PMC Copyright Notice
    </a>
</div>

        <section class="pmc-page-banner" role="banner">
            
                
                    <div><img src="/corehtml/pmc/pmcgifs/logo-apsb.gif" alt="Logo of apsb" usemap="#logo-imagemap" /><map id="logo-imagemap" name="logo-imagemap"><area target="pmc_ext" rel="noopener noreferrer" shape="rect" coords="6,31,115,50" alt="Guide for Authors" title="Guide for Authors" href="http://www.elsevier.com/journals/acta-pharmaceutica-sinica-b/2211-3835/guide-for-authors" ref="reftype=publisher&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" /><area target="pmc_ext" rel="noopener noreferrer" shape="rect" coords="121,32,162,50" alt="About this journal" title="About this journal" href="http://www.journals.elsevier.com/acta-pharmaceutica-sinica-b" ref="reftype=publisher&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" /><area target="pmc_ext" rel="noopener noreferrer" shape="rect" coords="169,32,284,51" alt="Explore this journal" title="Explore this journal" href="http://www.sciencedirect.com/science/journal/22113835" ref="reftype=publisher&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" /><area target="pmc_ext" rel="noopener noreferrer" shape="rect" coords="0,0,499,74" alt="Acta Pharmaceutica Sinica. B" title="Acta Pharmaceutica Sinica. B" href="http://www.sciencedirect.com/science/journal/22113835" ref="reftype=publisher&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" /></map></div> 
                
            
        </section>
        <section  role="document">
            
                <div id="mc" class=" article lit-style content pmc-wm slang-all page-box"><!--main-content--><div class="jig-ncbiinpagenav" data-jigconfig="smoothScroll: false, allHeadingLevels: ['h2'], headingExclude: ':hidden,.nomenu'"><div class="fm-sec half_rhythm no_top_margin"><div class="fm-flexbox"><div class="fm-citation"><div class="citation-default"><div class="part1"><span id="pmcmata">Acta Pharm Sin B.</span> 2020 Aug; 10(8): 1347–1359. </div><div class="part2"><span class="fm-vol-iss-date">Published online 2020 Jan 31. </span>  <span class="doi"><span>doi: </span><a href="//doi.org/10.1016%2Fj.apsb.2020.01.015" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CCrosslink%7CDOI">10.1016/j.apsb.2020.01.015</a></span></div></div></div><div class="fm-ids"><div class="fm-citation-pmcid"><span class="fm-citation-ids-label">PMCID: </span><span>PMC7488363</span></div><div class="fm-citation-pmid">PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/32963936">32963936</a></div></div></div><h1 class="content-title">Gene therapy for neurodegenerative disorders: advances, insights and prospects</h1><div class="half_rhythm"><div class="contrib-group fm-author"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=Chen%20W%5BAuthor%5D" id="au1" class="affpopup" co-rid="_co_idm139752576232416" co-class="co-affbox">Wei Chen</a>,<sup>a,</sup><sup>b</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Hu%20Y%5BAuthor%5D" id="au2" class="affpopup" co-rid="_co_idm139752576231168" co-class="co-affbox">Yang Hu</a>,<sup>b,</sup><sup>&#x02217;</sup> and  <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Ju%20D%5BAuthor%5D" id="au3" class="affpopup" co-rid="_co_idm139752596681664" co-class="co-affbox">Dianwen Ju</a><sup>a,</sup><sup>&#x02217;</sup></div><div style="display:none" class="contrib-group aff-tip"><div id="_co_idm139752576232416"><h3 class="no_margin">Wei Chen</h3><p><sup>a</sup>Department of Biological Medicines, Fudan University School of Pharmacy, Shanghai 201203, China</p><p><sup>b</sup>Department of Ophthalmology, Stanford University School of Medicine, Palo Alto, CA 94304, USA</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Chen%20W%5BAuthor%5D">Wei Chen</a></div></div><div id="_co_idm139752576231168"><h3 class="no_margin">Yang Hu</h3><p><sup>b</sup>Department of Ophthalmology, Stanford University School of Medicine, Palo Alto, CA 94304, USA</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Hu%20Y%5BAuthor%5D">Yang Hu</a></div></div><div id="_co_idm139752596681664"><h3 class="no_margin">Dianwen Ju</h3><p><sup>a</sup>Department of Biological Medicines, Fudan University School of Pharmacy, Shanghai 201203, China</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Ju%20D%5BAuthor%5D">Dianwen Ju</a></div></div></div></div><div class="half_rhythm"><div class="togglers fm-copyright-license"><a href="#" class="pmctoggle" rid="idm139752591832768_ai">Author information</a> <a href="#" class="pmctoggle" rid="idm139752591832768_an">Article notes</a> <a href="#" class="pmctoggle" rid="idm139752591832768_cpl">Copyright and License information</a> <a href="/pmc/about/disclaimer/" style="margin-left: 1em">PMC Disclaimer</a></div><div class="fm-authors-info hide half_rhythm" id="idm139752591832768_ai" style="display:none"><div class="fm-affl" id="aff1"><sup>a</sup>Department of Biological Medicines, Fudan University School of Pharmacy, Shanghai 201203, China</div><div class="fm-affl" id="aff2"><sup>b</sup>Department of Ophthalmology, Stanford University School of Medicine, Palo Alto, CA 94304, USA</div><div><span class="contrib-email" id="au2">Yang Hu: <a href="mailto:dev@null" data-email="ude.drofnats@gnayuh" class="oemail">ude.drofnats@gnayuh</a>; </span> <span class="contrib-email" id="au3">Dianwen Ju: <a href="mailto:dev@null" data-email="nc.ude.naduf@ujnewnaid" class="oemail">nc.ude.naduf@ujnewnaid</a></span> </div><div id="cor1"><sup>&#x02217;</sup>Corresponding authors. Tel.: +1 650 7243941, fax: +1 650 4977936 (Yang Hu); Tel.: +86 21 51980037, fax: +86 21 51980036 (Dianwen Ju). <a href="mailto:dev@null" data-email="ude.drofnats@gnayuh" class="oemail">ude.drofnats@gnayuh</a><span style="unicode-bidi:bidi-override">, </span><a href="mailto:dev@null" data-email="nc.ude.naduf@ujnewnaid" class="oemail">nc.ude.naduf@ujnewnaid</a></div></div><div class="fm-article-notes hide half_rhythm" id="idm139752591832768_an" style="display:none"><div class="fm-pubdate half_rhythm">Received 2019 Oct 14; Revised 2019 Nov 9; Accepted 2019 Dec 6.</div></div><div class="permissions half_rhythm hide" id="idm139752591832768_cpl" style="display:none"><div class="fm-copyright half_rhythm"><a href="/pmc/about/copyright/">Copyright</a> &#x000a9; 2020 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences. Production and hosting by Elsevier B.V.</div><div class="license half_rhythm">This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).</div></div></div><div id="pmclinksbox" class="links-box whole_rhythm hidden" role="complementary" aria-label="Related or updated information about this article."></div></div><div class="sec"></div><div id="abs0010" lang="en" class="tsec sec"><h2 class="head no_bottom_margin" id="abs0010title">Abstract</h2><!--article-meta--><div><p class="p p-first-last">Gene therapy is rapidly emerging as a powerful therapeutic strategy for a wide range of neurodegenerative disorders, including Alzheimer's disease (AD), Parkinson's disease (PD) and Huntington's disease (HD). Some early clinical trials have failed to achieve satisfactory therapeutic effects. Efforts to enhance effectiveness are now concentrating on three major fields: identification of new vectors, novel therapeutic targets, and reliable of delivery routes for transgenes. These approaches are being assessed closely in preclinical and clinical trials, which may ultimately provide powerful treatments for patients. Here, we discuss advances and challenges of gene therapy for neurodegenerative disorders, highlighting promising technologies, targets, and future prospects.</p></div><div class="sec"><strong class="kwd-title">Key words: </strong><span class="kwd-text">Gene therapy, Neurodegenerative disorders, Adeno-associated viruses, Central nervous system, Delivery routes</span></div><div class="sec"><strong class="kwd-title">Abbreviations: </strong><span class="kwd-text">AADC, aromatic-<span class="small-caps">l</span>-amino-acid; AAVs, adeno-associated viruses; AD, Alzheimer's disease; Adv, adenovirus; ARSA, arylsulfatase A; ASOs, antisense oligonucleotides; ASPA, aspartoacylase; BBB, blood&#x02013;brain barrier; BCSFB, blood&#x02013;cerebrospinal fluid barrier; Bip, glucose regulated protein 78; BRB, blood&#x02013;retina barrier; CHOP, CCAAT/enhancer binding homologous protein; CLN6, ceroidlipofuscinosis neuronal protein 6; CNS, central nervous system; CSF, cerebrospinal fluid; ER, endoplasmic reticulum; FDA, U.S. Food and Drug Administration; GAA, lysosomal acid <em>&#x003b1;</em>-glucosidase; GAD, glutamic acid decarboxylase; GDNF, glial derived neurotrophic factor; HD, Huntington's disease; HSPGs, heparin sulfate proteoglycans; HTT, mutant huntingtin; IDS, iduronate 2-sulfatase; Lamp2a, lysosomal-associated membrane protein 2a; LVs, retrovirus/lentivirus; mTOR, mammalian target of rapamycin; NGF, nerve growth factor; PD, Parkinson's disease; PGRN, Progranulin; PINK1, putative kinase 1; PTEN, phosphatase and tensin homolog; RGCs, retinal ganglion cells; RNAi, RNA interference; RPE, retinal pigmented epithelial; SGSH, lysosomal heparan-<em>N</em>-sulfamidase gene; siRNA, small interfering RNA; SMN, survival motor neuron; SOD, superoxide dismutase; SUMF, sulfatase-modifying factor; TFEB, transcription factor EB; TPP1, tripeptidyl peptidase 1; TREM2, triggering receptor expressed on myeloid cells 2; UPR, unfolded protein response; ZFPs, zinc finger proteins</span></div></div><div id="abs0015" lang="en" class="tsec sec"><h2 class="head no_bottom_margin" id="abs0015title">Graphical abstract</h2><!--article-meta--><div><p class="p p-first-last">Gene therapy for neurodegenerative disorders has made the unprecedented progress. This review summarizes advances and challenges of gene therapy for neurodegenerative disorders, highlighting promising technologies, targets, and future prospects with the authors&#x02019; insights and experience.<!--fig ft0--><!--fig @position="anchor" mode=article f4--><!--fig mode="anchored" f5--></p><div class="fig  iconblock anchored whole_rhythm" id="undfig1"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm139752601407808"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=7488363_fx1.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="Image 1" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC7488363/bin/fx1.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm139752601407808"><a target="object" rel="noopener" href="/pmc/articles/PMC7488363/figure/undfig1/?report=objectonly">Open in a separate window</a></div></div><p></p></div></div><div id="sec1" class="tsec sec"><h2 class="head no_bottom_margin" id="sec1title">1. Introduction</h2><p id="p0245" class="p p-first">Over the past few decades, gene therapy for neurodegenerative disorders has made straightforward progress. Growing understanding of the pathogenetic mechanisms of these diseases has enabled numerous advances in key technologies to converge including identification of novel therapeutic targets and new vectors<a href="#bib1" rid="bib1" class=" bibr popnode"><sup>1</sup></a>. This increased knowledge has led to remarkable targeting by multiple genetic interventions of the root causes of neurodegenerative disorders with both single-gene and complex etiologies. The sustained, even permanent therapeutic effects of gene therapy are especially appealing for compartmentalized organs such as eye, cochlea or central nervous system (CNS), which structures are difficult to treat because most agents cannot breach the physiological barriers such as the blood&#x02013;cerebrospinal fluid barrier (BCSFB), blood&#x02013;retina barrier (BRB), and blood&#x02013;brain barrier (BBB)<a href="#bib2" rid="bib2" class=" bibr popnode">2</a>, <a href="#bib3" rid="bib3" class=" bibr popnode">3</a>, <a href="#bib4" rid="bib4" class=" bibr popnode">4</a>. Furthermore, some genetic targets that are refractory to treatment with traditional agents are potentially manageable by gene therapy, which is capable of both gene silencing to handle gain of function mutations and gene overexpression to handle loss of function mutations.</p><p id="p0250">Viral and non-viral vectors can successfully direct transgenes that express therapeutic proteins, antibodies, Cas9/gRNA for gene editing, microRNAs, and small interfering RNA (siRNA) to diseased tissues in human and animals. For neurodegenerative disorders, the most commonly applied vector is one of the adeno-associated viruses (AAVs)<a href="#bib5" rid="bib5" class=" bibr popnode"><sup>5</sup></a>. Additionally, a large number of capsids can be employed across species to favorably target multiple tissues and cells within the CNS, including oligodendrocytes, astrocytes and neurons<a href="#bib6" rid="bib6" class=" bibr popnode">6</a>, <a href="#bib7" rid="bib7" class=" bibr popnode">7</a>, <a href="#bib8" rid="bib8" class=" bibr popnode">8</a>, <a href="#bib9" rid="bib9" class=" bibr popnode">9</a>, <a href="#bib10" rid="bib10" class=" bibr popnode">10</a>, <a href="#bib11" rid="bib11" class=" bibr popnode">11</a>, <a href="#bib12" rid="bib12" class=" bibr popnode">12</a>, <a href="#bib13" rid="bib13" class=" bibr popnode">13</a>.</p><p id="p0255">It is critical that there have been significant advances in developing effective delivery routes, especially for the CNS and eye. Preclinical studies have demonstrated that numerous routes of gene delivery, including subpial, intracerebroventricular, intrathecal, intraparenchymal, intravitreal, and subretinal injection, can attain sufficient gene quantities in diseased tissues<a href="#bib14" rid="bib14" class=" bibr popnode">14</a>, <a href="#bib15" rid="bib15" class=" bibr popnode">15</a>, <a href="#bib16" rid="bib16" class=" bibr popnode">16</a>, <a href="#bib17" rid="bib17" class=" bibr popnode">17</a>. Intravenous injection has the advantage of being noninvasive, but the BBB and BRB are troublesome obstacles to the passage of agents into CNS or optic nerve<a href="#bib18" rid="bib18" class=" bibr popnode"><sup>18</sup></a>. Intramuscular injection provides an effective route for the delivery and production of vaccines and antibodies, and has the theoretical capacity to supply a source of antibodies that permit treatments to cross these physiological barriers in sufficient levels for clinical benefits<a href="#bib19" rid="bib19" class=" bibr popnode"><sup>19</sup></a>. It is noteworthy that recently reported vectors have an unequaled capability to transfer genes to the CNS after systemic injection. These vectors are an obvious improvement over AAV9 and potentially enhance our ability to treat additional neurological disorders<a href="#bib20" rid="bib20" class=" bibr popnode"><sup>20</sup></a><sup>,</sup><a href="#bib21" rid="bib21" class=" bibr popnode"><sup>21</sup></a>.</p><p id="p0260" class="p p-last">There have been a considerable number of clinical trials of gene therapy for neurodegenerative disorders (<a href="/pmc/articles/PMC7488363/table/tbl1/" target="table" class="fig-table-link figpopup" rid-figpopup="tbl1" rid-ob="ob-tbl1" co-legend-rid=""><span>Table 1</span></a>). Some early clinical trials failed to achieve satisfactory therapeutic effects, perhaps due to insufficient biodistribution within their intended tissues. With improvement in AAVs and non-viral delivery systems, gene therapies have shown wider transgene expression and therapeutic safety. Importantly, there have been recent reports of excellent functional outcomes in experimental models of numerous neurodegenerative disorders, including Alzheimer's disease (AD), Huntington's disease (HD), aromatic-<span class="small-caps">l</span>-amino-acid decarboxylase (AADC) deficiency, and Parkinson's disease (PD)<a href="#bib5" rid="bib5" class=" bibr popnode"><sup>5</sup></a><sup>,</sup><a href="#bib22" rid="bib22" class=" bibr popnode">22</a>, <a href="#bib23" rid="bib23" class=" bibr popnode">23</a>, <a href="#bib24" rid="bib24" class=" bibr popnode">24</a>, <a href="#bib25" rid="bib25" class=" bibr popnode">25</a>. Here we review clinical and preclinical studies to describe recent advances in gene therapy for neurodegenerative disorders. We focus on the critical properties that efficient treatment by gene therapy requires, including vector design and selection of transgene strategy, target, and delivery route. We also discuss the challenges and future prospects of gene therapy, and share our own insights and experience.</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap anchored whole_rhythm" id="tbl1"><h3>Table 1</h3><!--caption a7--><div class="caption"><p>Ongoing gene therapy clinical trials for neurodegenerative disorders.</p></div><div class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><th rowspan="1" colspan="1">Disorders</th><th rowspan="1" colspan="1">Trial code</th><th rowspan="1" colspan="1">Delivery route</th><th rowspan="1" colspan="1">Gene therapy</th><th rowspan="1" colspan="1">Phase</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">Alzheimer's disease</td><td rowspan="1" colspan="1"><a id="__tag_881094976" class="tag_hotlink" href="https://clinicaltrials.gov/ct2/show/NCT00876863" ref="reftype=extlink-clinical-trial&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CBody&amp;TO=External%7CResource%7CClinical%20Trials%7CClinicalTrials.gov"><span class="tag-json" style="display:none">{"type":"clinical-trial","attrs":{"text":"NCT00876863","term_id":"NCT00876863"}}</span>NCT00876863</a></td><td rowspan="1" colspan="1">Direct basal forebrain injection</td><td rowspan="1" colspan="1">AAV2-NGF</td><td rowspan="1" colspan="1">Phase &#x02161;</td></tr><tr><td rowspan="1" colspan="1">Huntington's disease</td><td rowspan="1" colspan="1"><a id="__tag_881094971" class="tag_hotlink" href="https://clinicaltrials.gov/ct2/show/NCT02519036" ref="reftype=extlink-clinical-trial&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CBody&amp;TO=External%7CResource%7CClinical%20Trials%7CClinicalTrials.gov"><span class="tag-json" style="display:none">{"type":"clinical-trial","attrs":{"text":"NCT02519036","term_id":"NCT02519036"}}</span>NCT02519036</a></td><td rowspan="1" colspan="1">Intrathecal injection</td><td rowspan="1" colspan="1">ASOs to HTT messenger RNA</td><td rowspan="1" colspan="1">Phase &#x02162;</td></tr><tr><td rowspan="1" colspan="1">Huntington's disease</td><td rowspan="1" colspan="1"><a id="__tag_881094972" class="tag_hotlink" href="https://clinicaltrials.gov/ct2/show/NCT03225833" ref="reftype=extlink-clinical-trial&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CBody&amp;TO=External%7CResource%7CClinical%20Trials%7CClinicalTrials.gov"><span class="tag-json" style="display:none">{"type":"clinical-trial","attrs":{"text":"NCT03225833","term_id":"NCT03225833"}}</span>NCT03225833</a><br /><a id="__tag_881094959" class="tag_hotlink" href="https://clinicaltrials.gov/ct2/show/NCT03225846" ref="reftype=extlink-clinical-trial&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CBody&amp;TO=External%7CResource%7CClinical%20Trials%7CClinicalTrials.gov"><span class="tag-json" style="display:none">{"type":"clinical-trial","attrs":{"text":"NCT03225846","term_id":"NCT03225846"}}</span>NCT03225846</a></td><td rowspan="1" colspan="1">Intrathecal injection</td><td rowspan="1" colspan="1">ASOs to HTT mutant pre-messenger RNA</td><td rowspan="1" colspan="1">Phase &#x02160;</td></tr><tr><td rowspan="1" colspan="1">Pompe's disease</td><td rowspan="1" colspan="1"><a id="__tag_881094981" class="tag_hotlink" href="https://clinicaltrials.gov/ct2/show/NCT02240407" ref="reftype=extlink-clinical-trial&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CBody&amp;TO=External%7CResource%7CClinical%20Trials%7CClinicalTrials.gov"><span class="tag-json" style="display:none">{"type":"clinical-trial","attrs":{"text":"NCT02240407","term_id":"NCT02240407"}}</span>NCT02240407</a></td><td rowspan="1" colspan="1">Intramuscular injection</td><td rowspan="1" colspan="1">AAV9-GAA</td><td rowspan="1" colspan="1">No results</td></tr><tr><td rowspan="1" colspan="1">Pompe's disease</td><td rowspan="1" colspan="1"><a id="__tag_881094967" class="tag_hotlink" href="https://clinicaltrials.gov/ct2/show/NCT00976352" ref="reftype=extlink-clinical-trial&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CBody&amp;TO=External%7CResource%7CClinical%20Trials%7CClinicalTrials.gov"><span class="tag-json" style="display:none">{"type":"clinical-trial","attrs":{"text":"NCT00976352","term_id":"NCT00976352"}}</span>NCT00976352</a></td><td rowspan="1" colspan="1">Intramuscular injection</td><td rowspan="1" colspan="1">AAV1-GAA</td><td rowspan="1" colspan="1">Phase &#x02161;</td></tr><tr><td rowspan="1" colspan="1">Parkinson's disease</td><td rowspan="1" colspan="1"><a id="__tag_881094980" class="tag_hotlink" href="https://clinicaltrials.gov/ct2/show/NCT03065192" ref="reftype=extlink-clinical-trial&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CBody&amp;TO=External%7CResource%7CClinical%20Trials%7CClinicalTrials.gov"><span class="tag-json" style="display:none">{"type":"clinical-trial","attrs":{"text":"NCT03065192","term_id":"NCT03065192"}}</span>NCT03065192</a><br /><a href="https://clinicaltrials.gov/ct2/show/NCT01793543" data-ga-action="click_feat_suppl" ref="reftype=extlink-ClinicalTrials.gov&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CBody&amp;TO=External%7CResource%7CClinical%20Trials%7CClinicalTrials.gov" target="_blank">NCT01793543</a></td><td rowspan="1" colspan="1">Intraputaminal injection</td><td rowspan="1" colspan="1">AAV2-AADC</td><td rowspan="1" colspan="1">Phase &#x02160;</td></tr><tr><td rowspan="1" colspan="1">Parkinson's disease</td><td rowspan="1" colspan="1"><a id="__tag_881094973" class="tag_hotlink" href="https://clinicaltrials.gov/ct2/show/NCT01621581" ref="reftype=extlink-clinical-trial&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CBody&amp;TO=External%7CResource%7CClinical%20Trials%7CClinicalTrials.gov"><span class="tag-json" style="display:none">{"type":"clinical-trial","attrs":{"text":"NCT01621581","term_id":"NCT01621581"}}</span>NCT01621581</a></td><td rowspan="1" colspan="1">Intraputaminal injection</td><td rowspan="1" colspan="1">AAV2-GDNF</td><td rowspan="1" colspan="1">Phase &#x02160;</td></tr><tr><td rowspan="1" colspan="1">Parkinson's disease</td><td rowspan="1" colspan="1"><a id="__tag_881094977" class="tag_hotlink" href="https://clinicaltrials.gov/ct2/show/NCT02418598" ref="reftype=extlink-clinical-trial&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CBody&amp;TO=External%7CResource%7CClinical%20Trials%7CClinicalTrials.gov"><span class="tag-json" style="display:none">{"type":"clinical-trial","attrs":{"text":"NCT02418598","term_id":"NCT02418598"}}</span>NCT02418598</a></td><td rowspan="1" colspan="1">Intraputaminal injection</td><td rowspan="1" colspan="1">AAV2-AADC</td><td rowspan="1" colspan="1">Phase &#x02161;</td></tr><tr><td rowspan="1" colspan="1">Parkinson's disease</td><td rowspan="1" colspan="1"><a id="__tag_881094982" class="tag_hotlink" href="https://clinicaltrials.gov/ct2/show/NCT00400634" ref="reftype=extlink-clinical-trial&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CBody&amp;TO=External%7CResource%7CClinical%20Trials%7CClinicalTrials.gov"><span class="tag-json" style="display:none">{"type":"clinical-trial","attrs":{"text":"NCT00400634","term_id":"NCT00400634"}}</span>NCT00400634</a><br /><a id="__tag_881094966" class="tag_hotlink" href="https://clinicaltrials.gov/ct2/show/NCT00985517" ref="reftype=extlink-clinical-trial&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CBody&amp;TO=External%7CResource%7CClinical%20Trials%7CClinicalTrials.gov"><span class="tag-json" style="display:none">{"type":"clinical-trial","attrs":{"text":"NCT00985517","term_id":"NCT00985517"}}</span>NCT00985517</a></td><td rowspan="1" colspan="1">Intraputaminal injection</td><td rowspan="1" colspan="1">AAV2-neurturin</td><td rowspan="1" colspan="1">Phase &#x02161;</td></tr><tr><td rowspan="1" colspan="1">Parkinson's disease</td><td rowspan="1" colspan="1"><a id="__tag_881094961" class="tag_hotlink" href="https://clinicaltrials.gov/ct2/show/NCT00627588" ref="reftype=extlink-clinical-trial&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CBody&amp;TO=External%7CResource%7CClinical%20Trials%7CClinicalTrials.gov"><span class="tag-json" style="display:none">{"type":"clinical-trial","attrs":{"text":"NCT00627588","term_id":"NCT00627588"}}</span>NCT00627588</a></td><td rowspan="1" colspan="1">Intraputaminal injection</td><td rowspan="1" colspan="1">Lentivirus-AADC</td><td rowspan="1" colspan="1">Phase &#x02160;</td></tr><tr><td rowspan="1" colspan="1">Parkinson's disease</td><td rowspan="1" colspan="1"><a id="__tag_881094960" class="tag_hotlink" href="https://clinicaltrials.gov/ct2/show/NCT00643890" ref="reftype=extlink-clinical-trial&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CBody&amp;TO=External%7CResource%7CClinical%20Trials%7CClinicalTrials.gov"><span class="tag-json" style="display:none">{"type":"clinical-trial","attrs":{"text":"NCT00643890","term_id":"NCT00643890"}}</span>NCT00643890</a></td><td rowspan="1" colspan="1">Injection into the subthalamic nucleus</td><td rowspan="1" colspan="1">AAV2-GAD</td><td rowspan="1" colspan="1">Phase &#x02161;</td></tr><tr><td rowspan="1" colspan="1">Metachromic leukodystrophy</td><td rowspan="1" colspan="1"><a id="__tag_881094969" class="tag_hotlink" href="https://clinicaltrials.gov/ct2/show/NCT01801709" ref="reftype=extlink-clinical-trial&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CBody&amp;TO=External%7CResource%7CClinical%20Trials%7CClinicalTrials.gov"><span class="tag-json" style="display:none">{"type":"clinical-trial","attrs":{"text":"NCT01801709","term_id":"NCT01801709"}}</span>NCT01801709</a></td><td rowspan="1" colspan="1">Intracerebral injection</td><td rowspan="1" colspan="1">AAVrh10-ARSA</td><td rowspan="1" colspan="1">No results</td></tr><tr><td rowspan="1" colspan="1">Spinal muscular atrophy</td><td rowspan="1" colspan="1"><a id="__tag_881094968" class="tag_hotlink" href="https://clinicaltrials.gov/ct2/show/NCT02122952" ref="reftype=extlink-clinical-trial&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CBody&amp;TO=External%7CResource%7CClinical%20Trials%7CClinicalTrials.gov"><span class="tag-json" style="display:none">{"type":"clinical-trial","attrs":{"text":"NCT02122952","term_id":"NCT02122952"}}</span>NCT02122952</a></td><td rowspan="1" colspan="1">Intravenous injection</td><td rowspan="1" colspan="1">AAV9-SMN</td><td rowspan="1" colspan="1">Phase &#x02160;</td></tr><tr><td rowspan="1" colspan="1">Spinal muscular atrophy</td><td rowspan="1" colspan="1"><a id="__tag_881094978" class="tag_hotlink" href="https://clinicaltrials.gov/ct2/show/NCT02292537" ref="reftype=extlink-clinical-trial&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CBody&amp;TO=External%7CResource%7CClinical%20Trials%7CClinicalTrials.gov"><span class="tag-json" style="display:none">{"type":"clinical-trial","attrs":{"text":"NCT02292537","term_id":"NCT02292537"}}</span>NCT02292537</a></td><td rowspan="1" colspan="1">Intrathecal injection</td><td rowspan="1" colspan="1">ASOs targeting SMN2 splicing</td><td rowspan="1" colspan="1">Phase &#x02162;</td></tr><tr><td rowspan="1" colspan="1">Amyotrophic lateral sclerosis</td><td rowspan="1" colspan="1"><a id="__tag_881094964" class="tag_hotlink" href="https://clinicaltrials.gov/ct2/show/NCT01041222" ref="reftype=extlink-clinical-trial&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CBody&amp;TO=External%7CResource%7CClinical%20Trials%7CClinicalTrials.gov"><span class="tag-json" style="display:none">{"type":"clinical-trial","attrs":{"text":"NCT01041222","term_id":"NCT01041222"}}</span>NCT01041222</a></td><td rowspan="1" colspan="1">Intrathecal injection</td><td rowspan="1" colspan="1">ASOs to SOD1</td><td rowspan="1" colspan="1">Phase &#x02160;</td></tr><tr><td rowspan="1" colspan="1">Mucopolysaccharidosis type III A</td><td rowspan="1" colspan="1"><a id="__tag_881094979" class="tag_hotlink" href="https://clinicaltrials.gov/ct2/show/NCT01474343" ref="reftype=extlink-clinical-trial&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CBody&amp;TO=External%7CResource%7CClinical%20Trials%7CClinicalTrials.gov"><span class="tag-json" style="display:none">{"type":"clinical-trial","attrs":{"text":"NCT01474343","term_id":"NCT01474343"}}</span>NCT01474343</a></td><td rowspan="1" colspan="1">Intracerebral injection</td><td rowspan="1" colspan="1">AAVrh10-SGSH</td><td rowspan="1" colspan="1">Phase &#x02160;</td></tr><tr><td rowspan="1" colspan="1">Mucopolysaccharidosis type III A</td><td rowspan="1" colspan="1"><a id="__tag_881094963" class="tag_hotlink" href="https://clinicaltrials.gov/ct2/show/NCT02053064" ref="reftype=extlink-clinical-trial&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CBody&amp;TO=External%7CResource%7CClinical%20Trials%7CClinicalTrials.gov"><span class="tag-json" style="display:none">{"type":"clinical-trial","attrs":{"text":"NCT02053064","term_id":"NCT02053064"}}</span>NCT02053064</a></td><td rowspan="1" colspan="1">Intracerebral injection</td><td rowspan="1" colspan="1">AAVrh10-SUMF1</td><td rowspan="1" colspan="1">Phase &#x02161;</td></tr><tr><td rowspan="1" colspan="1">Mucopolysaccharidosis type II</td><td rowspan="1" colspan="1"><a id="__tag_881094958" class="tag_hotlink" href="https://clinicaltrials.gov/ct2/show/NCT03041324" ref="reftype=extlink-clinical-trial&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CBody&amp;TO=External%7CResource%7CClinical%20Trials%7CClinicalTrials.gov"><span class="tag-json" style="display:none">{"type":"clinical-trial","attrs":{"text":"NCT03041324","term_id":"NCT03041324"}}</span>NCT03041324</a></td><td rowspan="1" colspan="1">Intravenous injection</td><td rowspan="1" colspan="1">AAV6-IDS</td><td rowspan="1" colspan="1">Phase &#x02161;</td></tr><tr><td rowspan="1" colspan="1">Batten</td><td rowspan="1" colspan="1"><a id="__tag_881094962" class="tag_hotlink" href="https://clinicaltrials.gov/ct2/show/NCT02725580" ref="reftype=extlink-clinical-trial&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CBody&amp;TO=External%7CResource%7CClinical%20Trials%7CClinicalTrials.gov"><span class="tag-json" style="display:none">{"type":"clinical-trial","attrs":{"text":"NCT02725580","term_id":"NCT02725580"}}</span>NCT02725580</a></td><td rowspan="1" colspan="1">Intrathecal injection</td><td rowspan="1" colspan="1">AAV9-CLN6</td><td rowspan="1" colspan="1">Phase &#x02160;/&#x02161;</td></tr><tr><td rowspan="1" colspan="1">Batten</td><td rowspan="1" colspan="1"><a id="__tag_881094970" class="tag_hotlink" href="https://clinicaltrials.gov/ct2/show/NCT01414985" ref="reftype=extlink-clinical-trial&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CBody&amp;TO=External%7CResource%7CClinical%20Trials%7CClinicalTrials.gov"><span class="tag-json" style="display:none">{"type":"clinical-trial","attrs":{"text":"NCT01414985","term_id":"NCT01414985"}}</span>NCT01414985</a></td><td rowspan="1" colspan="1">Intracranial injection</td><td rowspan="1" colspan="1">AAVrh10-TPP1</td><td rowspan="1" colspan="1">Phase &#x02160;/&#x02161;</td></tr><tr><td rowspan="1" colspan="1">Batten</td><td rowspan="1" colspan="1"><a id="__tag_881094965" class="tag_hotlink" href="https://clinicaltrials.gov/ct2/show/NCT01161576" ref="reftype=extlink-clinical-trial&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CBody&amp;TO=External%7CResource%7CClinical%20Trials%7CClinicalTrials.gov"><span class="tag-json" style="display:none">{"type":"clinical-trial","attrs":{"text":"NCT01161576","term_id":"NCT01161576"}}</span>NCT01161576</a></td><td rowspan="1" colspan="1">Intracranial injection</td><td rowspan="1" colspan="1">AAVrh10-TPP1</td><td rowspan="1" colspan="1">Phase &#x02160;</td></tr><tr><td rowspan="1" colspan="1">Canavan</td><td rowspan="1" colspan="1">NA</td><td rowspan="1" colspan="1">Intraparenchymal injection</td><td rowspan="1" colspan="1">AAV2-ASPA</td><td rowspan="1" colspan="1">Phase &#x02160;</td></tr></tbody></table></div><div class="largeobj-link align_right" id="largeobj_idm139752599153040"><a target="object" rel="noopener" href="/pmc/articles/PMC7488363/table/tbl1/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><div id="fn-a.k.a.f.i.e.a"><p class="p p-first-last">NA, not applicable.</p></div></div></div></div><div id="sec2" class="tsec sec"><h2 class="head no_bottom_margin" id="sec2title">2. Transgene strategies</h2><p id="p0265" class="p p-first">Transgene strategies have been designed to deliver any nucleic acid as a genomic cargo, including siRNA, cDNA (gene addition or augmentation), microRNA, guide RNA (gene editing), RNA or DNA editing enzyme, docking site for a DNA binding protein, antisense oligonucleotide, or shRNA<a href="#bib2" rid="bib2" class=" bibr popnode"><sup>2</sup></a><sup>,</sup><a href="#bib20" rid="bib20" class=" bibr popnode"><sup>20</sup></a><sup>,</sup><a href="#bib26" rid="bib26" class=" bibr popnode">26</a>, <a href="#bib27" rid="bib27" class=" bibr popnode">27</a>, <a href="#bib28" rid="bib28" class=" bibr popnode">28</a>. Importantly, none of these genomic cargos should be larger than 4.7&#x000a0;kb for AAV-based gene therapy, the size of the AAV genome<a href="#bib2" rid="bib2" class=" bibr popnode"><sup>2</sup></a>. Gene addition or augmentation has been assessed as a treatment strategy for several neurodegenerative disorders, including PD, Canavan disease, spinal muscular atrophy, and AD. This approach has been evaluated for targeted delivery of cDNA for AADC, survival motor neuron (SMN), human aspartoacylase (ASPA), and nerve growth factor (NGF), and has been reported to be effective and well tolerated with reduced clinical stabilization over a long-term follow-up research<a href="#bib2" rid="bib2" class=" bibr popnode"><sup>2</sup></a><sup>,</sup><a href="#bib29" rid="bib29" class=" bibr popnode"><sup>29</sup></a><sup>,</sup><a href="#bib30" rid="bib30" class=" bibr popnode"><sup>30</sup></a>.</p><p id="p0270">Engineered transcriptional regulators and gene editing targeted to specific genes are also being investigated as novel therapeutic applications for neurodegenerative diseases. Zinc finger proteins (ZFPs) are appealing experimental substances from a clinical perspective due to the similarity of rodent and human proteins and their relatively short genomes. However, although a clinical trial of inserting the iduronate 2-sulfatase (IDS) gene into albumin loci to treat mucopolysaccharidosis II has been carried out, successful gene editing will not be easy to achieve because of the off-target effects<a href="#bib31" rid="bib31" class=" bibr popnode"><sup>31</sup></a>. The recent suggestion that CRISPR/Cas9 nanocomplexes targeting BACE1 could suppress cognitive deficits and amyloid <em>&#x003b2;</em>-associated pathologies in AD highlights the huge application potential of non-viral vectors or viral vectors based CRISPR/Cas9 gene editing for neurodegenerative disorders. However, there are still many hurdlers need to be overcome when applying this approach to treat human neurodegenerative diseases, especially safety concerns<a href="#bib31" rid="bib31" class=" bibr popnode"><sup>31</sup></a><sup>,</sup><a href="#bib32" rid="bib32" class=" bibr popnode"><sup>32</sup></a>.</p><p id="p0275" class="p p-last">Another promising transgene strategy is gene silencing. RNA interference (RNAi) is a widespread biological process in which siRNAs decrease synthesis of specific targeted proteins by degrading their corresponding mRNAs. Multiple clinical trials have suggested that artificial siRNAs can be utilized in humans to inhibit targeted proteins or genes and are commonly well tolerated (<em>e</em>.<em>g</em>., <a id="__tag_881094975" class="tag_hotlink" href="https://clinicaltrials.gov/ct2/show/NCT01559077" ref="reftype=extlink-clinical-trial&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CBody&amp;TO=External%7CResource%7CClinical%20Trials%7CClinicalTrials.gov"><span class="tag-json" style="display:none">{"type":"clinical-trial","attrs":{"text":"NCT01559077","term_id":"NCT01559077"}}</span>NCT01559077</a> and <a id="__tag_881094974" class="tag_hotlink" href="https://clinicaltrials.gov/ct2/show/NCT01437059" ref="reftype=extlink-clinical-trial&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CBody&amp;TO=External%7CResource%7CClinical%20Trials%7CClinicalTrials.gov"><span class="tag-json" style="display:none">{"type":"clinical-trial","attrs":{"text":"NCT01437059","term_id":"NCT01437059"}}</span>NCT01437059</a>)<a href="#bib33" rid="bib33" class=" bibr popnode">33</a>, <a href="#bib34" rid="bib34" class=" bibr popnode">34</a>, <a href="#bib35" rid="bib35" class=" bibr popnode">35</a>. For example, recent clinical study demonstrated that HD patients showed dose-dependent reductions in concentrations of mutant huntingtin (HTT) after intrathecal injection of an antisense oligonucleotide (IONIS-HTTRx), suggesting this agent maybe a promising therapeutic<a href="#bib36" rid="bib36" class=" bibr popnode"><sup>36</sup></a>. Notably, because synthetic shRNAs or microRNA produced from a single injection of AAV can generate a more lasting gene silencing than artificial siRNAs, these substances provide superior gene therapy approaches for neurodegenerative disorders. For instance, the preclinical research indicated that one-dose administration of gene therapy candidate VY-HTT01 (Voyager Therapeutics) could effectively reduce the levels of HTT responsible for HD in critical brain areas of nonhuman primates. Moreover, studies demonstrating that synthetic primary-microRNA cassettes or AAV5 expressing a microRNA targeting HTT (AAV5-miHTT, UniQure) can generate efficacious, safe production of mature-microRNAs targeting ataxin-1 and HTT in mouse models of spinocerebellar ataxia type-1 and HD, respectively, provide proof-of-concept support for these strategies to utilize RNAi<a href="#bib36" rid="bib36" class=" bibr popnode">36</a>, <a href="#bib37" rid="bib37" class=" bibr popnode">37</a>, <a href="#bib38" rid="bib38" class=" bibr popnode">38</a>, <a href="#bib39" rid="bib39" class=" bibr popnode">39</a>. Overall, the rational for transgene strategies selection would be determined by multiple factors including safety concerns, insertional mutagenesis and genotoxicity as well as different pathological conditions<a href="#bib2" rid="bib2" class=" bibr popnode"><sup>2</sup></a>.</p></div><div id="sec3" class="tsec sec"><h2 class="head no_bottom_margin" id="sec3title">3. Vectors: viral and non-viral based gene therapy</h2><div id="sec3.1" class="sec sec-first"><h3 id="sec3.1title">3.1. Viral vectors</h3><p id="p0280" class="p p-first">AAV based vectors have been applied almost exclusively in clinical trials of gene therapy for neurodegenerative diseases. AAV serotypes are the major determinant of several crucial characteristics of successful AAV-based gene therapy, including biodistribution, tissue tropism, and susceptibility to neutralizing antibody generated <em>in&#x000a0;vivo.</em> Discovering how the specific serotypes distribute gene cargos to their intended tissues for vector delivery is vital for developing a reliable and predictable gene therapy strategy<a href="#bib6" rid="bib6" class=" bibr popnode"><sup>6</sup></a><sup>,</sup><a href="#bib40" rid="bib40" class=" bibr popnode">40</a>, <a href="#bib41" rid="bib41" class=" bibr popnode">41</a>, <a href="#bib42" rid="bib42" class=" bibr popnode">42</a>, <a href="#bib43" rid="bib43" class=" bibr popnode">43</a>. More than one hundred AAV variants consisting of 13 serotypes (AAV1&#x02013;13) have been identified from humans and nonhuman primates<a href="#bib44" rid="bib44" class=" bibr popnode">44</a>, <a href="#bib45" rid="bib45" class=" bibr popnode">45</a>, <a href="#bib46" rid="bib46" class=" bibr popnode">46</a>, <a href="#bib47" rid="bib47" class=" bibr popnode">47</a>, <a href="#bib48" rid="bib48" class=" bibr popnode">48</a>. Because of its relative safety profile and its sustained expression in neurons, AAV2 has been used in numerous clinical trials and is currently considered a satisfactory vector for gene therapy of neurodegenerative disorders<a href="#bib48" rid="bib48" class=" bibr popnode">48</a>, <a href="#bib49" rid="bib49" class=" bibr popnode">49</a>, <a href="#bib50" rid="bib50" class=" bibr popnode">50</a>, <a href="#bib51" rid="bib51" class=" bibr popnode">51</a>. Specifically, researchers indicated that intracerebral administration of AAV2-NGF is well tolerated and shows evidences of therapeutic effect on cognitive decline in AD-related dementia<a href="#bib50" rid="bib50" class=" bibr popnode"><sup>50</sup></a>. Interestingly, after administration near or into cerebral ventricles, AAV4 has a predilection to transfect ependymal cells, which constitute the epithelial lining of neuroblasts and the lateral ventricles<a href="#bib52" rid="bib52" class=" bibr popnode"><sup>52</sup></a><sup>,</sup><a href="#bib53" rid="bib53" class=" bibr popnode"><sup>53</sup></a>. Because the BBB is an important barrier hindering delivery of most vectors to the CNS, the ability of AAV9 and AAVrh.10 to penetrate this obstacle is also consequential<a href="#bib21" rid="bib21" class=" bibr popnode"><sup>21</sup></a><sup>,</sup><a href="#bib54" rid="bib54" class=" bibr popnode"><sup>54</sup></a><sup>,</sup><a href="#bib55" rid="bib55" class=" bibr popnode"><sup>55</sup></a>. Interestingly, reports that AAV-PHP.B, a recently engineered AAV capsid, can transduce more than 50% of astrocytes and neurons and deliver far more AAV genomes (forty fold greater) into the CNS after intravenous injection than other capsids, highlight the critical importance of capsid engineering<a href="#bib20" rid="bib20" class=" bibr popnode"><sup>20</sup></a><sup>,</sup><a href="#bib56" rid="bib56" class=" bibr popnode"><sup>56</sup></a>. Indeed cell-type specific screening of different AAV capsid libraries has identified increasing numbers of bioengineered AAV capsids with specific tropisms<a href="#bib57" rid="bib57" class=" bibr popnode"><sup>57</sup></a>.</p><p id="p0285" class="p p-last">Adenovirus (Adv) is an icosahedral capsid virus with size ranging from 70 to 100&#x000a0;nm. Adv cannot insert its gene into the host genome, which leads to relative transient transgene expression but an excellent safety profile. The innate immune responses against Adv restricts Adv's therapeutic potential efficacy for CNS gene therapy<a href="#bib58" rid="bib58" class=" bibr popnode"><sup>58</sup></a><sup>,</sup><a href="#bib59" rid="bib59" class=" bibr popnode"><sup>59</sup></a>. Although few studies use Adv as gene therapy vectors to treat neurodegenerative disorders, it should be pointed out, however, that Adv is well tolerated with little side effects in these researches<a href="#bib59" rid="bib59" class=" bibr popnode"><sup>59</sup></a>. Unlike AAV and Adv capsids, retrovirus/lentivirus (LVs) could fully integrate DNA into the host genome through reverse transcription, thus providing more stable and longer transgene expression <em>in&#x000a0;vivo</em>. Of note, these insertions should be controlled under strict conditions to avoid genotoxicity and insertional mutagenesis. The one important clinical trial to date is the use of a lentiviral vector, which can deliver larger DNA cargos for PD<a href="#bib60" rid="bib60" class=" bibr popnode"><sup>60</sup></a>. Their data indicated that ProSavin, a lentiviral vector-based gene therapy aimed at restoring dopamine production, improved motor behavior and demonstrated safe in all patients with advanced PD<a href="#bib60" rid="bib60" class=" bibr popnode"><sup>60</sup></a>. Further investigations into Adv and LVs-mediated gene therapy of neurodegenerative disorders are desperately needed given the limited clinical data thus far.</p></div><div id="sec3.2" class="sec sec-last"><h3 id="sec3.2title">3.2. Non-viral vectors</h3><p id="p0290" class="p p-first-last">Although most clinical trials have used viral vectors such as AAVs, lentivirus, Adv, and retroviruses to carry therapeutic genes, these vectors have numerous drawbacks, including broad tropism, limited loading capacity, difficulty in vector production, and host inflammatory responses<a href="#bib61" rid="bib61" class=" bibr popnode">61</a>, <a href="#bib62" rid="bib62" class=" bibr popnode">62</a>, <a href="#bib63" rid="bib63" class=" bibr popnode">63</a>, <a href="#bib64" rid="bib64" class=" bibr popnode">64</a>, <a href="#bib65" rid="bib65" class=" bibr popnode">65</a>, <a href="#bib66" rid="bib66" class=" bibr popnode">66</a>. Gene therapies based on non-viral vectors have the potential to avoid several of these drawbacks, especially those related to safety<a href="#bib67" rid="bib67" class=" bibr popnode">67</a>, <a href="#bib68" rid="bib68" class=" bibr popnode">68</a>, <a href="#bib69" rid="bib69" class=" bibr popnode">69</a>. Moreover, although few of these strategies have been used in the clinic, it is extremely important to exploit novel kinds of vectors, particularly nanoparticles and liposomes. Based on the composition of the carriers' material, non-viral delivery vectors can be sorted into lipid-based vectors and polymeric vectors. The most extensively applied non-viral gene carriers are lipid-based vectors<a href="#bib70" rid="bib70" class=" bibr popnode"><sup>70</sup></a>. Neutral lipids, like cholesterol, DOPE, and DSPE, have served as the &#x02018;helper lipid&#x02019; among liposomal components to improve liposome stability and transfection capacity<a href="#bib71" rid="bib71" class=" bibr popnode"><sup>71</sup></a>. The prominent features of cationic lipids, such as DOTAP, DODAP, DOTMA, and DC-cholesterol, which have been used for gene therapy, include three major domains: hydrophobic tails, linking groups, and cationic cap groups<a href="#bib69" rid="bib69" class=" bibr popnode"><sup>69</sup></a><sup>,</sup><a href="#bib72" rid="bib72" class=" bibr popnode"><sup>72</sup></a>. The main shortcomings of cationic lipids are their unsatisfactory pharmacokinetic biodistribution due to nonspecific binding and rapid clearance, and their cytotoxicity<a href="#bib69" rid="bib69" class=" bibr popnode"><sup>69</sup></a><sup>,</sup><a href="#bib73" rid="bib73" class=" bibr popnode"><sup>73</sup></a>. To overcome these drawbacks, optimized cationic lipids with appropriate p<em>K</em>a values have been developed<a href="#bib68" rid="bib68" class=" bibr popnode"><sup>68</sup></a><sup>,</sup><a href="#bib70" rid="bib70" class=" bibr popnode"><sup>70</sup></a>. Lipidoids (lipid-like materials), magnetic nanoparticles, and exosomes have also shown promise as gene delivery carriers for neurodegenerative disorders<a href="#bib74" rid="bib74" class=" bibr popnode">74</a>, <a href="#bib75" rid="bib75" class=" bibr popnode">75</a>, <a href="#bib76" rid="bib76" class=" bibr popnode">76</a>. For instance, recent studies indicated that magnetic Fe<sub>3</sub>O<sub>4</sub> nanoparticles coated with <em>N</em>-isopropylacrylamide derivatives and oleic acid molecules carrying shRNA-<em>&#x003b1;</em>-<em>syn</em> can significantly alleviate PD in mice<a href="#bib74" rid="bib74" class=" bibr popnode"><sup>74</sup></a>. Cationic polymers provide another kind of non-viral vector that is extremely attractive for gene therapy due to their capacity for endosomal/lysosome escape, which is the result of their sponge-proton effect, fine spherical architecture, and tremendous chemical diversity<a href="#bib70" rid="bib70" class=" bibr popnode"><sup>70</sup></a><sup>,</sup><a href="#bib77" rid="bib77" class=" bibr popnode">77</a>, <a href="#bib78" rid="bib78" class=" bibr popnode">78</a>, <a href="#bib79" rid="bib79" class=" bibr popnode">79</a>. Overall, therefore, non-viral gene therapy has improved substantially in recent decades. Additional insights into the relationship between structure and function of gene delivery material and fuller understanding of the critical factors that restrict effective gene delivery are likely to advance the clinical treatment of neurodegenerative disorders. We summarize the types, specific characteristics, advantages and disadvantages of viral and non-viral vectors in this section in <a href="/pmc/articles/PMC7488363/table/tbl2/" target="table" class="fig-table-link figpopup" rid-figpopup="tbl2" rid-ob="ob-tbl2" co-legend-rid=""><span>Table 2</span></a>.</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap anchored whole_rhythm" id="tbl2"><h3>Table 2</h3><!--caption a7--><div class="caption"><p>Comparison of the different gene vectors for neurodegenerative disorders.</p></div><div class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><th rowspan="1" colspan="1">Vector type</th><th rowspan="1" colspan="1">Specific characteristics</th><th rowspan="1" colspan="1">Advantage</th><th rowspan="1" colspan="1">Disadvantage</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">AAVs</td><td rowspan="1" colspan="1">Numerous AAV serotypes; lack of targeting and site-specific; relative safety profile</td><td rowspan="1" colspan="1">Relative stable transgene expression; nonpathogenic; various serotypes available</td><td rowspan="1" colspan="1">Immune responses; limited gene packaging capacity</td></tr><tr><td rowspan="1" colspan="1">Adv</td><td rowspan="1" colspan="1">Adv cannot introduce its gene into the host genome</td><td rowspan="1" colspan="1">Lower genotoxicity and insertional mutagenesis</td><td rowspan="1" colspan="1">Immune responses; relative transient transgene expression; re-administration; requires receptors for cell uptake</td></tr><tr><td rowspan="1" colspan="1">LVs</td><td rowspan="1" colspan="1">Retroviruses can integrate DNA payloads into the host genome</td><td rowspan="1" colspan="1">Lower frequency of administration; stable and long-term transgene expression</td><td rowspan="1" colspan="1">Immune responses; genotoxicity; insertional mutagenesis</td></tr><tr><td rowspan="1" colspan="1">Polymer- and lipid-based vectors</td><td rowspan="1" colspan="1">Non-viral vectors can be altered to impart desired functionalities</td><td rowspan="1" colspan="1">Large-scale production; controlled release; large gene packaging capacity; lower immunogenicity</td><td rowspan="1" colspan="1">Cytotoxicity; nonspecific binding and rapid clearance</td></tr></tbody></table></div><div class="largeobj-link align_right" id="largeobj_idm139752601619712"><a target="object" rel="noopener" href="/pmc/articles/PMC7488363/table/tbl2/?report=objectonly">Open in a separate window</a></div></div></div></div><div id="sec4" class="tsec sec"><h2 class="head no_bottom_margin" id="sec4title">4. Target selection for neurodegenerative disorders</h2><p id="p0295" class="p p-first">Neurodegenerative disorders are characterized by progressive dysfunction of neurons in specific regions of CNS, eventually leading to disability and death. The growing number of recently identified targets enlarges the range of potential clinical applications. However, as shown in <a href="/pmc/articles/PMC7488363/table/tbl1/" target="table" class="fig-table-link figpopup" rid-figpopup="tbl1" rid-ob="ob-tbl1" co-legend-rid=""><span>Table 1</span></a>, many therapeutic agents and their related targets offer nothing beyond symptomatic relief and do not address the underlying pathology<a href="#bib80" rid="bib80" class=" bibr popnode"><sup>80</sup></a>. It is therefore urgently necessary to identify promising pathogenic targets for gene therapy of neurodegenerative disorders, as indicated in <a href="/pmc/articles/PMC7488363/table/tbl3/" target="table" class="fig-table-link figpopup" rid-figpopup="tbl3" rid-ob="ob-tbl3" co-legend-rid=""><span>Table 3</span></a><a href="#bib81" rid="bib81" class=" bibr popnode">81</a>, <a href="#bib82" rid="bib82" class=" bibr popnode">82</a>, <a href="#bib83" rid="bib83" class=" bibr popnode">83</a>, <a href="#bib84" rid="bib84" class=" bibr popnode">84</a>, <a href="#bib85" rid="bib85" class=" bibr popnode">85</a>, <a href="#bib86" rid="bib86" class=" bibr popnode">86</a>, <a href="#bib87" rid="bib87" class=" bibr popnode">87</a>, <a href="#bib88" rid="bib88" class=" bibr popnode">88</a>, <a href="#bib89" rid="bib89" class=" bibr popnode">89</a>, <a href="#bib90" rid="bib90" class=" bibr popnode">90</a>, <a href="#bib91" rid="bib91" class=" bibr popnode">91</a>, <a href="#bib92" rid="bib92" class=" bibr popnode">92</a>, <a href="#bib93" rid="bib93" class=" bibr popnode">93</a>, <a href="#bib94" rid="bib94" class=" bibr popnode">94</a>, <a href="#bib95" rid="bib95" class=" bibr popnode">95</a>, <a href="#bib96" rid="bib96" class=" bibr popnode">96</a>, <a href="#bib97" rid="bib97" class=" bibr popnode">97</a>, <a href="#bib98" rid="bib98" class=" bibr popnode">98</a>, <a href="#bib99" rid="bib99" class=" bibr popnode">99</a>, <a href="#bib100" rid="bib100" class=" bibr popnode">100</a>.</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap anchored whole_rhythm" id="tbl3"><h3>Table 3</h3><!--caption a7--><div class="caption"><p>Representative promising therapeutic targets for gene therapy of neurodegenerative disorders.</p></div><div class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><th rowspan="1" colspan="1">Target selection</th><th rowspan="1" colspan="1">Disorder</th><th rowspan="1" colspan="1">Gene therapy</th><th rowspan="1" colspan="1">Delivery route</th><th rowspan="1" colspan="1">Ref.</th></tr></thead><tbody><tr><td rowspan="6" colspan="1">ER stress and UPR</td><td rowspan="1" colspan="1">Traumatic optic nerve injury</td><td rowspan="1" colspan="1">AAV2-XBP-1</td><td rowspan="1" colspan="1">Intravitreal injection</td><td rowspan="1" colspan="1"><a href="#bib81" rid="bib81" class=" bibr popnode">81</a></td></tr><tr><td rowspan="1" colspan="1">Parkinson's disease</td><td rowspan="1" colspan="1">AAV2-XBP-1</td><td rowspan="1" colspan="1">Unilateral brain injection</td><td rowspan="1" colspan="1"><a href="#bib82" rid="bib82" class=" bibr popnode">82</a></td></tr><tr><td rowspan="1" colspan="1">Optic neuritis and encephalomyelitis</td><td rowspan="1" colspan="1">AAV2-CHOP shRNA</td><td rowspan="1" colspan="1">Intravitreal injection</td><td rowspan="1" colspan="1"><a href="#bib83" rid="bib83" class=" bibr popnode">83</a></td></tr><tr><td rowspan="1" colspan="1">Parkinson's disease</td><td rowspan="1" colspan="1">AAV5-Bip</td><td rowspan="1" colspan="1">Intracerebral injection</td><td rowspan="1" colspan="1"><a href="#bib84" rid="bib84" class=" bibr popnode">84</a></td></tr><tr><td rowspan="1" colspan="1">Amyotrophic lateral sclerosis</td><td rowspan="1" colspan="1">AAV6-SIL1</td><td rowspan="1" colspan="1">Unilateral brain injection</td><td rowspan="1" colspan="1"><a href="#bib85" rid="bib85" class=" bibr popnode">85</a></td></tr><tr><td rowspan="1" colspan="1">Huntington's disease</td><td rowspan="1" colspan="1">AAV2-XBP-1</td><td rowspan="1" colspan="1">Intrastriatal injection</td><td rowspan="1" colspan="1"><a href="#bib86" rid="bib86" class=" bibr popnode">86</a></td></tr><tr><td rowspan="6" colspan="1">mTOR signaling</td><td rowspan="1" colspan="1">Optic nerve injury</td><td rowspan="1" colspan="1">AAV2-AKT</td><td rowspan="1" colspan="1">Intravitreal injection</td><td rowspan="1" colspan="1"><a href="#bib87" rid="bib87" class=" bibr popnode">87</a></td></tr><tr><td rowspan="1" colspan="1">Optic nerve injury</td><td rowspan="1" colspan="1">AAV2-S6K1</td><td rowspan="1" colspan="1">Intravitreal injection</td><td rowspan="1" colspan="1"><a href="#bib88" rid="bib88" class=" bibr popnode">88</a></td></tr><tr><td rowspan="1" colspan="1">Optic nerve injury</td><td rowspan="1" colspan="1">AAV2-PTEN</td><td rowspan="1" colspan="1">Intravitreal injection</td><td rowspan="1" colspan="1"><a href="#bib89" rid="bib89" class=" bibr popnode">89</a></td></tr><tr><td rowspan="1" colspan="1">Parkinson's disease</td><td rowspan="1" colspan="1">AAV1-AKT</td><td rowspan="1" colspan="1">Intrastriatal injection</td><td rowspan="1" colspan="1"><a href="#bib90" rid="bib90" class=" bibr popnode">90</a></td></tr><tr><td rowspan="1" colspan="1">Alzheimer's disease and Parkinson's disease</td><td rowspan="1" colspan="1">AAV1-AKT</td><td rowspan="1" colspan="1">Intrastriatal injection</td><td rowspan="1" colspan="1"><a href="#bib91" rid="bib91" class=" bibr popnode">91</a></td></tr><tr><td rowspan="1" colspan="1">Huntington's disease</td><td rowspan="1" colspan="1">AAV1-caRheb</td><td rowspan="1" colspan="1">Unilateral brain injection</td><td rowspan="1" colspan="1"><a href="#bib92" rid="bib92" class=" bibr popnode">92</a></td></tr><tr><td rowspan="2" colspan="1">Mitochondrial function</td><td rowspan="1" colspan="1">Parkinson's disease</td><td rowspan="1" colspan="1">AAV2-HSP70</td><td rowspan="1" colspan="1">Substantial nigra dense area injection</td><td rowspan="1" colspan="1"><a href="#bib93" rid="bib93" class=" bibr popnode">93</a></td></tr><tr><td rowspan="1" colspan="1">Alzheimer's disease</td><td rowspan="1" colspan="1">AAV2-PINK1</td><td rowspan="1" colspan="1">Intrahippocampal injection</td><td rowspan="1" colspan="1"><a href="#bib94" rid="bib94" class=" bibr popnode">94</a></td></tr><tr><td rowspan="1" colspan="1">Epigenetic regulation</td><td rowspan="1" colspan="1">Alzheimer's disease</td><td rowspan="1" colspan="1">AAV2-PSD95-6ZF-VP64</td><td rowspan="1" colspan="1">Intrahippocampal injection</td><td rowspan="1" colspan="1"><a href="#bib95" rid="bib95" class=" bibr popnode">95</a></td></tr><tr><td rowspan="4" colspan="1">Autophagy</td><td rowspan="1" colspan="1">Alzheimer's disease</td><td rowspan="1" colspan="1">AAV2-PINK1</td><td rowspan="1" colspan="1">Intrahippocampal injection</td><td rowspan="1" colspan="1"><a href="#bib94" rid="bib94" class=" bibr popnode">94</a></td></tr><tr><td rowspan="1" colspan="1">Parkinson's disease</td><td rowspan="1" colspan="1">AAV6-Lamp2a</td><td rowspan="1" colspan="1">Intrastriatal injection</td><td rowspan="1" colspan="1"><a href="#bib96" rid="bib96" class=" bibr popnode">96</a></td></tr><tr><td rowspan="1" colspan="1">Parkinson's disease</td><td rowspan="1" colspan="1">AAV2-TFEB</td><td rowspan="1" colspan="1">Unilateral brain injection</td><td rowspan="1" colspan="1"><a href="#bib97" rid="bib97" class=" bibr popnode">97</a></td></tr><tr><td rowspan="1" colspan="1">Amyotrophic lateral sclerosis</td><td rowspan="1" colspan="1">AAV9-snapin</td><td rowspan="1" colspan="1">Intravenous injection</td><td rowspan="1" colspan="1"><a href="#bib98" rid="bib98" class=" bibr popnode">98</a></td></tr><tr><td rowspan="2" colspan="1">Microglial and astrocyte function</td><td rowspan="1" colspan="1">Alzheimer's disease</td><td rowspan="1" colspan="1">AAV2/8-sTREM2</td><td rowspan="1" colspan="1">Intracerebral injection</td><td rowspan="1" colspan="1"><a href="#bib99" rid="bib99" class=" bibr popnode">99</a></td></tr><tr><td rowspan="1" colspan="1">Alzheimer's disease</td><td rowspan="1" colspan="1">Lentivirus-PGRN</td><td rowspan="1" colspan="1">Unilateral brain injection</td><td rowspan="1" colspan="1"><a href="#bib100" rid="bib100" class=" bibr popnode">100</a></td></tr></tbody></table></div><div class="largeobj-link align_right" id="largeobj_idm139752595971152"><a target="object" rel="noopener" href="/pmc/articles/PMC7488363/table/tbl3/?report=objectonly">Open in a separate window</a></div></div><div id="sec4.1" class="sec"><h3 id="sec4.1title">4.1. Endoplasmic reticulum stress and unfolded protein response</h3><p id="p0300" class="p p-first-last">Almost all neurodegenerative disorders share the same pathological characteristic: abnormal accumulation of misfolded proteins<a href="#bib101" rid="bib101" class=" bibr popnode"><sup>101</sup></a><sup>,</sup><a href="#bib102" rid="bib102" class=" bibr popnode"><sup>102</sup></a>. The negative consequences of aggregating misfolded proteins include generation of endoplasmic reticulum (ER) stress and ER-associated degradation<a href="#bib103" rid="bib103" class=" bibr popnode"><sup>103</sup></a>. Misfolded proteins, such as amyloid <em>&#x003b2;</em> oligomers and <em>&#x003b1;</em>-synuclein, which aggregate in the ER-lumen, destabilize ER calcium homeostasis and distort unfolded protein response (UPR) signaling intended to restore cellular proteostasis, but instead resulting in proapoptotic responses and neuron death<a href="#bib104" rid="bib104" class=" bibr popnode">104</a>, <a href="#bib105" rid="bib105" class=" bibr popnode">105</a>, <a href="#bib106" rid="bib106" class=" bibr popnode">106</a>. Importantly, investigators, including ourselves, have suggested that gene therapies to reduce ER stress by targeting UPR signaling to enhance protein folding are more likely to provide long-term, local therapeutic effects than antibodies and small molecules. AAV delivered to the mouse retina to downregulate CCAAT/enhancer binding homologous protein (CHOP) or activate XBP-1 prevents the optic nerve degeneration and apoptotic death of retinal ganglion cells (RGCs) that is triggered by glaucoma, optic neuritis, and traumatic optic nerve injury<a href="#bib81" rid="bib81" class=" bibr popnode"><sup>81</sup></a><sup>,</sup><a href="#bib83" rid="bib83" class=" bibr popnode"><sup>83</sup></a><sup>,</sup><a href="#bib107" rid="bib107" class=" bibr popnode"><sup>107</sup></a>. Similarly, AAVs-XBP-1 administered locally to the striatum or substantia nigra block neurodegeneration induced by neurotoxins that experimentally model HD and PD<a href="#bib82" rid="bib82" class=" bibr popnode"><sup>82</sup></a><sup>,</sup><a href="#bib86" rid="bib86" class=" bibr popnode"><sup>86</sup></a><sup>,</sup><a href="#bib108" rid="bib108" class=" bibr popnode"><sup>108</sup></a><sup>,</sup><a href="#bib109" rid="bib109" class=" bibr popnode"><sup>109</sup></a>. Moreover, gene therapy consisting of overexpression of BiP (glucose regulated protein 78) to treat experimental PD has been reported to reduce dopaminergic neuron apoptosis, enhance motor performance, and delay disease progression<a href="#bib84" rid="bib84" class=" bibr popnode"><sup>84</sup></a>. The same strategy has excellent effects in a mouse model of amyotrophic lateral sclerosis (ALS); intracerebral delivery of AAV6-SIL1 restores ER homeostasis and prolongs survival<a href="#bib85" rid="bib85" class=" bibr popnode"><sup>85</sup></a>. Because upregulation of UPR signaling has been reported to sustain the proliferation and invasion of glioblastoma, however, safety assessment in long-term follow-up studies will be required before this approach can be considered for the clinic<a href="#bib110" rid="bib110" class=" bibr popnode"><sup>110</sup></a><sup>,</sup><a href="#bib111" rid="bib111" class=" bibr popnode"><sup>111</sup></a>.</p></div><div id="sec4.2" class="sec"><h3 id="sec4.2title">4.2. mTOR signaling</h3><p id="p0305" class="p p-first-last">Signaling transductions of mammalian target of rapamycin (mTOR) have been reported to play a pathogenic role in neurodegenerative disorders with diverse clinical characteristics, such as AD, PD, HD, and traumatic brain and optic nerve injury<a href="#bib112" rid="bib112" class=" bibr popnode"><sup>112</sup></a><sup>,</sup><a href="#bib113" rid="bib113" class=" bibr popnode"><sup>113</sup></a>. Abnormal mTOR signaling is likely to have distinct effects in different neural cells, such as those in the substantial nigra, caudate nucleus, retina, and entorhinal cortex, but degeneration is the common fate of all of these cells because they are unable to clear toxic protein accumulation<a href="#bib114" rid="bib114" class=" bibr popnode"><sup>114</sup></a>. Our work has previously demonstrated that delivery to retina by AAV of positive regulators or effectors of mTOR signaling (such as AAV2-AKT and AAV2-S6K1) or AAV-mediated deletion from retina of negative regulators of mTOR signaling (such as PTEN) can prevent death of RGCs and promote CNS axon regeneration following traumatic optic nerve injury<a href="#bib87" rid="bib87" class=" bibr popnode">87</a>, <a href="#bib88" rid="bib88" class=" bibr popnode">88</a>, <a href="#bib89" rid="bib89" class=" bibr popnode">89</a><sup>,</sup><a href="#bib115" rid="bib115" class=" bibr popnode"><sup>115</sup></a>. Other investigators report that AAV-based overexpression of S6K1 or AKT also has therapeutic effects in a mouse model of PD, indicating that activation of mTOR signaling may provide a new treatment option for PD and traumatic nerve injury<a href="#bib90" rid="bib90" class=" bibr popnode"><sup>90</sup></a><sup>,</sup><a href="#bib91" rid="bib91" class=" bibr popnode"><sup>91</sup></a>. Of note, multiple studies have suggested that mTOR signaling is hyperactivated in HD and AD, and that reinstating aberrant mTORC1 activity can rescue neurodegeneration. Future studies should therefore focus on the cellular and molecular mechanisms that relate mTOR signaling and neurodegenerative disorders<a href="#bib92" rid="bib92" class=" bibr popnode"><sup>92</sup></a><sup>,</sup><a href="#bib116" rid="bib116" class=" bibr popnode">116</a>, <a href="#bib117" rid="bib117" class=" bibr popnode">117</a>, <a href="#bib118" rid="bib118" class=" bibr popnode">118</a>, <a href="#bib119" rid="bib119" class=" bibr popnode">119</a>.</p></div><div id="sec4.3" class="sec"><h3 id="sec4.3title">4.3. Mitochondrial function</h3><p id="p0310" class="p p-first-last">Mitochondrial respiratory dysfunction has been shown to contribute to numerous neurodegeneration disorders, such as AD, PD, HD, glaucoma, ALS, and lysosomal storage diseases<a href="#bib120" rid="bib120" class=" bibr popnode">120</a>, <a href="#bib121" rid="bib121" class=" bibr popnode">121</a>, <a href="#bib122" rid="bib122" class=" bibr popnode">122</a>. These disorders exhibit many characteristics of mitochondrial respiratory dysfunction, including limited regulation of mitochondrial quality, oxidative damage, NAD<sup>+</sup> depletion, disrupted ATP synthesis, protein aggregates, and unbalanced mitochondrial calcium homeostasis<a href="#bib120" rid="bib120" class=" bibr popnode">120</a>, <a href="#bib121" rid="bib121" class=" bibr popnode">121</a>, <a href="#bib122" rid="bib122" class=" bibr popnode">122</a>, <a href="#bib123" rid="bib123" class=" bibr popnode">123</a>, <a href="#bib124" rid="bib124" class=" bibr popnode">124</a>. Therapeutic agents that inhibit mitochondrial damage or promote mitochondrial biogenesis, among them CoQ<sub>10</sub>, Bendavia, MitoQ, and NAM, mitigate neurodegeneration in mouse models<a href="#bib121" rid="bib121" class=" bibr popnode"><sup>121</sup></a><sup>,</sup><a href="#bib125" rid="bib125" class=" bibr popnode">125</a>, <a href="#bib126" rid="bib126" class=" bibr popnode">126</a>, <a href="#bib127" rid="bib127" class=" bibr popnode">127</a>, <a href="#bib128" rid="bib128" class=" bibr popnode">128</a>. Moreover, gene therapy that overexpresses regulators of mitochondrial oxidative stress and dynamics, such as PGC-1<em>&#x003b1;</em>, HSP70, TFEB, can reduce neurotoxicity in experimental PD and HD, suggesting that these strategies may be significant therapeutic approaches for other neurodegeneration diseases<a href="#bib93" rid="bib93" class=" bibr popnode"><sup>93</sup></a><sup>,</sup><a href="#bib129" rid="bib129" class=" bibr popnode"><sup>129</sup></a>. However, clinical translations of mitochondrial treatments have been unsatisfactory, which may be because patients enter clinical trials when their neurodegenerative disorders are too advanced for effective intervention. Optimism about mitochondrial-based gene therapy for neurodegenerative disorders continues to be warranted, particularly for those with obvious mitochondrial dysfunctions<a href="#bib130" rid="bib130" class=" bibr popnode"><sup>130</sup></a>.</p></div><div id="sec4.4" class="sec"><h3 id="sec4.4title">4.4. Epigenetic regulation</h3><p id="p0315" class="p p-first-last">Epigenetic regulatory mechanisms, such as chromatin remodeling, DNA methylation, histone variant, and histone post-translational modification, have been suggested to regulate numerous aspects of axonal development and neuronal survival<a href="#bib131" rid="bib131" class=" bibr popnode"><sup>131</sup></a>. One study presented evidence that changes in H3K27ac or H3K4me3 occurred in connection with genetic variants in AD, suggesting an important function for immune-associated enhancers and promoter proteins in determining AD susceptibility<a href="#bib132" rid="bib132" class=" bibr popnode"><sup>132</sup></a>. Another study demonstrated that H4K16ac, a histone associated with DNA repair and neurodegenerative disorders, is significantly reduced in the cortex of AD patients, suggesting that the aged brain of these individuals is incapable of upregulating H4K16ac<a href="#bib133" rid="bib133" class=" bibr popnode"><sup>133</sup></a>. It is also noteworthy that multiple reports have associated loss of H3K4me3, a protein related to gene activation, with the deterioration found in PD and HD, but that overexpression of H3K4me3 can accelerate A&#x02013;T mutation that mitigates behavioral impairments and neurodegeneration<a href="#bib134" rid="bib134" class=" bibr popnode">134</a>, <a href="#bib135" rid="bib135" class=" bibr popnode">135</a>, <a href="#bib136" rid="bib136" class=" bibr popnode">136</a>. Additionally, HDAC inhibitors can prevent neurodegeneration in models of glaucoma, AD, and HD, despite the differences in pathogenesis<a href="#bib137" rid="bib137" class=" bibr popnode">137</a>, <a href="#bib138" rid="bib138" class=" bibr popnode">138</a>, <a href="#bib139" rid="bib139" class=" bibr popnode">139</a>, <a href="#bib140" rid="bib140" class=" bibr popnode">140</a>. These reports demonstrate that epigenetic profiles are regulated in neurodegenerative diseases and suggest that better understanding of these mechanisms could provide the foundation for developing more precisely targeted epigenome therapies. For example, recent work suggesting that epigenetic editing of the post-synaptic density protein 95 gene can improve cognition in AD highlights the potential of epigenetic regulation-based gene therapy for neurodegenerative disorders<a href="#bib95" rid="bib95" class=" bibr popnode"><sup>95</sup></a>.</p></div><div id="sec4.5" class="sec"><h3 id="sec4.5title">4.5. Autophagy</h3><p id="p0320" class="p p-first-last">Autophagy, the process by which evolutionarily-conserved intracellular machinery degrades dysfunctional organelles and denatured proteins in lysosomes, has been demonstrated to be associated with the severity of such neurodegenerative disorders as AD, PD, HD, glaucoma and ALS<a href="#bib141" rid="bib141" class=" bibr popnode"><sup>141</sup></a><sup>,</sup><a href="#bib142" rid="bib142" class=" bibr popnode"><sup>142</sup></a>. Neuroprotection by autophagy is mainly due to its elimination of misfolded proteins, including tau, HTT, and <em>&#x003b1;</em>-synuclein<a href="#bib142" rid="bib142" class=" bibr popnode"><sup>142</sup></a><sup>,</sup><a href="#bib143" rid="bib143" class=" bibr popnode"><sup>143</sup></a>. Previous work has indicated that PTEN-induced overexpression of putative kinase 1 (PINK1) mediated by AAV2 promotes autophagy that facilitates clearance of dysfunctional mitochondria, which in turn ameliorates the loss of mitochondrial functions, cognitive decline and synapses induced by amyloid <em>&#x003b2;</em> oligomers in experimental AD<a href="#bib94" rid="bib94" class=" bibr popnode"><sup>94</sup></a>. Similarly, overexpression of the transcription factor EB (TFEB) or lysosome-associated membrane protein 2a <em>via</em> intracerebral injection of AAV vectors can effectively alleviate <em>&#x003b1;</em>-synuclein-induced neurodegeneration in PD by enhancing axon regeneration and neuron survival; these benefits have been attributed to induction of lysosome biogenesis and chaperone-mediated autophagy<a href="#bib96" rid="bib96" class=" bibr popnode"><sup>96</sup></a><sup>,</sup><a href="#bib97" rid="bib97" class=" bibr popnode"><sup>97</sup></a>. Additionally, overexpressing snapin (AAV9-snapin) rescues defects in retrograde transport, which reverse impairments of autophagy/lysosomes, improve mitochondrial fitness, enhance motor neuron survival, and mitigate disease phenotypes in mouse ALS<a href="#bib98" rid="bib98" class=" bibr popnode"><sup>98</sup></a>. Although multiple lines of evidence therefore support the potential of gene therapies to treat neurodegenerative disorders by regulating autophagy, the approach is challenged by difficulties in target selection and limited understanding of underlying mechanisms.</p></div><div id="sec4.6" class="sec"><h3 id="sec4.6title">4.6. Microglial and astrocyte function</h3><p id="p0325" class="p p-first">Microglia, as the major neuro-immune cells, execute numerous critical tasks: housekeeping functions that maintain neuronal wellbeing and neuronal networks, sentinel functions associated with constant perception of environmental changes, and defensive functions essential for neuroprotection<a href="#bib144" rid="bib144" class=" bibr popnode"><sup>144</sup></a>. Neuronal damage in AD, PD, HD, ALS, glaucoma, and the degeneration associated with chronic and acute trauma stems from disruption of these microglial functions and neuroinflammation. Preventing dysregulation of these functions therefore represents a potential mode of treatment. Specifically, variants of microglial surface innate-immune receptors, such as complement receptor 1 (CR1), CD33, and triggering receptor expressed on myeloid cells 2 (TREM2), have been genetically associated with the risk for AD<a href="#bib145" rid="bib145" class=" bibr popnode">145</a>, <a href="#bib146" rid="bib146" class=" bibr popnode">146</a>, <a href="#bib147" rid="bib147" class=" bibr popnode">147</a>. Moreover, overexpression of soluble TREM2 mediated by AAVs improves microglial migration, proliferation, and degradation of amyloid <em>&#x003b2;</em> protein, which reduces amyloid plaque deposition and rescues dysfunctional spatial memory in a model of AD<a href="#bib99" rid="bib99" class=" bibr popnode"><sup>99</sup></a>. Additionally, by modulating microglial function, lentivirus-mediated haploinsufficiency of progranulin overexpression inhibits neuronal loss and spatial memory deficits in AD mice<a href="#bib100" rid="bib100" class=" bibr popnode"><sup>100</sup></a>.</p><p id="p0330" class="p p-last">Astrocytes fulfill lots of interactive and homeostatic functions in the CNS: regulating extracellular neurotransmitters and ions; providing energy metabolites; promoting neurogenesis; and controlling synaptic activity<a href="#bib148" rid="bib148" class=" bibr popnode"><sup>148</sup></a>. The complexity and diversity of these performances clearly suggest that the correct activities of astrocytes are very important to physiological functioning of the CNS, and their dysfunction can promote the progression of multiple neurodegenerative diseases<a href="#bib149" rid="bib149" class=" bibr popnode"><sup>149</sup></a>. A precise and effective approach to modulate astrocyte signaling pathways involves boosting or inhibiting genes in specific manners. Importantly, studies have demonstrated that AAV capsids AAV9P1 and Anc80L65 are promising tools for gene delivery to astrocytes, which could facilitate activation or inactivation of persisting dysfunction genes<a href="#bib150" rid="bib150" class=" bibr popnode"><sup>150</sup></a>. Moreover, pseudotyping lentiviruses with glycoproteins were found to selectively transfect astrocytes after intraparenchymal administration<a href="#bib150" rid="bib150" class=" bibr popnode"><sup>150</sup></a><sup>,</sup><a href="#bib151" rid="bib151" class=" bibr popnode"><sup>151</sup></a>. Nanoparticles functionalized with bradykinin B2 receptor antibodies, transferrin receptor or apolipoprotein E have also been indicated to successfully deliver siRNA and mRNA to astrocytes<a href="#bib152" rid="bib152" class=" bibr popnode"><sup>152</sup></a><sup>,</sup><a href="#bib153" rid="bib153" class=" bibr popnode"><sup>153</sup></a>. For example, optimized branched poly (<em>&#x003b2;</em>-amino ester)s are applied to deliver NGF expression DNA to astrocytes, and high transfection efficiency is achieved, which provides a viable gene therapy approach for neurodegenerative disorders<a href="#bib154" rid="bib154" class=" bibr popnode"><sup>154</sup></a>. Collectively, these studies indicate that targeting microglia or astrocyte may be a promising therapeutic strategy for neurodegenerative diseases.</p></div><div id="sec4.7" class="sec sec-last"><h3 id="sec4.7title">4.7. Neuronal progenitors or stem cell therapy</h3><p id="p0335" class="p p-first-last">The therapeutic strategies for neurodegenerative diseases may have a revolutionized change <em>via</em> transplanting neuronal progenitors or stem cells. However, better controlling of their proliferation and ameliorating their engraftment as well as improving their differentiation and survival are very important. To modulate stem cell function, delicate regulations of gene expression <em>via</em> gene therapy approaches are emerging as safe methods<a href="#bib155" rid="bib155" class=" bibr popnode"><sup>155</sup></a>. For example, Jakobsson et&#x000a0;al.<a href="#bib155" rid="bib155" class=" bibr popnode"><sup>155</sup></a> have used LVs-based CRISPR-Cas9 tool to knockout <em>DNMT1</em> in neural progenitor cells which results in feasible, proliferating cells and further implicating a novel gene therapy in human brain disease and development<a href="#bib156" rid="bib156" class=" bibr popnode"><sup>156</sup></a>. As another example, Biffi et&#x000a0;al.<a href="#bib157" rid="bib157" class=" bibr popnode"><sup>157</sup></a> have applied LVs to introduce functional genes into hematopoietic stem cells <em>ex&#x000a0;vivo</em> and indicated that transplantation of these engineered HSCs inhibited and alleviated the symptoms of metachromatic leukodystrophy. Although neuronal progenitors or stem cell therapy have previously demonstrated clinical benefit, these therapeutic strategies are often restricted, especially for disorder conditions owing to cell autonomous defects.</p></div></div><div id="sec5" class="tsec sec"><h2 class="head no_bottom_margin" id="sec5title">5. Delivery routes: a major determinant of efficacy and safety</h2><p id="p0340" class="p p-first">Gene delivery to sensory organs or CNS, including eye, spinal cord, and brain, is a challenging undertaking. Attaining a proper balance between treatment efficiency and compliance and safety is largely decided by the judicious combination of delivery routes and vectors. <a href="/pmc/articles/PMC7488363/figure/fig1/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig1" rid-ob="ob-fig1" co-legend-rid="lgnd_fig1"><span>Fig.&#x000a0;1</span></a> lists many of the preclinical studies and clinical trials and their multiple delivery routes and vectors that will be mentioned in the following section.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="fig1" co-legend-rid="lgnd_fig1"><a href="/pmc/articles/PMC7488363/figure/fig1/" target="figure" rid-figpopup="fig1" rid-ob="ob-fig1"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm139752595925200"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=7488363_gr1.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="Fig. 1" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC7488363/bin/gr1.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm139752595925200"><a target="object" rel="noopener" href="/pmc/articles/PMC7488363/figure/fig1/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_fig1"><div><a class="figpopup" href="/pmc/articles/PMC7488363/figure/fig1/" target="figure" rid-figpopup="fig1" rid-ob="ob-fig1">Figure&#x000a0;1</a></div><!--caption a7--><div class="caption"><p>Delivery routes of gene therapy for neurodegenerative disorders. Although intravenous or cerebrospinal fluid (intrathecal, intracerebroventricular, and subpial routes) administration can effectively treat multifocal disorders, intraparenchymal injection is the most frequently applied delivery route for brain diseases. Local gene delivery is preferable for diseases of the eye, because of its relatively straightforward surgical and instrumental accessibility. Intramuscular injection provides a strategy for vaccine and antibody delivery and production, and intrauterine injection may provide an approach to treat inherited neurodegenerative diseases.</p></div></div></div><div id="sec5.1" class="sec"><h3 id="sec5.1title">5.1. Intravenous injection</h3><p id="p0345" class="p p-first-last">The physiological barriers that compartmentalize sensory and CNS tissues, such as BBB, present serious obstacles to therapeutic gene access. AAV9 is one agent that effectively penetrates these barriers after intravenous injection. This feature enables widespread expression in CNS to treat multifocal disorders and acts as a stimulus for further technological exploration and development<a href="#bib158" rid="bib158" class=" bibr popnode">158</a>, <a href="#bib159" rid="bib159" class=" bibr popnode">159</a>, <a href="#bib160" rid="bib160" class=" bibr popnode">160</a>. Moreover, capsid engineering research has discovered AAV variants that seem to be superior to AAV9, such as AAV-AS, AAV-B1, and AAV.PHP.B, which represents a significant breakthrough for intravenous delivery<a href="#bib20" rid="bib20" class=" bibr popnode"><sup>20</sup></a><sup>,</sup><a href="#bib161" rid="bib161" class=" bibr popnode"><sup>161</sup></a><sup>,</sup><a href="#bib162" rid="bib162" class=" bibr popnode"><sup>162</sup></a>. This delivery route could also result in delivery of the gene cargos to most body tissues which has potential drawbacks but in some cases also potential advantages. Even though intravenous delivery of AAVs is noninvasive and technically feasible, major obstacles continue to complicate clinical applications, including the large doses necessary, generation of antibodies against AAVs, and ongoing safety concerns.</p></div><div id="sec5.2" class="sec"><h3 id="sec5.2title">5.2. Intraparenchymal injection</h3><p id="p0350" class="p p-first-last">Local delivery of vectors has obvious advantages over systemic administration. Intraparenchymal injection is tolerated well and delivers therapeutic genes directly to the neurons and brain region of interest, with little biodistribution to peripheral organs<a href="#bib5" rid="bib5" class=" bibr popnode"><sup>5</sup></a><sup>,</sup><a href="#bib24" rid="bib24" class=" bibr popnode"><sup>24</sup></a><sup>,</sup><a href="#bib163" rid="bib163" class=" bibr popnode"><sup>163</sup></a>. Vectors that do not bind heparin sulfate proteoglycans (HSPGs), like AAV1, AAV8, AAV9, and AAVrh.10, diffuse over larger regions after intraparenchymal injection than vectors that bind HSPGs, such as AAV2, AAV-DJ88, and AAV6<a href="#bib164" rid="bib164" class=" bibr popnode"><sup>164</sup></a>. For disorders such as Canavan disease, which has been treated with AAV2-ASPA, and PD, which has been treated with AAV2-AADC, AAV2 provides an appropriate vehicle to limit diffusion while obtaining satisfactory delivery<a href="#bib29" rid="bib29" class=" bibr popnode"><sup>29</sup></a>.</p></div><div id="sec5.3" class="sec"><h3 id="sec5.3title">5.3. Intrathecal, subpial, intracisternal, intracerebroventricular and intrauterine injection</h3><p id="p0355" class="p p-first-last">Other delivery routes include administration into various cerebrospinal fluid (CSF) compartments. Intrathecal injection of AAVs is especially suitable for delivering vectors to sensory neurons in dorsal root ganglia or motor neurons and has been well tolerated in numerous preclinical studies<a href="#bib12" rid="bib12" class=" bibr popnode"><sup>12</sup></a><sup>,</sup><a href="#bib165" rid="bib165" class=" bibr popnode"><sup>165</sup></a><sup>,</sup><a href="#bib166" rid="bib166" class=" bibr popnode"><sup>166</sup></a>. Interestingly, AAVs, such as AAVrh.10 and AAV9, primarily target spinal cord motor neurons following intrathecal injection in nonhuman primates<a href="#bib167" rid="bib167" class=" bibr popnode"><sup>167</sup></a>. Because subpial administration has only been investigated in the laboratory to date, translation of this dosing method for gene therapy of neurodegenerative disorders requires additional studies<a href="#bib15" rid="bib15" class=" bibr popnode"><sup>15</sup></a>. Preclinical studies have shown that intracisternal and intracerebroventricular administration also produces effective expression of transgenes in spinal cord and cerebral tissues that has alleviated symptoms in models of numerous neurodegenerative disorders, including AD, ALS, and spinal muscular atrophy<a href="#bib168" rid="bib168" class=" bibr popnode">168</a>, <a href="#bib169" rid="bib169" class=" bibr popnode">169</a>, <a href="#bib170" rid="bib170" class=" bibr popnode">170</a>. Additionally, integration-deficient lentiviral vectors (IDLVs) have recently been reported to transduce motor neurons efficiently and permanently after intrauterine injection, indicating the potential for IDLVs to become effective tools to treat inherited neurodegenerative diseases<a href="#bib171" rid="bib171" class=" bibr popnode"><sup>171</sup></a>.</p></div><div id="sec5.4" class="sec sec-last"><h3 id="sec5.4title">5.4. Gene therapy in eye diseases</h3><p id="p0360" class="p p-first">The eye is especially suitable for local injection of AAVs. U.S. Food and Drug Administration (FDA) approval of Luxturna (AAV2-RPE65) to treat Leber's hereditary optic neuropathy signals the arrival of the gene therapy era<a href="#bib172" rid="bib172" class=" bibr popnode"><sup>172</sup></a>. Local administration presents multiple advantages for treating ophthalmic diseases, largely because the relatively easy surgical and instrumental accessibility enables practical interventions and rapid examinations, and because the compartmental characteristics of the eye prevent systemic dispersion of the vectors. Intracameral administration provides delivery to the anterior chamber of the eye, which can be targeted to the cornea or the trabecular meshwork<a href="#bib173" rid="bib173" class=" bibr popnode"><sup>173</sup></a>. Notably, AAV-based gene therapies for ophthalmic diseases have mostly concentrated on retinal diseases, including the neurodegenerative retinal disorders, and have efficiently targeted the inner retina through intravitreal administration and the outer retina through subretinal administration<a href="#bib2" rid="bib2" class=" bibr popnode"><sup>2</sup></a>. These AAVs accumulate between the neural retina and the retinal pigmented epithelial (RPE) cell layer after subretinal administration<a href="#bib174" rid="bib174" class=" bibr popnode"><sup>174</sup></a>. Clinically, intravitreal administration has been used to produce AAV-based therapeutic protein expression or to target retinal ganglion cells<a href="#bib175" rid="bib175" class=" bibr popnode"><sup>175</sup></a>. However, this delivery route needs high doses of AAVs, which can increase the risk of inflammatory responses remarkably in comparison with subretinal administration<a href="#bib176" rid="bib176" class=" bibr popnode"><sup>176</sup></a><sup>,</sup><a href="#bib177" rid="bib177" class=" bibr popnode"><sup>177</sup></a>.</p><p id="p0365" class="p p-last">Taken together, the selection of delivery routes is a key one yet needs a balancing of numerous factors along a risk/benefit equation. Local delivery route of administration has been acknowledged to be the preferential choice for neurodegenerative disorders as it maximizes delivery while minimizing the safety concerns. In order to target more broadly than what local administration routes can achieve and avoid the invasiveness of the local injection procedures, new techniques were urgently required that achieve meaningful levels of gene transfer through these strategies. These delivery routes almost always need higher doses, putting burden on drug manufacturing and raising the risk of toxicity. In some circumstances, a variety of routes of injection are combined when certain disorders require many organs to be treated<a href="#bib178" rid="bib178" class=" bibr popnode"><sup>178</sup></a>.</p></div></div><div id="sec6" class="tsec sec"><h2 class="head no_bottom_margin" id="sec6title">6. Clinical challenges</h2><p id="p0370" class="p p-first-last">Numerous preclinical and clinical studies of gene therapy strategies for preventing or treating a wide range of neurodegenerative diseases have been carried out in recent decades<a href="#bib2" rid="bib2" class=" bibr popnode"><sup>2</sup></a>. However, safety concerns remain one of the biggest barriers to successful clinical application. Gene therapy may cause severe toxicity due to overexpression of the transgene in targeted tissues or expression in off target cells. Toxic effects have included impaired ambulation, ataxia, damaged dorsal root ganglia, elevated transaminases, and proprioceptive deficits<a href="#bib2" rid="bib2" class=" bibr popnode"><sup>2</sup></a><sup>,</sup><a href="#bib179" rid="bib179" class=" bibr popnode"><sup>179</sup></a>. Host responses can also affect the duration and safety of every gene therapy strategy. Patients with adaptive immune responses can produce corresponding neutralizing antibodies, which may prevent the vectors from reaching their intended tissues or cells<a href="#bib180" rid="bib180" class=" bibr popnode"><sup>180</sup></a><sup>,</sup><a href="#bib181" rid="bib181" class=" bibr popnode"><sup>181</sup></a>. Insertional mutagenesis and genotoxicity are probably also concerns when certain transgenes are injected with high-dose vectors<a href="#bib182" rid="bib182" class=" bibr popnode">182</a>, <a href="#bib183" rid="bib183" class=" bibr popnode">183</a>, <a href="#bib184" rid="bib184" class=" bibr popnode">184</a>. Potential gene-based therapeutic strategies to treat neurodegenerative disorders should therefore be carefully scrutinized for clinical development, including evaluation of available safety profiles and pharmacological effects, and identification of individuals who can benefit.</p></div><div id="sec7" class="tsec sec"><h2 class="head no_bottom_margin" id="sec7title">7. Concluding remarks and future prospects</h2><p id="p0375" class="p p-first-last">Gene therapy is an important emerging strategy for treating neurodegenerative disorders, which is especially suited for well-validated genetic targets that are not amenable to traditional therapies. It has been well tolerated and shown long-lasting efficacy in clinical trials for various human neurodegenerative diseases, including PD, AD, HD, and AADC deficiency<a href="#bib5" rid="bib5" class=" bibr popnode"><sup>5</sup></a><sup>,</sup><a href="#bib65" rid="bib65" class=" bibr popnode"><sup>65</sup></a>. Moreover, improvements in delivery, such as direct administration into the CNS, and carriers, such as AAV9 and liposomes, are being vigorously investigated and refined. Although non-viral vectors-based gene therapy has yet to be approved as therapeutics for neurodegenerative disorders, recent advances in the clinical trials have generated great excitement<a href="#bib32" rid="bib32" class=" bibr popnode">32</a>, <a href="#bib33" rid="bib33" class=" bibr popnode">33</a>, <a href="#bib34" rid="bib34" class=" bibr popnode">34</a>, <a href="#bib35" rid="bib35" class=" bibr popnode">35</a>, <a href="#bib36" rid="bib36" class=" bibr popnode">36</a>. Better understanding of the onset and progression of the neurodegenerative disorders will facilitate prompt diagnosis and target selection, which should allow early treatment for certain of these diseases. As progress continues in optimizing transgene design, delivery, and vectors, the prospects of gene therapy for neurodegenerative disorders will undoubtedly become even brighter.</p></div><div id="ack0010" class="tsec sec"><h2 class="head no_bottom_margin" id="ack0010title">Acknowledgments</h2><div class="sec"><p>Our work is supported by National Natural Science Foundation of China (Nos. 81773620 and 81573332) and National Key Basic Research Program of China (No. 2015CB931800) to Dianwen Ju and NIH NEI (EY024932, EY023295 and EY028106, USA) to Yang Hu.</p></div></div><div id="fn-group-a.l.e" class="tsec sec"><h2 class="head no_bottom_margin" id="fn-group-a.l.etitle">Footnotes</h2><!--back/fn-group--><div class="fm-sec half_rhythm small"><p class="fn sec" id="d32e637"><p id="ntpara0010" class="p p-first-last">Peer review under responsibility of Institute of Materia Medica, Chinese Academy of Medical Sciences and Chinese Pharmaceutical Association.</p></p></div></div><div id="appsec1" class="tsec bk-sec"><h2 class="head no_bottom_margin" id="appsec1title">Author contributions</h2><!--/article/back/sec/--><p id="p0380" class="p p-first-last">Wei Chen and Yang Hu wrote the manuscript. Yang Hu and Dianwen Ju designed structures and supervised the work. The final version of the paper has been approved by all authors.</p></div><div id="appsec2" class="tsec bk-sec"><h2 class="head no_bottom_margin" id="appsec2title">Conflicts of interest</h2><!--/article/back/sec/--><p id="p0175b" class="p p-first-last">All authors declare no competing interests.</p></div><div id="cebib0010" class="tsec sec"><h2 class="head no_bottom_margin" id="cebib0010title">References</h2><div class="ref-list-sec sec" id="reference-list"><div class="ref-cit-blk half_rhythm" id="bib1">1. <span class="element-citation" id="sref1">Dunbar C.E., High K.A., Joung J.K., Kohn D.B., Ozawa K., Sadelain M. Gene therapy comes of age. <span><span class="ref-journal">Science. </span>2018;<span class="ref-vol">59</span></span> eaan4672. [<a href="https://pubmed.ncbi.nlm.nih.gov/29326244" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Science&amp;title=Gene+therapy+comes+of+age&amp;author=C.E.+Dunbar&amp;author=K.A.+High&amp;author=J.K.+Joung&amp;author=D.B.+Kohn&amp;author=K.+Ozawa&amp;volume=59&amp;publication_year=2018&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib2">2. <span class="element-citation" id="sref2">Hudry E., Vandenberghe L.H. Therapeutic AAV gene transfer to the nervous system: a clinical reality. <span><span class="ref-journal">Neuron. </span>2019;<span class="ref-vol">101</span>:839–862.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/30844402" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Neuron&amp;title=Therapeutic+AAV+gene+transfer+to+the+nervous+system:+a+clinical+reality&amp;author=E.+Hudry&amp;author=L.H.+Vandenberghe&amp;volume=101&amp;publication_year=2019&amp;pages=839-862&amp;pmid=30844402&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib3">3. <span class="element-citation" id="sref3">Wang D., Tai P.W.L., Gao G. Adeno-associated virus vector as a platform for gene therapy delivery. <span><span class="ref-journal">Nat Rev Drug Discov. </span>2019;<span class="ref-vol">18</span>:358–378.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC6927556/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/30710128" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Rev+Drug+Discov&amp;title=Adeno-associated+virus+vector+as+a+platform+for+gene+therapy+delivery&amp;author=D.+Wang&amp;author=P.W.L.+Tai&amp;author=G.+Gao&amp;volume=18&amp;publication_year=2019&amp;pages=358-378&amp;pmid=30710128&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib4">4. <span class="element-citation" id="sref4">Lee J.H., Wang J.H., Chen J., Li F., Edwards T.L., Hewitt A.W. Gene therapy for visual loss: opportunities and concerns. <span><span class="ref-journal">Prog Retin Eye Res. </span>2019;<span class="ref-vol">68</span>:31–53.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/30170104" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Prog+Retin+Eye+Res&amp;title=Gene+therapy+for+visual+loss:+opportunities+and+concerns&amp;author=J.H.+Lee&amp;author=J.H.+Wang&amp;author=J.+Chen&amp;author=F.+Li&amp;author=T.L.+Edwards&amp;volume=68&amp;publication_year=2019&amp;pages=31-53&amp;pmid=30170104&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib5">5. <span class="element-citation" id="sref5">Weinberg M.S., Samulski R.J., McCown T.J. Adeno-associated virus (AAV) gene therapy for neurological disease. <span><span class="ref-journal">Neuropharmacology. </span>2013;<span class="ref-vol">69</span>:82–88.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC8887624/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/22465202" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Neuropharmacology&amp;title=Adeno-associated+virus+(AAV)+gene+therapy+for+neurological+disease&amp;author=M.S.+Weinberg&amp;author=R.J.+Samulski&amp;author=T.J.+McCown&amp;volume=69&amp;publication_year=2013&amp;pages=82-88&amp;pmid=22465202&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib6">6. <span class="element-citation" id="sref6">Samaranch L., Salegio E.A., San Sebastian W., Kells A.P., Bringas J.R., Forsayeth J. Strong cortical and spinal cord transduction after AAV7 and AAV9 delivery into the CSF of non-human primates. <span><span class="ref-journal">Hum Gene Ther. </span>2013;<span class="ref-vol">24</span>:526–532.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3655626/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/23517473" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Hum+Gene+Ther&amp;title=Strong+cortical+and+spinal+cord+transduction+after+AAV7+and+AAV9+delivery+into+the+CSF+of+non-human+primates&amp;author=L.+Samaranch&amp;author=E.A.+Salegio&amp;author=W.+San+Sebastian&amp;author=A.P.+Kells&amp;author=J.R.+Bringas&amp;volume=24&amp;publication_year=2013&amp;pages=526-532&amp;pmid=23517473&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib7">7. <span class="element-citation" id="sref7">Xiang C., Zhang Y., Guo W., Liang X.J. Biomimetic carbon nanotubes for neurological disease therapeutics as inherent medication. <span><span class="ref-journal">Acta Pharm Sin B. </span>2020;<span class="ref-vol">10</span>:239–248.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7016289/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/32082970" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Acta+Pharm+Sin+B&amp;title=Biomimetic+carbon+nanotubes+for+neurological+disease+therapeutics+as+inherent+medication&amp;author=C.+Xiang&amp;author=Y.+Zhang&amp;author=W.+Guo&amp;author=X.J.+Liang&amp;volume=10&amp;publication_year=2020&amp;pages=239-248&amp;pmid=32082970&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib8">8. <span class="element-citation" id="sref8">Cearley C.N., Vandenberghe L.H., Parente M.K., Carnish E.R., Wilson J.M., Wolfe J.H. Expanded repertoire of AAV vector serotypes mediate unique patterns of transduction in mouse brain. <span><span class="ref-journal">Mol Ther. </span>2008;<span class="ref-vol">16</span>:1710–1718.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3056207/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/18714307" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Mol+Ther&amp;title=Expanded+repertoire+of+AAV+vector+serotypes+mediate+unique+patterns+of+transduction+in+mouse+brain&amp;author=C.N.+Cearley&amp;author=L.H.+Vandenberghe&amp;author=M.K.+Parente&amp;author=E.R.+Carnish&amp;author=J.M.+Wilson&amp;volume=16&amp;publication_year=2008&amp;pages=1710-1718&amp;pmid=18714307&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib9">9. <span class="element-citation" id="sref9">Bartlett J.S., Samulski R.J., McCown T.J. Selective and rapid uptake of adeno-associated virus type 2 in brain. <span><span class="ref-journal">Hum Gene Ther. </span>1998;<span class="ref-vol">9</span>:1181–1186.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/9625257" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Hum+Gene+Ther&amp;title=Selective+and+rapid+uptake+of+adeno-associated+virus+type+2+in+brain&amp;author=J.S.+Bartlett&amp;author=R.J.+Samulski&amp;author=T.J.+McCown&amp;volume=9&amp;publication_year=1998&amp;pages=1181-1186&amp;pmid=9625257&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib10">10. <span class="element-citation" id="sref10">Hutson T.H., Verhaagen J., Y&#x000e1;&#x000f1;ez-Mu&#x000f1;oz R.J., Moon L.D. Corticospinal tract transduction: a comparison of seven adeno-associated viral vector serotypes and a non-integrating lentiviral vector. <span><span class="ref-journal">Gene Ther. </span>2012;<span class="ref-vol">19</span>:49–60.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3160493/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/21562590" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Gene+Ther&amp;title=Corticospinal+tract+transduction:+a+comparison+of+seven+adeno-associated+viral+vector+serotypes+and+a+non-integrating+lentiviral+vector&amp;author=T.H.+Hutson&amp;author=J.+Verhaagen&amp;author=R.J.+Y&#x000e1;&#x000f1;ez-Mu&#x000f1;oz&amp;author=L.D.+Moon&amp;volume=19&amp;publication_year=2012&amp;pages=49-60&amp;pmid=21562590&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib11">11. <span class="element-citation" id="sref11">Katz M.L., Tecedor L., Chen Y., Williamson B.G., Lysenko E., Wininger F.A. AAV gene transfer delays disease onset in a TPP1-deficient canine model of the late infantile form of Batten disease. <span><span class="ref-journal">Sci Transl Med. </span>2015;<span class="ref-vol">7</span></span> 313ra180. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4968409/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/26560358" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Sci+Transl+Med&amp;title=AAV+gene+transfer+delays+disease+onset+in+a+TPP1-deficient+canine+model+of+the+late+infantile+form+of+Batten+disease&amp;author=M.L.+Katz&amp;author=L.+Tecedor&amp;author=Y.+Chen&amp;author=B.G.+Williamson&amp;author=E.+Lysenko&amp;volume=7&amp;publication_year=2015&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib12">12. <span class="element-citation" id="sref12">Federici T., Taub J.S., Baum G.R., Gray S.J., Grieger J.C., Matthews K.A. Robust spinal motor neuron transduction following intrathecal delivery of AAV9 in pigs. <span><span class="ref-journal">Gene Ther. </span>2012;<span class="ref-vol">19</span>:852–859.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/21918551" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Gene+Ther&amp;title=Robust+spinal+motor+neuron+transduction+following+intrathecal+delivery+of+AAV9+in+pigs&amp;author=T.+Federici&amp;author=J.S.+Taub&amp;author=G.R.+Baum&amp;author=S.J.+Gray&amp;author=J.C.+Grieger&amp;volume=19&amp;publication_year=2012&amp;pages=852-859&amp;pmid=21918551&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib13">13. <span class="element-citation" id="sref13">Passini M.A., Watson D.J., Vite C.H., Landsburg D.J., Feigenbaum A.L., Wolfe J.H. Intraventricular brain injection of adeno-associated virus type 1 (AAV1) in neonatal mice results in complementary patterns of neuronal transduction to AAV2 and total long-term correction of storage lesions in the brains of <em>&#x003b2;</em>-glucuronidase deficient mice. <span><span class="ref-journal">J Virol. </span>2003;<span class="ref-vol">77</span>:7034–7040.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC156185/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/12768022" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Virol&amp;title=Intraventricular+brain+injection+of+adeno-associated+virus+type+1+(AAV1)+in+neonatal+mice+results+in+complementary+patterns+of+neuronal+transduction+to+AAV2+and+total+long-term+correction+of+storage+lesions+in+the+brains+of+&#x003b2;-glucuronidase+deficient+mice&amp;author=M.A.+Passini&amp;author=D.J.+Watson&amp;author=C.H.+Vite&amp;author=D.J.+Landsburg&amp;author=A.L.+Feigenbaum&amp;volume=77&amp;publication_year=2003&amp;pages=7034-7040&amp;pmid=12768022&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib14">14. <span class="element-citation" id="sref14">Richardson R.M., Gimenez F., Salegio E.A., Su X., Bringas J., Berger M.S. T2 imaging in monitoring of intraparenchymal real-time convection-enhanced delivery. <span><span class="ref-journal">Neurosurgery. </span>2011;<span class="ref-vol">69</span>:154–163.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/21430597" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Neurosurgery&amp;title=T2+imaging+in+monitoring+of+intraparenchymal+real-time+convection-enhanced+delivery&amp;author=R.M.+Richardson&amp;author=F.+Gimenez&amp;author=E.A.+Salegio&amp;author=X.+Su&amp;author=J.+Bringas&amp;volume=69&amp;publication_year=2011&amp;pages=154-163&amp;pmid=21430597&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib15">15. <span class="element-citation" id="sref15">Miyanohara A., Kamizato K., Juhas S., Juhasova J., Navarro M., Marsala S. Potent spinal parenchymal AAV9-mediated gene delivery by subpial injection in adult rats and pigs. <span><span class="ref-journal">Mol Ther Methods Clin Dev. </span>2016;<span class="ref-vol">3</span>:16046.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4943453/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/27462649" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Mol+Ther+Methods+Clin+Dev&amp;title=Potent+spinal+parenchymal+AAV9-mediated+gene+delivery+by+subpial+injection+in+adult+rats+and+pigs&amp;author=A.+Miyanohara&amp;author=K.+Kamizato&amp;author=S.+Juhas&amp;author=J.+Juhasova&amp;author=M.+Navarro&amp;volume=3&amp;publication_year=2016&amp;pages=16046&amp;pmid=27462649&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib16">16. <span class="element-citation" id="sref16">Morabito G., Giannelli S.G., Ordazzo G., Bido S., Castoldi V., Indrigo M. AAV-PHP.B-mediated global-scale expression in the mouse nervous system enables <em>GBA1</em> gene therapy for wide protection from synucleinopathy. <span><span class="ref-journal">Mol Ther. </span>2017;<span class="ref-vol">25</span>:2727–2742.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC5768559/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/28882452" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Mol+Ther&amp;title=AAV-PHP.B-mediated+global-scale+expression+in+the+mouse+nervous+system+enables+GBA1+gene+therapy+for+wide+protection+from+synucleinopathy&amp;author=G.+Morabito&amp;author=S.G.+Giannelli&amp;author=G.+Ordazzo&amp;author=S.+Bido&amp;author=V.+Castoldi&amp;volume=25&amp;publication_year=2017&amp;pages=2727-2742&amp;pmid=28882452&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib17">17. <span class="element-citation" id="sref17">Passini M.A., Bu J., Richards A.M., Treleaven C.M., Sullivan J.A., O'Riordan C.R. Translational fidelity of intrathecal delivery of self-complementary AAV9-survival motor neuron 1 for spinal muscular atrophy. <span><span class="ref-journal">Hum Gene Ther. </span>2014;<span class="ref-vol">25</span>:619–630.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/24617515" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Hum+Gene+Ther&amp;title=Translational+fidelity+of+intrathecal+delivery+of+self-complementary+AAV9-survival+motor+neuron+1+for+spinal+muscular+atrophy&amp;author=M.A.+Passini&amp;author=J.+Bu&amp;author=A.M.+Richards&amp;author=C.M.+Treleaven&amp;author=J.A.+Sullivan&amp;volume=25&amp;publication_year=2014&amp;pages=619-630&amp;pmid=24617515&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib18">18. <span class="element-citation" id="sref18">Challis R.C., Ravindra Kumar S., Chan K.Y., Challis C., Beadle K., Jang M.J. Systemic AAV vectors for widespread and targeted gene delivery in rodents. <span><span class="ref-journal">Nat Protoc. </span>2019;<span class="ref-vol">14</span>:379–414.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/30626963" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Protoc&amp;title=Systemic+AAV+vectors+for+widespread+and+targeted+gene+delivery+in+rodents&amp;author=R.C.+Challis&amp;author=S.+Ravindra+Kumar&amp;author=K.Y.+Chan&amp;author=C.+Challis&amp;author=K.+Beadle&amp;volume=14&amp;publication_year=2019&amp;pages=379-414&amp;pmid=30626963&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib19">19. <span class="element-citation" id="sref19">Balazs A.B., Bloom J.D., Hong C.M., Rao D.S., Baltimore D. Broad protection against influenza infection by vectored immunoprophylaxis in mice. <span><span class="ref-journal">Nat Biotechnol. </span>2013;<span class="ref-vol">31</span>:647–652.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4030719/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/23728362" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Biotechnol&amp;title=Broad+protection+against+influenza+infection+by+vectored+immunoprophylaxis+in+mice&amp;author=A.B.+Balazs&amp;author=J.D.+Bloom&amp;author=C.M.+Hong&amp;author=D.S.+Rao&amp;author=D.+Baltimore&amp;volume=31&amp;publication_year=2013&amp;pages=647-652&amp;pmid=23728362&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib20">20. <span class="element-citation" id="sref20">Deverman B.E., Pravdo P.L., Simpson B.P., Kumar S.R., Chan K.Y., Banerjee A. Cre-dependent selection yields AAV variants for widespread gene transfer to the adult brain. <span><span class="ref-journal">Nat Biotechnol. </span>2016;<span class="ref-vol">34</span>:204–209.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC5088052/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/26829320" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Biotechnol&amp;title=Cre-dependent+selection+yields+AAV+variants+for+widespread+gene+transfer+to+the+adult+brain&amp;author=B.E.+Deverman&amp;author=P.L.+Pravdo&amp;author=B.P.+Simpson&amp;author=S.R.+Kumar&amp;author=K.Y.+Chan&amp;volume=34&amp;publication_year=2016&amp;pages=204-209&amp;pmid=26829320&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib21">21. <span class="element-citation" id="sref21">Duque S., Joussemet B., Riviere C., Marais T., Dubreil L., Douar A.M. Intravenous administration of self-complementary AAV9 enables transgene delivery to adult motor neurons. <span><span class="ref-journal">Mol Ther. </span>2009;<span class="ref-vol">17</span>:1187–1196.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2835208/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/19367261" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Mol+Ther&amp;title=Intravenous+administration+of+self-complementary+AAV9+enables+transgene+delivery+to+adult+motor+neurons&amp;author=S.+Duque&amp;author=B.+Joussemet&amp;author=C.+Riviere&amp;author=T.+Marais&amp;author=L.+Dubreil&amp;volume=17&amp;publication_year=2009&amp;pages=1187-1196&amp;pmid=19367261&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib22">22. <span class="element-citation" id="sref22">Hwu W.L., Muramatsu S., Tseng S.H., Tzen K.Y., Lee N.C., Chien Y.H. Gene therapy for aromatic <span class="small-caps">l</span>-amino acid decarboxylase deficiency. <span><span class="ref-journal">Sci Transl Med. </span>2012;<span class="ref-vol">4</span></span> 134ra61. [<a href="https://pubmed.ncbi.nlm.nih.gov/22593174" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Sci+Transl+Med&amp;title=Gene+therapy+for+aromatic+l-amino+acid+decarboxylase+deficiency&amp;author=W.L.+Hwu&amp;author=S.+Muramatsu&amp;author=S.H.+Tseng&amp;author=K.Y.+Tzen&amp;author=N.C.+Lee&amp;volume=4&amp;publication_year=2012&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib23">23. <span class="element-citation" id="sref23">Sehara Y., Fujimoto K.I., Ikeguchi K., Katakai Y., Ono F., Takino N. Persistent expression of dopamine-synthesizing enzymes 15 years after gene transfer in a primate model of Parkinson's disease. <span><span class="ref-journal">Hum Gene Ther Clin Dev. </span>2017;<span class="ref-vol">28</span>:74–79.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/28279081" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Hum+Gene+Ther+Clin+Dev&amp;title=Persistent+expression+of+dopamine-synthesizing+enzymes+15+years+after+gene+transfer+in+a+primate+model+of+Parkinson's+disease&amp;author=Y.+Sehara&amp;author=K.I.+Fujimoto&amp;author=K.+Ikeguchi&amp;author=Y.+Katakai&amp;author=F.+Ono&amp;volume=28&amp;publication_year=2017&amp;pages=74-79&amp;pmid=28279081&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib24">24. <span class="element-citation" id="sref24">Mittermeyer G., Christine C.W., Rosenbluth K.H., Baker S.L., Starr P., Larson P. Long-term evaluation of a phase 1 study of AADC gene therapy for Parkinson's disease. <span><span class="ref-journal">Hum Gene Ther. </span>2012;<span class="ref-vol">23</span>:377–381.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4530392/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/22424171" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Hum+Gene+Ther&amp;title=Long-term+evaluation+of+a+phase+1+study+of+AADC+gene+therapy+for+Parkinson's+disease&amp;author=G.+Mittermeyer&amp;author=C.W.+Christine&amp;author=K.H.+Rosenbluth&amp;author=S.L.+Baker&amp;author=P.+Starr&amp;volume=23&amp;publication_year=2012&amp;pages=377-381&amp;pmid=22424171&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib25">25. <span class="element-citation" id="sref25">Murphy S.R., Chang C.C., Dogbevia G., Bryleva E.Y., Bowen Z., Hasan M.T. <em>Acat1</em> knockdown gene therapy decreases amyloid-beta in a mouse model of Alzheimer's disease. <span><span class="ref-journal">Mol Ther. </span>2013;<span class="ref-vol">21</span>:1497–1506.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3734664/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/23774792" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Mol+Ther&amp;title=Acat1+knockdown+gene+therapy+decreases+amyloid-beta+in+a+mouse+model+of+Alzheimer's+disease&amp;author=S.R.+Murphy&amp;author=C.C.+Chang&amp;author=G.+Dogbevia&amp;author=E.Y.+Bryleva&amp;author=Z.+Bowen&amp;volume=21&amp;publication_year=2013&amp;pages=1497-1506&amp;pmid=23774792&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib26">26. <span class="element-citation" id="sref26">Han C.L., Ge M., Liu Y.P., Zhao X.M., Wang K.L., Chen N. LncRNA H19 contributes to hippocampal glial cell activation <em>via</em> JAK/STAT signaling in a rat model of temporal lobe epilepsy. <span><span class="ref-journal">J Neuroinflammation. </span>2018;<span class="ref-vol">15</span>:103.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC5894243/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/29636074" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Neuroinflammation&amp;title=LncRNA+H19+contributes+to+hippocampal+glial+cell+activation+via+JAK/STAT+signaling+in+a+rat+model+of+temporal+lobe+epilepsy&amp;author=C.L.+Han&amp;author=M.+Ge&amp;author=Y.P.+Liu&amp;author=X.M.+Zhao&amp;author=K.L.+Wang&amp;volume=15&amp;publication_year=2018&amp;pages=103&amp;pmid=29636074&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib27">27. <span class="element-citation" id="sref27">Garanto A., Chung D.C., Duijkers L., Corral-Serrano J.C., Messchaert M., Xiao R. <em>In&#x000a0;vitro</em> and <em>in&#x000a0;vivo</em> rescue of aberrant splicing in CEP290-associated LCA by antisense oligonucleotide delivery. <span><span class="ref-journal">Hum Mol Genet. </span>2016;<span class="ref-vol">25</span>:2552–2563.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC6086559/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/27106101" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Hum+Mol+Genet&amp;title=In&#x000a0;vitro+and+in&#x000a0;vivo+rescue+of+aberrant+splicing+in+CEP290-associated+LCA+by+antisense+oligonucleotide+delivery&amp;author=A.+Garanto&amp;author=D.C.+Chung&amp;author=L.+Duijkers&amp;author=J.C.+Corral-Serrano&amp;author=M.+Messchaert&amp;volume=25&amp;publication_year=2016&amp;pages=2552-2563&amp;pmid=27106101&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib28">28. <span class="element-citation" id="sref28">Leone P., Shera D., McPhee S.W., Francis J.S., Kolodny E.H., Bilaniuk L.T. Long-term follow-up after gene therapy for canavan disease. <span><span class="ref-journal">Sci Transl Med. </span>2012;<span class="ref-vol">4</span></span> 165ra163. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3794457/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/23253610" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Sci+Transl+Med&amp;title=Long-term+follow-up+after+gene+therapy+for+canavan+disease&amp;author=P.+Leone&amp;author=D.+Shera&amp;author=S.W.+McPhee&amp;author=J.S.+Francis&amp;author=E.H.+Kolodny&amp;volume=4&amp;publication_year=2012&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib29">29. <span class="element-citation" id="sref29">Mendell J.R., Al-Zaidy S., Shell R., Arnold W.D., Rodino-Klapac L.R., Prior T.W. Single-dose gene-replacement therapy for spinal muscular atrophy. <span><span class="ref-journal">N Engl J Med. </span>2017;<span class="ref-vol">377</span>:1713–1722.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/29091557" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=N+Engl+J+Med&amp;title=Single-dose+gene-replacement+therapy+for+spinal+muscular+atrophy&amp;author=J.R.+Mendell&amp;author=S.+Al-Zaidy&amp;author=R.+Shell&amp;author=W.D.+Arnold&amp;author=L.R.+Rodino-Klapac&amp;volume=377&amp;publication_year=2017&amp;pages=1713-1722&amp;pmid=29091557&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib30">30. <span class="element-citation" id="sref30">Harmatz P., Muenzer J., Burton B.K., Ficicioglu C., Lau H., Leslie N.D. Update on phase 1/2 clinical trials for MPS I and MPS II using ZFN-mediated <em>in&#x000a0;vivo</em> genome editing. <span><span class="ref-journal">Mol Genet Metabol. </span>2018;<span class="ref-vol">123</span>:S59–S60.</span> <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Mol+Genet+Metabol&amp;title=Update+on+phase+1/2+clinical+trials+for+MPS+I+and+MPS+II+using+ZFN-mediated+in&#x000a0;vivo+genome+editing&amp;author=P.+Harmatz&amp;author=J.+Muenzer&amp;author=B.K.+Burton&amp;author=C.+Ficicioglu&amp;author=H.+Lau&amp;volume=123&amp;publication_year=2018&amp;pages=S59-S60&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib31">31. <span class="element-citation" id="sref31">Park H., Oh J., Shim G., Cho B., Chang Y., Kim S. <em>In&#x000a0;vivo</em> neuronal gene editing <em>via</em> CRISPR-Cas9 amphiphilic nanocomplexes alleviates deficits in mouse models of Alzheimer's disease. <span><span class="ref-journal">Nat Neurosci. </span>2019;<span class="ref-vol">22</span>:524–528.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/30858603" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Neurosci&amp;title=In&#x000a0;vivo+neuronal+gene+editing+via+CRISPR-Cas9+amphiphilic+nanocomplexes+alleviates+deficits+in+mouse+models+of+Alzheimer's+disease&amp;author=H.+Park&amp;author=J.+Oh&amp;author=G.+Shim&amp;author=B.+Cho&amp;author=Y.+Chang&amp;volume=22&amp;publication_year=2019&amp;pages=524-528&amp;pmid=30858603&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib32">32. <span class="element-citation" id="sref32">Setten R.L., Rossi J.J., Han S.P. The current state and future directions of RNAi-based therapeutics. <span><span class="ref-journal">Nat Rev Drug Discov. </span>2019;<span class="ref-vol">18</span>:421–446.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/30846871" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Rev+Drug+Discov&amp;title=The+current+state+and+future+directions+of+RNAi-based+therapeutics&amp;author=R.L.+Setten&amp;author=J.J.+Rossi&amp;author=S.P.+Han&amp;volume=18&amp;publication_year=2019&amp;pages=421-446&amp;pmid=30846871&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib33">33. <span class="element-citation" id="sref33">Fitzgerald K., Frank-Kamenetsky M., Shulga-Morskaya S., Liebow A., Bettencourt B.R., Sutherland J.E. Effect of an RNA interference drug on the synthesis of proprotein convertase subtilisin/kexin type 9 (PCSK9) and the concentration of serum LDL cholesterol in healthy volunteers: a randomised, single-blind, placebo-controlled, phase 1 trial. <span><span class="ref-journal">Lancet. </span>2014;<span class="ref-vol">383</span>:60–68.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4387547/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/24094767" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Lancet&amp;title=Effect+of+an+RNA+interference+drug+on+the+synthesis+of+proprotein+convertase+subtilisin/kexin+type+9+(PCSK9)+and+the+concentration+of+serum+LDL+cholesterol+in+healthy+volunteers:+a+randomised,+single-blind,+placebo-controlled,+phase+1+trial&amp;author=K.+Fitzgerald&amp;author=M.+Frank-Kamenetsky&amp;author=S.+Shulga-Morskaya&amp;author=A.+Liebow&amp;author=B.R.+Bettencourt&amp;volume=383&amp;publication_year=2014&amp;pages=60-68&amp;pmid=24094767&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib34">34. <span class="element-citation" id="sref34">Coelho T., Adams D., Silva A., Lozeron P., Hawkins P.N., Mant T. Safety and efficacy of RNAi therapy for transthyretin amyloidosis. <span><span class="ref-journal">N Engl J Med. </span>2013;<span class="ref-vol">369</span>:819–829.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/23984729" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=N+Engl+J+Med&amp;title=Safety+and+efficacy+of+RNAi+therapy+for+transthyretin+amyloidosis&amp;author=T.+Coelho&amp;author=D.+Adams&amp;author=A.+Silva&amp;author=P.+Lozeron&amp;author=P.N.+Hawkins&amp;volume=369&amp;publication_year=2013&amp;pages=819-829&amp;pmid=23984729&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib35">35. <span class="element-citation" id="sref35">Spronck E.A., Brouwers C.C., Vall&#x000e8;s A., de Haan M., Petry H., van Deventer S.J. AAV5-miHTT gene therapy demonstrates sustained huntingtin lowering and functional improvement in Huntington disease mouse models. <span><span class="ref-journal">Mol Ther Methods Clin Dev. </span>2019;<span class="ref-vol">13</span>:334–343.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC6446047/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/30984798" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Mol+Ther+Methods+Clin+Dev&amp;title=AAV5-miHTT+gene+therapy+demonstrates+sustained+huntingtin+lowering+and+functional+improvement+in+Huntington+disease+mouse+models&amp;author=E.A.+Spronck&amp;author=C.C.+Brouwers&amp;author=A.+Vall&#x000e8;s&amp;author=M.+de+Haan&amp;author=H.+Petry&amp;volume=13&amp;publication_year=2019&amp;pages=334-343&amp;pmid=30984798&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib36">36. <span class="element-citation" id="sref36">Tabrizi S.J., Leavitt B.R., Landwehrmeyer G.B., Wild E.J., Saft C., Barker R.A. Targeting huntingtin expression in patients with Huntington's disease. <span><span class="ref-journal">N Engl J Med. </span>2019;<span class="ref-vol">380</span>:2307–2316.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/31059641" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=N+Engl+J+Med&amp;title=Targeting+huntingtin+expression+in+patients+with+Huntington's+disease&amp;author=S.J.+Tabrizi&amp;author=B.R.+Leavitt&amp;author=G.B.+Landwehrmeyer&amp;author=E.J.+Wild&amp;author=C.+Saft&amp;volume=380&amp;publication_year=2019&amp;pages=2307-2316&amp;pmid=31059641&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib37">37. <span class="element-citation" id="sref37">Her L.S., Mao S.H., Chang C.Y., Cheng P.H., Chang Y.F., Yang H.I. MiR-196a enhances neuronal morphology through suppressing RANBP10 to provide neuroprotection in Huntington's disease. <span><span class="ref-journal">Theranostics. </span>2017;<span class="ref-vol">7</span>:2452–2462.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC5525749/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/28744327" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Theranostics&amp;title=MiR-196a+enhances+neuronal+morphology+through+suppressing+RANBP10+to+provide+neuroprotection+in+Huntington's+disease&amp;author=L.S.+Her&amp;author=S.H.+Mao&amp;author=C.Y.+Chang&amp;author=P.H.+Cheng&amp;author=Y.F.+Chang&amp;volume=7&amp;publication_year=2017&amp;pages=2452-2462&amp;pmid=28744327&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib38">38. <span class="element-citation" id="sref38">Srinivasan S., Selvan S.T., Archunan G., Gulyas B., Padmanabhan P. MicroRNAs&#x02014;the next generation therapeutic targets in human diseases. <span><span class="ref-journal">Theranostics. </span>2013;<span class="ref-vol">3</span>:930–942.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3881095/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/24396504" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Theranostics&amp;title=MicroRNAs&#x02014;the+next+generation+therapeutic+targets+in+human+diseases&amp;author=S.+Srinivasan&amp;author=S.T.+Selvan&amp;author=G.+Archunan&amp;author=B.+Gulyas&amp;author=P.+Padmanabhan&amp;volume=3&amp;publication_year=2013&amp;pages=930-942&amp;pmid=24396504&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib39">39. <span class="element-citation" id="sref39">Sudhakar V., Richardson R.M. Gene therapy for neurodegenerative diseases. <span><span class="ref-journal">Neurotherapeutics. </span>2019;<span class="ref-vol">16</span>:166–175.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC6361055/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/30542906" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Neurotherapeutics&amp;title=Gene+therapy+for+neurodegenerative+diseases&amp;author=V.+Sudhakar&amp;author=R.M.+Richardson&amp;volume=16&amp;publication_year=2019&amp;pages=166-175&amp;pmid=30542906&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib40">40. <span class="element-citation" id="sref40">Ciesielska A., Mittermeyer G., Hadaczek P., Kells A.P., Forsayeth J., Bankiewicz K.S. Anterograde axonal transport of AAV2-GDNF in rat basal ganglia. <span><span class="ref-journal">Mol Ther. </span>2011;<span class="ref-vol">19</span>:922–927.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3098627/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/21102559" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Mol+Ther&amp;title=Anterograde+axonal+transport+of+AAV2-GDNF+in+rat+basal+ganglia&amp;author=A.+Ciesielska&amp;author=G.+Mittermeyer&amp;author=P.+Hadaczek&amp;author=A.P.+Kells&amp;author=J.+Forsayeth&amp;volume=19&amp;publication_year=2011&amp;pages=922-927&amp;pmid=21102559&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib41">41. <span class="element-citation" id="sref41">Kells A.P., Hadaczek P., Yin D., Bringas J., Varenika V., Forsayeth J. Efficient gene therapy based method for the delivery of therapeutics to primate cortex. <span><span class="ref-journal">Proc Natl Acad Sci U S A. </span>2009;<span class="ref-vol">106</span>:2407–2411.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2650169/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/19193857" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Proc+Natl+Acad+Sci+U+S+A&amp;title=Efficient+gene+therapy+based+method+for+the+delivery+of+therapeutics+to+primate+cortex&amp;author=A.P.+Kells&amp;author=P.+Hadaczek&amp;author=D.+Yin&amp;author=J.+Bringas&amp;author=V.+Varenika&amp;volume=106&amp;publication_year=2009&amp;pages=2407-2411&amp;pmid=19193857&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib42">42. <span class="element-citation" id="sref42">Green F., Samaranch L., Zhang H.S., Manning-Bog A., Meyer K., Forsayeth J. Axonal transport of AAV9 in nonhuman primate brain. <span><span class="ref-journal">Gene Ther. </span>2016;<span class="ref-vol">23</span>:520–526.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4893316/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/26953486" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Gene+Ther&amp;title=Axonal+transport+of+AAV9+in+nonhuman+primate+brain&amp;author=F.+Green&amp;author=L.+Samaranch&amp;author=H.S.+Zhang&amp;author=A.+Manning-Bog&amp;author=K.+Meyer&amp;volume=23&amp;publication_year=2016&amp;pages=520-526&amp;pmid=26953486&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib43">43. <span class="element-citation" id="sref43">Samaranch L., Blits B., San Sebastian W., Hadaczek P., Bringas J., Sudhakar V. MR-guided parenchymal delivery of adeno-associated viral vector serotype 5 in non-human primate brain. <span><span class="ref-journal">Gene Ther. </span>2017;<span class="ref-vol">24</span>:253–261.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC5404203/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/28300083" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Gene+Ther&amp;title=MR-guided+parenchymal+delivery+of+adeno-associated+viral+vector+serotype+5+in+non-human+primate+brain&amp;author=L.+Samaranch&amp;author=B.+Blits&amp;author=W.+San+Sebastian&amp;author=P.+Hadaczek&amp;author=J.+Bringas&amp;volume=24&amp;publication_year=2017&amp;pages=253-261&amp;pmid=28300083&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib44">44. <span class="element-citation" id="sref44">Arbetman A.E., Lochrie M., Zhou S., Wellman J., Scallan C., Doroudchi M.M. Novel caprine adeno-associated virus (AAV) capsid (AAV-Go.1) is closely related to the primate AAV-5 and has unique tropism and neutralization properties. <span><span class="ref-journal">J Virol. </span>2005;<span class="ref-vol">79</span>:15238–15245.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1316006/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/16306595" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Virol&amp;title=Novel+caprine+adeno-associated+virus+(AAV)+capsid+(AAV-Go.1)+is+closely+related+to+the+primate+AAV-5+and+has+unique+tropism+and+neutralization+properties&amp;author=A.E.+Arbetman&amp;author=M.+Lochrie&amp;author=S.+Zhou&amp;author=J.+Wellman&amp;author=C.+Scallan&amp;volume=79&amp;publication_year=2005&amp;pages=15238-15245&amp;pmid=16306595&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib45">45. <span class="element-citation" id="sref45">Sabatino D.E., Mingozzi F., Hui D.J., Chen H., Colosi P., Ertl H.C. Identification of mouse AAV capsid-specific CD8<sup>+</sup> T cell epitopes. <span><span class="ref-journal">Mol Ther. </span>2005;<span class="ref-vol">12</span>:1023–1033.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/16263332" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Mol+Ther&amp;title=Identification+of+mouse+AAV+capsid-specific+CD8++T+cell+epitopes&amp;author=D.E.+Sabatino&amp;author=F.+Mingozzi&amp;author=D.J.+Hui&amp;author=H.+Chen&amp;author=P.+Colosi&amp;volume=12&amp;publication_year=2005&amp;pages=1023-1033&amp;pmid=16263332&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib46">46. <span class="element-citation" id="sref46">Gao G., Vandenberghe L.H., Alvira M.R., Lu Y., Calcedo R., Zhou X. Clades of adeno-associated viruses are widely disseminated in human tissues. <span><span class="ref-journal">J Virol. </span>2004;<span class="ref-vol">78</span>:6381–6388.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC416542/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/15163731" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Virol&amp;title=Clades+of+adeno-associated+viruses+are+widely+disseminated+in+human+tissues&amp;author=G.+Gao&amp;author=L.H.+Vandenberghe&amp;author=M.R.+Alvira&amp;author=Y.+Lu&amp;author=R.+Calcedo&amp;volume=78&amp;publication_year=2004&amp;pages=6381-6388&amp;pmid=15163731&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib47">47. <span class="element-citation" id="sref47">Gao G., Alvira M.R., Somanathan S., Lu Y., Vandenberghe L.H., Rux J.J. Adeno-associated viruses undergo substantial evolution in primates during natural infections. <span><span class="ref-journal">Proc Natl Acad Sci U S A. </span>2003;<span class="ref-vol">100</span>:6081–6086.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC156329/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/12716974" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Proc+Natl+Acad+Sci+U+S+A&amp;title=Adeno-associated+viruses+undergo+substantial+evolution+in+primates+during+natural+infections&amp;author=G.+Gao&amp;author=M.R.+Alvira&amp;author=S.+Somanathan&amp;author=Y.+Lu&amp;author=L.H.+Vandenberghe&amp;volume=100&amp;publication_year=2003&amp;pages=6081-6086&amp;pmid=12716974&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib48">48. <span class="element-citation" id="sref48">LeWitt P.A., Rezai A.R., Leehey M.A., Ojemann S.G., Flaherty A.W., Eskandar E.N. AAV2-GAD gene therapy for advanced Parkinson's disease: a double-blind, sham-surgery controlled, randomised trial. <span><span class="ref-journal">Lancet Neurol. </span>2011;<span class="ref-vol">10</span>:309–319.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/21419704" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Lancet+Neurol&amp;title=AAV2-GAD+gene+therapy+for+advanced+Parkinson's+disease:+a+double-blind,+sham-surgery+controlled,+randomised+trial&amp;author=P.A.+LeWitt&amp;author=A.R.+Rezai&amp;author=M.A.+Leehey&amp;author=S.G.+Ojemann&amp;author=A.W.+Flaherty&amp;volume=10&amp;publication_year=2011&amp;pages=309-319&amp;pmid=21419704&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib49">49. <span class="element-citation" id="sref49">Marks W.J., Ostrem J.L., Verhagen L., Starr P.A., Larson P.S., Bakay R.A. Safety and tolerability of intraputaminal delivery of CERE-120 (adeno-associated virus serotype 2-neurturin) to patients with idiopathic Parkinson's disease: an open-label, phase I trial. <span><span class="ref-journal">Lancet Neurol. </span>2008;<span class="ref-vol">7</span>:400–408.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/18387850" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Lancet+Neurol&amp;title=Safety+and+tolerability+of+intraputaminal+delivery+of+CERE-120+(adeno-associated+virus+serotype+2-neurturin)+to+patients+with+idiopathic+Parkinson's+disease:+an+open-label,+phase+I+trial&amp;author=W.J.+Marks&amp;author=J.L.+Ostrem&amp;author=L.+Verhagen&amp;author=P.A.+Starr&amp;author=P.S.+Larson&amp;volume=7&amp;publication_year=2008&amp;pages=400-408&amp;pmid=18387850&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib50">50. <span class="element-citation" id="sref50">Rafii M.S., Tuszynski M.H., Thomas R.G., Barba D., Brewer J.B., Rissman R.A. Adeno associated viral vector (serotype 2)-nerve growth factor for patients with Alzheimer disease: a randomized clinical trial. <span><span class="ref-journal">JAMA Neurol. </span>2018;<span class="ref-vol">75</span>:834–841.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC5885277/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/29582053" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=JAMA+Neurol&amp;title=Adeno+associated+viral+vector+(serotype+2)-nerve+growth+factor+for+patients+with+Alzheimer+disease:+a+randomized+clinical+trial&amp;author=M.S.+Rafii&amp;author=M.H.+Tuszynski&amp;author=R.G.+Thomas&amp;author=D.+Barba&amp;author=J.B.+Brewer&amp;volume=75&amp;publication_year=2018&amp;pages=834-841&amp;pmid=29582053&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib51">51. <span class="element-citation" id="sref51">Marks W.J., Bartus R.T., Siffert J., Davis C.S., Lozano A., Boulis N. Gene delivery of AAV2-neurturin for Parkinson's disease: a double-blind, randomised, controlled trial. <span><span class="ref-journal">Lancet Neurol. </span>2010;<span class="ref-vol">9</span>:1164–1172.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/20970382" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Lancet+Neurol&amp;title=Gene+delivery+of+AAV2-neurturin+for+Parkinson's+disease:+a+double-blind,+randomised,+controlled+trial&amp;author=W.J.+Marks&amp;author=R.T.+Bartus&amp;author=J.+Siffert&amp;author=C.S.+Davis&amp;author=A.+Lozano&amp;volume=9&amp;publication_year=2010&amp;pages=1164-1172&amp;pmid=20970382&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib52">52. <span class="element-citation" id="sref52">Liu G., Martins I.H., Chiorini J.A., Davidson B.L. Adeno-associated virus type 4 (AAV4) targets ependyma and astrocytes in the subventricular zone and RMS. <span><span class="ref-journal">Gene Ther. </span>2005;<span class="ref-vol">12</span>:1503–1508.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/15944733" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Gene+Ther&amp;title=Adeno-associated+virus+type+4+(AAV4)+targets+ependyma+and+astrocytes+in+the+subventricular+zone+and+RMS&amp;author=G.+Liu&amp;author=I.H.+Martins&amp;author=J.A.+Chiorini&amp;author=B.L.+Davidson&amp;volume=12&amp;publication_year=2005&amp;pages=1503-1508&amp;pmid=15944733&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib53">53. <span class="element-citation" id="sref53">Davidson B.L., Stein C.S., Heth J.A., Martins I., Kotin R.M., Derksen T.A. Recombinant adeno-associated virus type 2, 4, and 5 vectors: transduction of variant cell types and regions in the mammalian central nervous system. <span><span class="ref-journal">Proc Natl Acad Sci U S A. </span>2000;<span class="ref-vol">97</span>:3428–3432.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC16256/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/10688913" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Proc+Natl+Acad+Sci+U+S+A&amp;title=Recombinant+adeno-associated+virus+type+2,+4,+and+5+vectors:+transduction+of+variant+cell+types+and+regions+in+the+mammalian+central+nervous+system&amp;author=B.L.+Davidson&amp;author=C.S.+Stein&amp;author=J.A.+Heth&amp;author=I.+Martins&amp;author=R.M.+Kotin&amp;volume=97&amp;publication_year=2000&amp;pages=3428-3432&amp;pmid=10688913&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib54">54. <span class="element-citation" id="sref54">Adachi K., Enoki T., Kawano Y., Veraz M., Nakai H. Drawing a high-resolution functional map of adeno-associated virus capsid by massively parallel sequencing. <span><span class="ref-journal">Nat Commun. </span>2014;<span class="ref-vol">5</span>:3075.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3941020/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/24435020" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Commun&amp;title=Drawing+a+high-resolution+functional+map+of+adeno-associated+virus+capsid+by+massively+parallel+sequencing&amp;author=K.+Adachi&amp;author=T.+Enoki&amp;author=Y.+Kawano&amp;author=M.+Veraz&amp;author=H.+Nakai&amp;volume=5&amp;publication_year=2014&amp;pages=3075&amp;pmid=24435020&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib55">55. <span class="element-citation" id="sref55">Albright B.H., Storey C.M., Murlidharan G., Castellanos Rivera R.M., Berry G.E., Madigan V.J. Mapping the structural determinants required for AAVrh.10 transport across the blood&#x02013;brain barrier. <span><span class="ref-journal">Mol Ther. </span>2018;<span class="ref-vol">26</span>:510–523.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC5835146/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/29175157" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Mol+Ther&amp;title=Mapping+the+structural+determinants+required+for+AAVrh.10+transport+across+the+blood&#x02013;brain+barrier&amp;author=B.H.+Albright&amp;author=C.M.+Storey&amp;author=G.+Murlidharan&amp;author=R.M.+Castellanos+Rivera&amp;author=G.E.+Berry&amp;volume=26&amp;publication_year=2018&amp;pages=510-523&amp;pmid=29175157&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib56">56. <span class="element-citation" id="sref56">Allen W.E., Kauvar I.V., Chen M.Z., Richman E.B., Yang S.J., Chan K. Global representations of goal-directed behavior in distinct cell types of mouse neocortex. <span><span class="ref-journal">Neuron. </span>2017;<span class="ref-vol">94</span>:891–907.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC5723385/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/28521139" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Neuron&amp;title=Global+representations+of+goal-directed+behavior+in+distinct+cell+types+of+mouse+neocortex&amp;author=W.E.+Allen&amp;author=I.V.+Kauvar&amp;author=M.Z.+Chen&amp;author=E.B.+Richman&amp;author=S.J.+Yang&amp;volume=94&amp;publication_year=2017&amp;pages=891-907&amp;pmid=28521139&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib57">57. <span class="element-citation" id="sref57">Dalkara D., Byrne L.C., Klimczak R.R., Visel M., Yin L., Merigan W.H. <em>In&#x000a0;vivo</em>-directed evolution of a new adeno-associated virus for therapeutic outer retinal gene delivery from the vitreous. <span><span class="ref-journal">Sci Transl Med. </span>2013;<span class="ref-vol">5</span></span> 189ra76. [<a href="https://pubmed.ncbi.nlm.nih.gov/23761039" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Sci+Transl+Med&amp;title=In&#x000a0;vivo-directed+evolution+of+a+new+adeno-associated+virus+for+therapeutic+outer+retinal+gene+delivery+from+the+vitreous&amp;author=D.+Dalkara&amp;author=L.C.+Byrne&amp;author=R.R.+Klimczak&amp;author=M.+Visel&amp;author=L.+Yin&amp;volume=5&amp;publication_year=2013&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib58">58. <span class="element-citation" id="sref58">Kritzinger A., Ferger B., Gillardon F., Stierstorfer B., Birk G., Kochanek S. Age-related pathology after adenoviral overexpression of the leucine-rich repeat kinase 2 in the mouse striatum. <span><span class="ref-journal">Neurobiol Aging. </span>2018;<span class="ref-vol">66</span>:97–111.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/29550548" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Neurobiol+Aging&amp;title=Age-related+pathology+after+adenoviral+overexpression+of+the+leucine-rich+repeat+kinase+2+in+the+mouse+striatum&amp;author=A.+Kritzinger&amp;author=B.+Ferger&amp;author=F.+Gillardon&amp;author=B.+Stierstorfer&amp;author=G.+Birk&amp;volume=66&amp;publication_year=2018&amp;pages=97-111&amp;pmid=29550548&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib59">59. <span class="element-citation" id="sref59">Barkats M., Bilang-Bleuel A., Buc-Caron M.H., Castel-Barthe M.N., Corti O., Finiels F. Adenovirus in the brain: recent advances of gene therapy for neurodegenerative diseases. <span><span class="ref-journal">Prog Neurobiol. </span>1998;<span class="ref-vol">55</span>:333–341.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/9654383" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Prog+Neurobiol&amp;title=Adenovirus+in+the+brain:+recent+advances+of+gene+therapy+for+neurodegenerative+diseases&amp;author=M.+Barkats&amp;author=A.+Bilang-Bleuel&amp;author=M.H.+Buc-Caron&amp;author=M.N.+Castel-Barthe&amp;author=O.+Corti&amp;volume=55&amp;publication_year=1998&amp;pages=333-341&amp;pmid=9654383&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib60">60. <span class="element-citation" id="sref60">Palfi S., Gurruchaga J.M., Ralph G.S., Lepetit H., Lavisse S., Buttery P.C. Long-term safety and tolerability of ProSavin, a lentiviral vector-based gene therapy for Parkinson's disease: a dose escalation, open-label, phase 1/2 trial. <span><span class="ref-journal">Lancet. </span>2014;<span class="ref-vol">383</span>:1138–1146.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/24412048" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Lancet&amp;title=Long-term+safety+and+tolerability+of+ProSavin,+a+lentiviral+vector-based+gene+therapy+for+Parkinson's+disease:+a+dose+escalation,+open-label,+phase+1/2+trial&amp;author=S.+Palfi&amp;author=J.M.+Gurruchaga&amp;author=G.S.+Ralph&amp;author=H.+Lepetit&amp;author=S.+Lavisse&amp;volume=383&amp;publication_year=2014&amp;pages=1138-1146&amp;pmid=24412048&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib61">61. <span class="element-citation" id="sref61">Waehler R., Russell S.J., Curiel D.T. Engineering targeted viral vectors for gene therapy. <span><span class="ref-journal">Nat Rev Genet. </span>2007;<span class="ref-vol">8</span>:573–587.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7097627/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/17607305" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Rev+Genet&amp;title=Engineering+targeted+viral+vectors+for+gene+therapy&amp;author=R.+Waehler&amp;author=S.J.+Russell&amp;author=D.T.+Curiel&amp;volume=8&amp;publication_year=2007&amp;pages=573-587&amp;pmid=17607305&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib62">62. <span class="element-citation" id="sref62">Thomas C.E., Ehrhardt A., Kay M.A. Progress and problems with the use of viral vectors for gene therapy. <span><span class="ref-journal">Nat Rev Genet. </span>2003;<span class="ref-vol">4</span>:346–358.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/12728277" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Rev+Genet&amp;title=Progress+and+problems+with+the+use+of+viral+vectors+for+gene+therapy&amp;author=C.E.+Thomas&amp;author=A.+Ehrhardt&amp;author=M.A.+Kay&amp;volume=4&amp;publication_year=2003&amp;pages=346-358&amp;pmid=12728277&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib63">63. <span class="element-citation" id="sref63">Baum C., Kustikova O., Modlich U., Li Z., Fehse B. Mutagenesis and oncogenesis by chromosomal insertion of gene transfer vectors. <span><span class="ref-journal">Hum Gene Ther. </span>2006;<span class="ref-vol">17</span>:253–263.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/16544975" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Hum+Gene+Ther&amp;title=Mutagenesis+and+oncogenesis+by+chromosomal+insertion+of+gene+transfer+vectors&amp;author=C.+Baum&amp;author=O.+Kustikova&amp;author=U.+Modlich&amp;author=Z.+Li&amp;author=B.+Fehse&amp;volume=17&amp;publication_year=2006&amp;pages=253-263&amp;pmid=16544975&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib64">64. <span class="element-citation" id="sref64">Bouard D., Alazard-Dany D., Cosset F.L. Viral vectors: from virology to transgene expression. <span><span class="ref-journal">Br J Pharmacol. </span>2009;<span class="ref-vol">157</span>:153–165.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2629647/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/18776913" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Br+J+Pharmacol&amp;title=Viral+vectors:+from+virology+to+transgene+expression&amp;author=D.+Bouard&amp;author=D.+Alazard-Dany&amp;author=F.L.+Cosset&amp;volume=157&amp;publication_year=2009&amp;pages=153-165&amp;pmid=18776913&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib65">65. <span class="element-citation" id="sref65">Bessis N., GarciaCozar F.J., Boissier M.C. Immune responses to gene therapy vectors: influence on vector function and effector mechanisms. <span><span class="ref-journal">Gene Ther. </span>2004;<span class="ref-vol">11</span>:S10–S17.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/15454952" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Gene+Ther&amp;title=Immune+responses+to+gene+therapy+vectors:+influence+on+vector+function+and+effector+mechanisms&amp;author=N.+Bessis&amp;author=F.J.+GarciaCozar&amp;author=M.C.+Boissier&amp;volume=11&amp;publication_year=2004&amp;pages=S10-S17&amp;pmid=15454952&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib66">66. <span class="element-citation" id="sref66">Deverman B.E., Ravina B.M., Bankiewicz K.S., Paul S.M., Sah D.W. Gene therapy for neurological disorders: progress and prospects. <span><span class="ref-journal">Nat Rev Drug Discov. </span>2018;<span class="ref-vol">17</span>:641–659.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/30093643" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Rev+Drug+Discov&amp;title=Gene+therapy+for+neurological+disorders:+progress+and+prospects&amp;author=B.E.+Deverman&amp;author=B.M.+Ravina&amp;author=K.S.+Bankiewicz&amp;author=S.M.+Paul&amp;author=D.W.+Sah&amp;volume=17&amp;publication_year=2018&amp;pages=641-659&amp;pmid=30093643&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib67">67. <span class="element-citation" id="sref67">Pack D.W., Hoffman A.S., Pun S., Stayton P.S. Design and development of polymers for gene delivery. <span><span class="ref-journal">Nat Rev Drug Discov. </span>2005;<span class="ref-vol">4</span>:581–593.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/16052241" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Rev+Drug+Discov&amp;title=Design+and+development+of+polymers+for+gene+delivery&amp;author=D.W.+Pack&amp;author=A.S.+Hoffman&amp;author=S.+Pun&amp;author=P.S.+Stayton&amp;volume=4&amp;publication_year=2005&amp;pages=581-593&amp;pmid=16052241&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib68">68. <span class="element-citation" id="sref68">Mintzer M.A., Simanek E.E. Nonviral vectors for gene delivery. <span><span class="ref-journal">Chem Rev. </span>2009;<span class="ref-vol">109</span>:259–302.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/19053809" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Chem+Rev&amp;title=Nonviral+vectors+for+gene+delivery&amp;author=M.A.+Mintzer&amp;author=E.E.+Simanek&amp;volume=109&amp;publication_year=2009&amp;pages=259-302&amp;pmid=19053809&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib69">69. <span class="element-citation" id="sref69">Buck J., Grossen P., Cullis P.R., Huwyler J., Witzigmann D. Lipid-based DNA therapeutics: hallmarks of non-viral gene delivery. <span><span class="ref-journal">ACS Nano. </span>2019;<span class="ref-vol">13</span>:3754–3782.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/30908008" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=ACS+Nano&amp;title=Lipid-based+DNA+therapeutics:+hallmarks+of+non-viral+gene+delivery&amp;author=J.+Buck&amp;author=P.+Grossen&amp;author=P.R.+Cullis&amp;author=J.+Huwyler&amp;author=D.+Witzigmann&amp;volume=13&amp;publication_year=2019&amp;pages=3754-3782&amp;pmid=30908008&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib70">70. <span class="element-citation" id="sref70">Yin H., Kanasty R.L., Eltoukhy A.A., Vegas A.J., Dorkin J.R., Anderson D.G. Non-viral vectors for gene-based therapy. <span><span class="ref-journal">Nat Rev Genet. </span>2014;<span class="ref-vol">15</span>:541–555.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/25022906" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Rev+Genet&amp;title=Non-viral+vectors+for+gene-based+therapy&amp;author=H.+Yin&amp;author=R.L.+Kanasty&amp;author=A.A.+Eltoukhy&amp;author=A.J.+Vegas&amp;author=J.R.+Dorkin&amp;volume=15&amp;publication_year=2014&amp;pages=541-555&amp;pmid=25022906&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib71">71. <span class="element-citation" id="sref71">Li W., Szoka F.C. Lipid-based nanoparticles for nucleic acid delivery. <span><span class="ref-journal">Pharm Res (N Y) </span>2007;<span class="ref-vol">24</span>:438–449.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/17252188" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Pharm+Res+(N+Y)&amp;title=Lipid-based+nanoparticles+for+nucleic+acid+delivery&amp;author=W.+Li&amp;author=F.C.+Szoka&amp;volume=24&amp;publication_year=2007&amp;pages=438-449&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib72">72. <span class="element-citation" id="sref72">Concei&#x000e7;&#x000e3;o M., Mendon&#x000e7;a L., N&#x000f3;brega C., Gomes C., Costa P., Hirai H. Intravenous administration of brain-targeted stable nucleic acid lipid particles alleviates Machado-Joseph disease neurological phenotype. <span><span class="ref-journal">Biomaterials. </span>2016;<span class="ref-vol">82</span>:124–137.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/26757259" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Biomaterials&amp;title=Intravenous+administration+of+brain-targeted+stable+nucleic+acid+lipid+particles+alleviates+Machado-Joseph+disease+neurological+phenotype&amp;author=M.+Concei&#x000e7;&#x000e3;o&amp;author=L.+Mendon&#x000e7;a&amp;author=C.+N&#x000f3;brega&amp;author=C.+Gomes&amp;author=P.+Costa&amp;volume=82&amp;publication_year=2016&amp;pages=124-137&amp;pmid=26757259&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib73">73. <span class="element-citation" id="sref73">Carradori D., Eyer J., Saulnier P., Pr&#x000e9;at V., des Rieux A. The therapeutic contribution of nanomedicine to treat neurodegenerative diseases <em>via</em> neural stem cell differentiation. <span><span class="ref-journal">Biomaterials. </span>2017;<span class="ref-vol">123</span>:77–91.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/28161683" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Biomaterials&amp;title=The+therapeutic+contribution+of+nanomedicine+to+treat+neurodegenerative+diseases+via+neural+stem+cell+differentiation&amp;author=D.+Carradori&amp;author=J.+Eyer&amp;author=P.+Saulnier&amp;author=V.+Pr&#x000e9;at&amp;author=A.+des+Rieux&amp;volume=123&amp;publication_year=2017&amp;pages=77-91&amp;pmid=28161683&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib74">74. <span class="element-citation" id="sref74">Niu S., Zhang L.K., Zhang L., Zhuang S., Zhan X., Chen W.Y. Inhibition by multifunctional magnetic nanoparticles loaded with <em>&#x003b1;</em>-synuclein RNAi plasmid in a Parkinson's disease model. <span><span class="ref-journal">Theranostics. </span>2017;<span class="ref-vol">7</span>:344–356.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC5197069/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/28042339" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Theranostics&amp;title=Inhibition+by+multifunctional+magnetic+nanoparticles+loaded+with+&#x003b1;-synuclein+RNAi+plasmid+in+a+Parkinson's+disease+model&amp;author=S.+Niu&amp;author=L.K.+Zhang&amp;author=L.+Zhang&amp;author=S.+Zhuang&amp;author=X.+Zhan&amp;volume=7&amp;publication_year=2017&amp;pages=344-356&amp;pmid=28042339&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib75">75. <span class="element-citation" id="sref75">Semple S.C., Akinc A., Chen J., Sandhu A.P., Mui B.L., Cho C.K. Rational design of cationic lipids for siRNA delivery. <span><span class="ref-journal">Nat Biotechnol. </span>2010;<span class="ref-vol">28</span>:172–176.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/20081866" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Biotechnol&amp;title=Rational+design+of+cationic+lipids+for+siRNA+delivery&amp;author=S.C.+Semple&amp;author=A.+Akinc&amp;author=J.+Chen&amp;author=A.P.+Sandhu&amp;author=B.L.+Mui&amp;volume=28&amp;publication_year=2010&amp;pages=172-176&amp;pmid=20081866&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib76">76. <span class="element-citation" id="sref76">Kojima R., Bojar D., Rizzi G., Hamri G.C., El-Baba M.D., Saxena P. Designer exosomes produced by implanted cells intracerebrally deliver therapeutic cargo for Parkinson's disease treatment. <span><span class="ref-journal">Nat Commun. </span>2018;<span class="ref-vol">9</span>:1305.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC5880805/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/29610454" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Commun&amp;title=Designer+exosomes+produced+by+implanted+cells+intracerebrally+deliver+therapeutic+cargo+for+Parkinson's+disease+treatment&amp;author=R.+Kojima&amp;author=D.+Bojar&amp;author=G.+Rizzi&amp;author=G.C.+Hamri&amp;author=M.D.+El-Baba&amp;volume=9&amp;publication_year=2018&amp;pages=1305&amp;pmid=29610454&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib77">77. <span class="element-citation" id="sref77">Chen W., Luan J., Wei G., Zhang X., Fan J., Zai W. <em>In&#x000a0;vivo</em> hepatocellular expression of interleukin-22 using penetratin-based hybrid nanoparticles as potential anti-hepatitis therapeutics. <span><span class="ref-journal">Biomaterials. </span>2018;<span class="ref-vol">187</span>:66–80.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/30296739" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Biomaterials&amp;title=In&#x000a0;vivo+hepatocellular+expression+of+interleukin-22+using+penetratin-based+hybrid+nanoparticles+as+potential+anti-hepatitis+therapeutics&amp;author=W.+Chen&amp;author=J.+Luan&amp;author=G.+Wei&amp;author=X.+Zhang&amp;author=J.+Fan&amp;volume=187&amp;publication_year=2018&amp;pages=66-80&amp;pmid=30296739&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib78">78. <span class="element-citation" id="sref78">Malhotra M., Tomaro-Duchesneau C., Prakash S. Synthesis of TAT peptide-tagged PEGylated chitosan nanoparticles for siRNA delivery targeting neurodegenerative diseases. <span><span class="ref-journal">Biomaterials. </span>2013;<span class="ref-vol">34</span>:1270–1280.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/23140978" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Biomaterials&amp;title=Synthesis+of+TAT+peptide-tagged+PEGylated+chitosan+nanoparticles+for+siRNA+delivery+targeting+neurodegenerative+diseases&amp;author=M.+Malhotra&amp;author=C.+Tomaro-Duchesneau&amp;author=S.+Prakash&amp;volume=34&amp;publication_year=2013&amp;pages=1270-1280&amp;pmid=23140978&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib79">79. <span class="element-citation" id="sref79">Morris V.B., Labhasetwar V. Arginine-rich polyplexes for gene delivery to neuronal cells. <span><span class="ref-journal">Biomaterials. </span>2015;<span class="ref-vol">60</span>:151–160.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4458175/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/26000961" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Biomaterials&amp;title=Arginine-rich+polyplexes+for+gene+delivery+to+neuronal+cells&amp;author=V.B.+Morris&amp;author=V.+Labhasetwar&amp;volume=60&amp;publication_year=2015&amp;pages=151-160&amp;pmid=26000961&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib80">80. <span class="element-citation" id="sref80">Borel F., Kay M.A., Mueller C. Recombinant AAV as a platform for translating the therapeutic potential of RNA interference. <span><span class="ref-journal">Mol Ther. </span>2014;<span class="ref-vol">22</span>:692–701.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3982504/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/24352214" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Mol+Ther&amp;title=Recombinant+AAV+as+a+platform+for+translating+the+therapeutic+potential+of+RNA+interference&amp;author=F.+Borel&amp;author=M.A.+Kay&amp;author=C.+Mueller&amp;volume=22&amp;publication_year=2014&amp;pages=692-701&amp;pmid=24352214&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib81">81. <span class="element-citation" id="sref81">Aguzzi A., O'Connor T. Protein aggregation diseases: pathogenicity and therapeutic perspectives. <span><span class="ref-journal">Nat Rev Drug Discov. </span>2010;<span class="ref-vol">9</span>:237–248.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/20190788" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Rev+Drug+Discov&amp;title=Protein+aggregation+diseases:+pathogenicity+and+therapeutic+perspectives&amp;author=A.+Aguzzi&amp;author=T.+O'Connor&amp;volume=9&amp;publication_year=2010&amp;pages=237-248&amp;pmid=20190788&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib82">82. <span class="element-citation" id="sref82">Soto C. Unfolding the role of protein misfolding in neurodegenerative diseases. <span><span class="ref-journal">Nat Rev Neurosci. </span>2003;<span class="ref-vol">4</span>:49–60.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/12511861" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Rev+Neurosci&amp;title=Unfolding+the+role+of+protein+misfolding+in+neurodegenerative+diseases&amp;author=C.+Soto&amp;volume=4&amp;publication_year=2003&amp;pages=49-60&amp;pmid=12511861&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib83">83. <span class="element-citation" id="sref83">Wang M., Kaufman R.J. Protein misfolding in the endoplasmic reticulum as a conduit to human disease. <span><span class="ref-journal">Nature. </span>2016;<span class="ref-vol">529</span>:326–335.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/26791723" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=Protein+misfolding+in+the+endoplasmic+reticulum+as+a+conduit+to+human+disease&amp;author=M.+Wang&amp;author=R.J.+Kaufman&amp;volume=529&amp;publication_year=2016&amp;pages=326-335&amp;pmid=26791723&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib84">84. <span class="element-citation" id="sref84">Hetz C., Russelakis-Carneiro M., Maundrell K., Castilla J., Soto C. Caspase-12 and endoplasmic reticulum stress mediate neurotoxicity of pathological prion protein. <span><span class="ref-journal">EMBO J. </span>2003;<span class="ref-vol">22</span>:5435–5445.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC213791/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/14532116" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=EMBO+J&amp;title=Caspase-12+and+endoplasmic+reticulum+stress+mediate+neurotoxicity+of+pathological+prion+protein&amp;author=C.+Hetz&amp;author=M.+Russelakis-Carneiro&amp;author=K.+Maundrell&amp;author=J.+Castilla&amp;author=C.+Soto&amp;volume=22&amp;publication_year=2003&amp;pages=5435-5445&amp;pmid=14532116&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib85">85. <span class="element-citation" id="sref85">Abisambra J.F., Jinwal U.K., Blair L.J., O'Leary J.C., Li Q., Brady S. Tau accumulation activates the unfolded protein response by impairing endoplasmic reticulum-associated degradation. <span><span class="ref-journal">J Neurosci. </span>2013;<span class="ref-vol">33</span>:9498–9507.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3733249/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/23719816" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Neurosci&amp;title=Tau+accumulation+activates+the+unfolded+protein+response+by+impairing+endoplasmic+reticulum-associated+degradation&amp;author=J.F.+Abisambra&amp;author=U.K.+Jinwal&amp;author=L.J.+Blair&amp;author=J.C.+O'Leary&amp;author=Q.+Li&amp;volume=33&amp;publication_year=2013&amp;pages=9498-9507&amp;pmid=23719816&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib86">86. <span class="element-citation" id="sref86">Cooper A.A., Gitler A.D., Cashikar A., Haynes C.M., Hill K.J., Bhullar B. <em>&#x003b1;</em>-Synuclein blocks ER-Golgi traffic and Rab1 rescues neuron loss in Parkinson's models. <span><span class="ref-journal">Science. </span>2006;<span class="ref-vol">313</span>:324–328.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1983366/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/16794039" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Science&amp;title=&#x003b1;-Synuclein+blocks+ER-Golgi+traffic+and+Rab1+rescues+neuron+loss+in+Parkinson's+models&amp;author=A.A.+Cooper&amp;author=A.D.+Gitler&amp;author=A.+Cashikar&amp;author=C.M.+Haynes&amp;author=K.J.+Hill&amp;volume=313&amp;publication_year=2006&amp;pages=324-328&amp;pmid=16794039&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib87">87. <span class="element-citation" id="sref87">Hu Y., Park K.K., Yang L., Wei X., Yang Q., Cho K.S. Differential effects of unfolded protein response pathways on axon injury-induced death of retinal ganglion cells. <span><span class="ref-journal">Neuron. </span>2012;<span class="ref-vol">73</span>:445–452.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3278720/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/22325198" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Neuron&amp;title=Differential+effects+of+unfolded+protein+response+pathways+on+axon+injury-induced+death+of+retinal+ganglion+cells&amp;author=Y.+Hu&amp;author=K.K.+Park&amp;author=L.+Yang&amp;author=X.+Wei&amp;author=Q.+Yang&amp;volume=73&amp;publication_year=2012&amp;pages=445-452&amp;pmid=22325198&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib88">88. <span class="element-citation" id="sref88">Yang L., Li S., Miao L., Huang H., Liang F., Teng X. Rescue of glaucomatous neurodegeneration by differentially modulating neuronal endoplasmic reticulum stress molecules. <span><span class="ref-journal">J Neurosci. </span>2016;<span class="ref-vol">36</span>:5891–5903.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4879204/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/27225776" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Neurosci&amp;title=Rescue+of+glaucomatous+neurodegeneration+by+differentially+modulating+neuronal+endoplasmic+reticulum+stress+molecules&amp;author=L.+Yang&amp;author=S.+Li&amp;author=L.+Miao&amp;author=H.+Huang&amp;author=F.+Liang&amp;volume=36&amp;publication_year=2016&amp;pages=5891-5903&amp;pmid=27225776&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib89">89. <span class="element-citation" id="sref89">Huang H., Miao L., Liang F., Liu X., Xu L., Teng X. Neuroprotection by eIF2<em>&#x003b1;</em>-CHOP inhibition and XBP-1 activation in EAE/optic neuritiss. <span><span class="ref-journal">Cell Death Dis. </span>2017;<span class="ref-vol">8</span></span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC5550873/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/28726788" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cell+Death+Dis&amp;title=Neuroprotection+by+eIF2&#x003b1;-CHOP+inhibition+and+XBP-1+activation+in+EAE/optic+neuritiss&amp;author=H.+Huang&amp;author=L.+Miao&amp;author=F.+Liang&amp;author=X.+Liu&amp;author=L.+Xu&amp;volume=8&amp;publication_year=2017&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib90">90. <span class="element-citation" id="sref90">Valenzuela V., Martinez G., Duran-Aniotz C., Hetz C. Gene therapy to target ER stress in brain diseases. <span><span class="ref-journal">Brain Res. </span>2016;<span class="ref-vol">1648</span>:561–570.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/27131987" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Brain+Res&amp;title=Gene+therapy+to+target+ER+stress+in+brain+diseases&amp;author=V.+Valenzuela&amp;author=G.+Martinez&amp;author=C.+Duran-Aniotz&amp;author=C.+Hetz&amp;volume=1648&amp;publication_year=2016&amp;pages=561-570&amp;pmid=27131987&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib91">91. <span class="element-citation" id="sref91">Zuleta A., Vidal R.L., Armentano D., Parsons G., Hetz C. AAV-mediated delivery of the transcription factor XBP1s into the striatum reduces mutant Huntingtin aggregation in a mouse model of Huntington's disease. <span><span class="ref-journal">Biochem Biophys Res Commun. </span>2012;<span class="ref-vol">420</span>:558–563.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/22445760" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Biochem+Biophys+Res+Commun&amp;title=AAV-mediated+delivery+of+the+transcription+factor+XBP1s+into+the+striatum+reduces+mutant+Huntingtin+aggregation+in+a+mouse+model+of+Huntington's+disease&amp;author=A.+Zuleta&amp;author=R.L.+Vidal&amp;author=D.+Armentano&amp;author=G.+Parsons&amp;author=C.+Hetz&amp;volume=420&amp;publication_year=2012&amp;pages=558-563&amp;pmid=22445760&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib92">92. <span class="element-citation" id="sref92">Sado M., Yamasaki Y., Iwanaga T., Onaka Y., Ibuki T., Nishihara S. Protective effect against Parkinson's disease-related insults through the activation of XBP1. <span><span class="ref-journal">Brain Res. </span>2009;<span class="ref-vol">1257</span>:16–24.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/19135031" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Brain+Res&amp;title=Protective+effect+against+Parkinson's+disease-related+insults+through+the+activation+of+XBP1&amp;author=M.+Sado&amp;author=Y.+Yamasaki&amp;author=T.+Iwanaga&amp;author=Y.+Onaka&amp;author=T.+Ibuki&amp;volume=1257&amp;publication_year=2009&amp;pages=16-24&amp;pmid=19135031&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib93">93. <span class="element-citation" id="sref93">Vald&#x000e9;s P., Mercado G., Vidal R.L., Molina C., Parsons G., Court F.A. Control of dopaminergic neuron survival by the unfolded protein response transcription factor XBP1. <span><span class="ref-journal">Proc Natl Acad Sci U S A. </span>2014;<span class="ref-vol">111</span>:6804–6809.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4020088/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/24753614" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Proc+Natl+Acad+Sci+U+S+A&amp;title=Control+of+dopaminergic+neuron+survival+by+the+unfolded+protein+response+transcription+factor+XBP1&amp;author=P.+Vald&#x000e9;s&amp;author=G.+Mercado&amp;author=R.L.+Vidal&amp;author=C.+Molina&amp;author=G.+Parsons&amp;volume=111&amp;publication_year=2014&amp;pages=6804-6809&amp;pmid=24753614&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib94">94. <span class="element-citation" id="sref94">Gorbatyuk M.S., Shabashvili A., Chen W., Meyers C., Sullivan L.F., Salganik M. Glucose regulated protein 78 diminishes <em>&#x003b1;</em>-synuclein neurotoxicity in a rat model of Parkinson disease. <span><span class="ref-journal">Mol Ther. </span>2012;<span class="ref-vol">20</span>:1327–1337.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3392977/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/22434142" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Mol+Ther&amp;title=Glucose+regulated+protein+78+diminishes+&#x003b1;-synuclein+neurotoxicity+in+a+rat+model+of+Parkinson+disease&amp;author=M.S.+Gorbatyuk&amp;author=A.+Shabashvili&amp;author=W.+Chen&amp;author=C.+Meyers&amp;author=L.F.+Sullivan&amp;volume=20&amp;publication_year=2012&amp;pages=1327-1337&amp;pmid=22434142&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib95">95. <span class="element-citation" id="sref95">Fil&#x000e9;zac de L'Etang A., Maharjan N., Cordeiro Bra&#x000f1;a M., Ruegsegger C., Rehmann R., Goswami A. Marinesco-Sj&#x000f6;gren syndrome protein SIL1 regulates motor neuron subtype-selective ER stress in ALS. <span><span class="ref-journal">Nat Neurosci. </span>2015;<span class="ref-vol">18</span>:227–238.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/25559081" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Neurosci&amp;title=Marinesco-Sj&#x000f6;gren+syndrome+protein+SIL1+regulates+motor+neuron+subtype-selective+ER+stress+in+ALS&amp;author=A.+Fil&#x000e9;zac+de+L'Etang&amp;author=N.+Maharjan&amp;author=M.+Cordeiro+Bra&#x000f1;a&amp;author=C.+Ruegsegger&amp;author=R.+Rehmann&amp;volume=18&amp;publication_year=2015&amp;pages=227-238&amp;pmid=25559081&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib96">96. <span class="element-citation" id="sref96">Obacz J., Avril T., Le Reste P.J., Urra H., Quillien V., Hetz C. Endoplasmic reticulum proteostasis in glioblastomas&#x02014;from molecular mechanisms to therapeutic perspectives. <span><span class="ref-journal">Sci Signal. </span>2017;<span class="ref-vol">10</span></span> eaal2323. [<a href="https://pubmed.ncbi.nlm.nih.gov/28292956" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Sci+Signal&amp;title=Endoplasmic+reticulum+proteostasis+in+glioblastomas&#x02014;from+molecular+mechanisms+to+therapeutic+perspectives&amp;author=J.+Obacz&amp;author=T.+Avril&amp;author=P.J.+Le+Reste&amp;author=H.+Urra&amp;author=V.+Quillien&amp;volume=10&amp;publication_year=2017&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib97">97. <span class="element-citation" id="sref97">Zhang X., Chen W., Fan J., Wang S., Xian Z., Luan J. Disrupting CD47-SIRP<em>&#x003b1;</em> axis alone or combined with autophagy depletion for the therapy of glioblastoma. <span><span class="ref-journal">Carcinogenesis. </span>2018;<span class="ref-vol">39</span>:689–699.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/29538621" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Carcinogenesis&amp;title=Disrupting+CD47-SIRP&#x003b1;+axis+alone+or+combined+with+autophagy+depletion+for+the+therapy+of+glioblastoma&amp;author=X.+Zhang&amp;author=W.+Chen&amp;author=J.+Fan&amp;author=S.+Wang&amp;author=Z.+Xian&amp;volume=39&amp;publication_year=2018&amp;pages=689-699&amp;pmid=29538621&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib98">98. <span class="element-citation" id="sref98">Crino P.B. mTOR: a pathogenic signaling pathway in developmental brain malformations. <span><span class="ref-journal">Trends Mol Med. </span>2011;<span class="ref-vol">17</span>:734–742.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/21890410" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Trends+Mol+Med&amp;title=mTOR:+a+pathogenic+signaling+pathway+in+developmental+brain+malformations&amp;author=P.B.+Crino&amp;volume=17&amp;publication_year=2011&amp;pages=734-742&amp;pmid=21890410&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib99">99. <span class="element-citation" id="sref99">Bockaert J., Marin P. mTOR in brain physiology and pathologies. <span><span class="ref-journal">Physiol Rev. </span>2015;<span class="ref-vol">95</span>:1157–1187.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/26269525" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Physiol+Rev&amp;title=mTOR+in+brain+physiology+and+pathologies&amp;author=J.+Bockaert&amp;author=P.+Marin&amp;volume=95&amp;publication_year=2015&amp;pages=1157-1187&amp;pmid=26269525&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib100">100. <span class="element-citation" id="sref100">Lipton J.O., Sahin M. The neurology of mTOR. <span><span class="ref-journal">Neuron. </span>2014;<span class="ref-vol">84</span>:275–291.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4223653/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/25374355" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Neuron&amp;title=The+neurology+of+mTOR&amp;author=J.O.+Lipton&amp;author=M.+Sahin&amp;volume=84&amp;publication_year=2014&amp;pages=275-291&amp;pmid=25374355&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib101">101. <span class="element-citation" id="sref101">Huang H., Miao L., Yang L., Liang F., Wang Q., Zhuang P. AKT-dependent and -independent pathways mediate PTEN deletion-induced CNS axon regeneration. <span><span class="ref-journal">Cell Death Dis. </span>2019;<span class="ref-vol">10</span>:203.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC6393504/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/30814515" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cell+Death+Dis&amp;title=AKT-dependent+and+-independent+pathways+mediate+PTEN+deletion-induced+CNS+axon+regeneration&amp;author=H.+Huang&amp;author=L.+Miao&amp;author=L.+Yang&amp;author=F.+Liang&amp;author=Q.+Wang&amp;volume=10&amp;publication_year=2019&amp;pages=203&amp;pmid=30814515&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib102">102. <span class="element-citation" id="sref102">Park K.K., Liu K., Hu Y., Smith P.D., Wang C., Cai B. Promoting axon regeneration in the adult CNS by modulation of the PTEN/mTOR pathway. <span><span class="ref-journal">Science. </span>2008;<span class="ref-vol">322</span>:963–966.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2652400/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/18988856" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Science&amp;title=Promoting+axon+regeneration+in+the+adult+CNS+by+modulation+of+the+PTEN/mTOR+pathway&amp;author=K.K.+Park&amp;author=K.+Liu&amp;author=Y.+Hu&amp;author=P.D.+Smith&amp;author=C.+Wang&amp;volume=322&amp;publication_year=2008&amp;pages=963-966&amp;pmid=18988856&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib103">103. <span class="element-citation" id="sref103">Yang L., Miao L., Liang F., Huang H., Teng X., Li S. The mTORC1 effectors S6K1 and 4E-BP play different roles in CNS axon regeneration. <span><span class="ref-journal">Nat Commun. </span>2014;<span class="ref-vol">5</span>:5416.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4228696/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/25382660" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Commun&amp;title=The+mTORC1+effectors+S6K1+and+4E-BP+play+different+roles+in+CNS+axon+regeneration&amp;author=L.+Yang&amp;author=L.+Miao&amp;author=F.+Liang&amp;author=H.+Huang&amp;author=X.+Teng&amp;volume=5&amp;publication_year=2014&amp;pages=5416&amp;pmid=25382660&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib104">104. <span class="element-citation" id="sref104">Miao L., Yang L., Huang H., Liang F., Ling C., Hu Y. mTORC1 is necessary but mTORC2 and GSK3<em>&#x003b2;</em> are inhibitory for AKT3-induced axon regeneration in the central nervous system. <span><span class="ref-journal">Elife. </span>2016;<span class="ref-vol">5</span></span> e14908. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4841781/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/27026523" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Elife&amp;title=mTORC1+is+necessary+but+mTORC2+and+GSK3&#x003b2;+are+inhibitory+for+AKT3-induced+axon+regeneration+in+the+central+nervous+system&amp;author=L.+Miao&amp;author=L.+Yang&amp;author=H.+Huang&amp;author=F.+Liang&amp;author=C.+Ling&amp;volume=5&amp;publication_year=2016&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib105">105. <span class="element-citation" id="sref105">Ries V., Henchcliffe C., Kareva T., Rzhetskaya M., Bland R., During M.J. Oncoprotein Akt/PKB induces trophic effects in murine models of Parkinson's disease. <span><span class="ref-journal">Proc Natl Acad Sci U S A. </span>2006;<span class="ref-vol">103</span>:18757–18762.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1654135/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/17116866" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Proc+Natl+Acad+Sci+U+S+A&amp;title=Oncoprotein+Akt/PKB+induces+trophic+effects+in+murine+models+of+Parkinson's+disease&amp;author=V.+Ries&amp;author=C.+Henchcliffe&amp;author=T.+Kareva&amp;author=M.+Rzhetskaya&amp;author=R.+Bland&amp;volume=103&amp;publication_year=2006&amp;pages=18757-18762&amp;pmid=17116866&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib106">106. <span class="element-citation" id="sref106">Cheng H.C., Kim S.R., Oo T.F., Kareva T., Yarygina O., Rzhetskaya M. Akt suppresses retrograde degeneration of dopaminergic axons by inhibition of macroautophagy. <span><span class="ref-journal">J Neurosci. </span>2011;<span class="ref-vol">31</span>:2125–2135.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3075005/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/21307249" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Neurosci&amp;title=Akt+suppresses+retrograde+degeneration+of+dopaminergic+axons+by+inhibition+of+macroautophagy&amp;author=H.C.+Cheng&amp;author=S.R.+Kim&amp;author=T.F.+Oo&amp;author=T.+Kareva&amp;author=O.+Yarygina&amp;volume=31&amp;publication_year=2011&amp;pages=2125-2135&amp;pmid=21307249&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib107">107. <span class="element-citation" id="sref107">Oddo S. The role of mTOR signaling in Alzheimer's disease. <span><span class="ref-journal">Front Biosci. </span>2012;<span class="ref-vol">4</span>:941–952.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4111148/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/22202101" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Front+Biosci&amp;title=The+role+of+mTOR+signaling+in+Alzheimer's+disease&amp;author=S.+Oddo&amp;volume=4&amp;publication_year=2012&amp;pages=941-952&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib108">108. <span class="element-citation" id="sref108">Morita T., Sobue K. Specification of neuronal polarity regulated by local translation of CRMP2 and Tau <em>via</em> the mTOR-p70S6K pathway. <span><span class="ref-journal">J Biol Chem. </span>2009;<span class="ref-vol">284</span>:27734–27745.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2785701/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/19648118" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Biol+Chem&amp;title=Specification+of+neuronal+polarity+regulated+by+local+translation+of+CRMP2+and+Tau+via+the+mTOR-p70S6K+pathway&amp;author=T.+Morita&amp;author=K.+Sobue&amp;volume=284&amp;publication_year=2009&amp;pages=27734-27745&amp;pmid=19648118&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib109">109. <span class="element-citation" id="sref109">Lee J.H., Tecedor L., Chen Y.H., Monteys A.M., Sowada M.J., Thompson L.M. Reinstating aberrant mTORC1 activity in Huntington's disease mice improves disease phenotypes. <span><span class="ref-journal">Neuron. </span>2015;<span class="ref-vol">85</span>:303–315.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4355620/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/25556834" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Neuron&amp;title=Reinstating+aberrant+mTORC1+activity+in+Huntington's+disease+mice+improves+disease+phenotypes&amp;author=J.H.+Lee&amp;author=L.+Tecedor&amp;author=Y.H.+Chen&amp;author=A.M.+Monteys&amp;author=M.J.+Sowada&amp;volume=85&amp;publication_year=2015&amp;pages=303-315&amp;pmid=25556834&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib110">110. <span class="element-citation" id="sref110">Ravikumar B., Vacher C., Berger Z., Davies J.E., Luo S., Oroz L.G. Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease. <span><span class="ref-journal">Nat Genet. </span>2004;<span class="ref-vol">36</span>:585–595.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/15146184" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Genet&amp;title=Inhibition+of+mTOR+induces+autophagy+and+reduces+toxicity+of+polyglutamine+expansions+in+fly+and+mouse+models+of+Huntington+disease&amp;author=B.+Ravikumar&amp;author=C.+Vacher&amp;author=Z.+Berger&amp;author=J.E.+Davies&amp;author=S.+Luo&amp;volume=36&amp;publication_year=2004&amp;pages=585-595&amp;pmid=15146184&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib111">111. <span class="element-citation" id="sref111">Pryor W.M., Biagioli M., Shahani N., Swarnkar S., Huang W.C., Page D.T. Huntingtin promotes mTORC1 signaling in the pathogenesis of Huntington's disease. <span><span class="ref-journal">Sci Signal. </span>2014;<span class="ref-vol">7</span>:ra103.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/25351248" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Sci+Signal&amp;title=Huntingtin+promotes+mTORC1+signaling+in+the+pathogenesis+of+Huntington's+disease&amp;author=W.M.+Pryor&amp;author=M.+Biagioli&amp;author=N.+Shahani&amp;author=S.+Swarnkar&amp;author=W.C.+Huang&amp;volume=7&amp;publication_year=2014&amp;pages=ra103&amp;pmid=25351248&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib112">112. <span class="element-citation" id="sref112">Murphy M.P., Hartley R.C. Mitochondria as a therapeutic target for common pathologies. <span><span class="ref-journal">Nat Rev Drug Discov. </span>2018;<span class="ref-vol">17</span>:865–886.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/30393373" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Rev+Drug+Discov&amp;title=Mitochondria+as+a+therapeutic+target+for+common+pathologies&amp;author=M.P.+Murphy&amp;author=R.C.+Hartley&amp;volume=17&amp;publication_year=2018&amp;pages=865-886&amp;pmid=30393373&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib113">113. <span class="element-citation" id="sref113">Johri A., Beal M.F. Mitochondrial dysfunction in neurodegenerative diseases. <span><span class="ref-journal">J Pharmacol Exp Therapeut. </span>2012;<span class="ref-vol">342</span>:619–630.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3422529/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/22700435" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Pharmacol+Exp+Therapeut&amp;title=Mitochondrial+dysfunction+in+neurodegenerative+diseases&amp;author=A.+Johri&amp;author=M.F.+Beal&amp;volume=342&amp;publication_year=2012&amp;pages=619-630&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib114">114. <span class="element-citation" id="sref114">Moreira P.I., Zhu X., Wang X., Lee H.G., Nunomura A., Petersen R.B. Mitochondria: a therapeutic target in neurodegeneration. <span><span class="ref-journal">Biochim Biophys Acta. </span>2010;<span class="ref-vol">1802</span>:212–220.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2790540/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/19853657" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Biochim+Biophys+Acta&amp;title=Mitochondria:+a+therapeutic+target+in+neurodegeneration&amp;author=P.I.+Moreira&amp;author=X.+Zhu&amp;author=X.+Wang&amp;author=H.G.+Lee&amp;author=A.+Nunomura&amp;volume=1802&amp;publication_year=2010&amp;pages=212-220&amp;pmid=19853657&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib115">115. <span class="element-citation" id="sref115">Chen W., Zhang X., Fan J., Zai W., Luan J., Li Y. Tethering interleukin-22 to apolipoprotein A-I ameliorates mice from acetaminophen-induced liver injury. <span><span class="ref-journal">Theranostics. </span>2017;<span class="ref-vol">7</span>:4135–4148.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC5695002/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/29158815" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Theranostics&amp;title=Tethering+interleukin-22+to+apolipoprotein+A-I+ameliorates+mice+from+acetaminophen-induced+liver+injury&amp;author=W.+Chen&amp;author=X.+Zhang&amp;author=J.+Fan&amp;author=W.+Zai&amp;author=J.+Luan&amp;volume=7&amp;publication_year=2017&amp;pages=4135-4148&amp;pmid=29158815&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib116">116. <span class="element-citation" id="sref116">Dawson T.M., Dawson V.L. Mitochondrial mechanisms of neuronal cell death: potential therapeutics. <span><span class="ref-journal">Annu Rev Pharmacol Toxicol. </span>2017;<span class="ref-vol">57</span>:437–454.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/28061689" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Annu+Rev+Pharmacol+Toxicol&amp;title=Mitochondrial+mechanisms+of+neuronal+cell+death:+potential+therapeutics&amp;author=T.M.+Dawson&amp;author=V.L.+Dawson&amp;volume=57&amp;publication_year=2017&amp;pages=437-454&amp;pmid=28061689&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib117">117. <span class="element-citation" id="sref117">McManus M.J., Murphy M.P., Franklin J.L. The mitochondria-targeted antioxidant MitoQ prevents loss of spatial memory retention and early neuropathology in a transgenic mouse model of Alzheimer's disease. <span><span class="ref-journal">J Neurosci. </span>2011;<span class="ref-vol">31</span>:15703–15715.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3334845/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/22049413" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Neurosci&amp;title=The+mitochondria-targeted+antioxidant+MitoQ+prevents+loss+of+spatial+memory+retention+and+early+neuropathology+in+a+transgenic+mouse+model+of+Alzheimer's+disease&amp;author=M.J.+McManus&amp;author=M.P.+Murphy&amp;author=J.L.+Franklin&amp;volume=31&amp;publication_year=2011&amp;pages=15703-15715&amp;pmid=22049413&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib118">118. <span class="element-citation" id="sref118">Williams P.A., Harder J.M., Foxworth N.E., Cochran K.E., Philip V.M., Porciatti V. Vitamin B3 modulates mitochondrial vulnerability and prevents glaucoma in aged mice. <span><span class="ref-journal">Science. </span>2017;<span class="ref-vol">355</span>:756–760.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC5408298/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/28209901" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Science&amp;title=Vitamin+B3+modulates+mitochondrial+vulnerability+and+prevents+glaucoma+in+aged+mice&amp;author=P.A.+Williams&amp;author=J.M.+Harder&amp;author=N.E.+Foxworth&amp;author=K.E.+Cochran&amp;author=V.M.+Philip&amp;volume=355&amp;publication_year=2017&amp;pages=756-760&amp;pmid=28209901&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib119">119. <span class="element-citation" id="sref119">Long A.N., Owens K., Schlappal A.E., Kristian T., Fishman P.S., Schuh R.A. Effect of nicotinamide mononucleotide on brain mitochondrial respiratory deficits in an Alzheimer's disease-relevant murine model. <span><span class="ref-journal">BMC Neurol. </span>2015;<span class="ref-vol">15</span>:19.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4358858/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/25884176" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=BMC+Neurol&amp;title=Effect+of+nicotinamide+mononucleotide+on+brain+mitochondrial+respiratory+deficits+in+an+Alzheimer's+disease-relevant+murine+model&amp;author=A.N.+Long&amp;author=K.+Owens&amp;author=A.E.+Schlappal&amp;author=T.+Kristian&amp;author=P.S.+Fishman&amp;volume=15&amp;publication_year=2015&amp;pages=19&amp;pmid=25884176&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib120">120. <span class="element-citation" id="sref120">Bingol B., Tea J.S., Phu L., Reichelt M., Bakalarski C.E., Song Q. The mitochondrial deubiquitinase USP30 opposes parkin-mediated mitophagy. <span><span class="ref-journal">Nature. </span>2014;<span class="ref-vol">510</span>:370–375.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/24896179" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=The+mitochondrial+deubiquitinase+USP30+opposes+parkin-mediated+mitophagy&amp;author=B.+Bingol&amp;author=J.S.+Tea&amp;author=L.+Phu&amp;author=M.+Reichelt&amp;author=C.E.+Bakalarski&amp;volume=510&amp;publication_year=2014&amp;pages=370-375&amp;pmid=24896179&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib121">121. <span class="element-citation" id="sref121">Dong Z., Wolfer D.P., Lipp H.P., B&#x000fc;eler H. Hsp70 gene transfer by adeno-associated virus inhibits MPTP-induced nigrostriatal degeneration in the mouse model of Parkinson disease. <span><span class="ref-journal">Mol Ther. </span>2005;<span class="ref-vol">11</span>:80–88.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/15585408" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Mol+Ther&amp;title=Hsp70+gene+transfer+by+adeno-associated+virus+inhibits+MPTP-induced+nigrostriatal+degeneration+in+the+mouse+model+of+Parkinson+disease&amp;author=Z.+Dong&amp;author=D.P.+Wolfer&amp;author=H.P.+Lipp&amp;author=H.+B&#x000fc;eler&amp;volume=11&amp;publication_year=2005&amp;pages=80-88&amp;pmid=15585408&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib122">122. <span class="element-citation" id="sref122">Tsunemi T., Ashe T.D., Morrison B.E., Soriano K.R., Au J., Roque R.A. PGC-1<em>&#x003b1;</em> rescues Huntington's disease proteotoxicity by preventing oxidative stress and promoting TFEB function. <span><span class="ref-journal">Sci Transl Med. </span>2012;<span class="ref-vol">4</span></span> 142ra97. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4096245/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/22786682" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Sci+Transl+Med&amp;title=PGC-1&#x003b1;+rescues+Huntington's+disease+proteotoxicity+by+preventing+oxidative+stress+and+promoting+TFEB+function&amp;author=T.+Tsunemi&amp;author=T.D.+Ashe&amp;author=B.E.+Morrison&amp;author=K.R.+Soriano&amp;author=J.+Au&amp;volume=4&amp;publication_year=2012&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib123">123. <span class="element-citation" id="sref123">Onyango I.G., Dennis J., Khan S.M. Mitochondrial dysfunction in Alzheimer's disease and the rationale for bioenergetics based therapies. <span><span class="ref-journal">Aging Dis. </span>2016;<span class="ref-vol">7</span>:201–214.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4809610/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/27114851" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Aging+Dis&amp;title=Mitochondrial+dysfunction+in+Alzheimer's+disease+and+the+rationale+for+bioenergetics+based+therapies&amp;author=I.G.+Onyango&amp;author=J.+Dennis&amp;author=S.M.+Khan&amp;volume=7&amp;publication_year=2016&amp;pages=201-214&amp;pmid=27114851&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib124">124. <span class="element-citation" id="sref124">Berson A., Nativio R., Berger S.L., Bonini N.M. Epigenetic regulation in neurodegenerative diseases. <span><span class="ref-journal">Trends Neurosci. </span>2018;<span class="ref-vol">41</span>:587–598.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC6174532/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/29885742" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Trends+Neurosci&amp;title=Epigenetic+regulation+in+neurodegenerative+diseases&amp;author=A.+Berson&amp;author=R.+Nativio&amp;author=S.L.+Berger&amp;author=N.M.+Bonini&amp;volume=41&amp;publication_year=2018&amp;pages=587-598&amp;pmid=29885742&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib125">125. <span class="element-citation" id="sref125">Gjoneska E., Pfenning A.R., Mathys H., Quon G., Kundaje A., Tsai L.H. Conserved epigenomic signals in mice and humans reveal immune basis of Alzheimer's disease. <span><span class="ref-journal">Nature. </span>2015;<span class="ref-vol">518</span>:365–369.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4530583/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/25693568" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=Conserved+epigenomic+signals+in+mice+and+humans+reveal+immune+basis+of+Alzheimer's+disease&amp;author=E.+Gjoneska&amp;author=A.R.+Pfenning&amp;author=H.+Mathys&amp;author=G.+Quon&amp;author=A.+Kundaje&amp;volume=518&amp;publication_year=2015&amp;pages=365-369&amp;pmid=25693568&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib126">126. <span class="element-citation" id="sref126">Nativio R., Donahue G., Berson A., Lan Y., Amlie-Wolf A., Tuzer F. Dysregulation of the epigenetic landscape of normal aging in Alzheimer's disease. <span><span class="ref-journal">Nat Neurosci. </span>2018;<span class="ref-vol">21</span>:497–505.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC6124498/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/29507413" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Neurosci&amp;title=Dysregulation+of+the+epigenetic+landscape+of+normal+aging+in+Alzheimer's+disease&amp;author=R.+Nativio&amp;author=G.+Donahue&amp;author=A.+Berson&amp;author=Y.+Lan&amp;author=A.+Amlie-Wolf&amp;volume=21&amp;publication_year=2018&amp;pages=497-505&amp;pmid=29507413&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib127">127. <span class="element-citation" id="sref127">Pavlou M.A.S., Pinho R., Paiva I., Outeiro T.F. The yin and yang of <em>&#x003b1;</em>-synuclein-associated epigenetics in Parkinson's disease. <span><span class="ref-journal">Brain. </span>2017;<span class="ref-vol">140</span>:878–886.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/27585855" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Brain&amp;title=The+yin+and+yang+of+&#x003b1;-synuclein-associated+epigenetics+in+Parkinson's+disease&amp;author=M.A.S.+Pavlou&amp;author=R.+Pinho&amp;author=I.+Paiva&amp;author=T.F.+Outeiro&amp;volume=140&amp;publication_year=2017&amp;pages=878-886&amp;pmid=27585855&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib128">128. <span class="element-citation" id="sref128">Vashishtha M., Ng C.W., Yildirim F., Gipson T.A., Kratter I.H., Bodai L. Targeting H3K4 trimethylation in Huntington disease. <span><span class="ref-journal">Proc Natl Acad Sci U S A. </span>2013;<span class="ref-vol">110</span>:E3027–E3036.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3740882/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/23872847" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Proc+Natl+Acad+Sci+U+S+A&amp;title=Targeting+H3K4+trimethylation+in+Huntington+disease&amp;author=M.+Vashishtha&amp;author=C.W.+Ng&amp;author=F.+Yildirim&amp;author=T.A.+Gipson&amp;author=I.H.+Kratter&amp;volume=110&amp;publication_year=2013&amp;pages=E3027-E3036&amp;pmid=23872847&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib129">129. <span class="element-citation" id="sref129">Li J., Hart R.P., Mallimo E.M., Swerdel M.R., Kusnecov A.W., Herrup K. EZH2-mediated H3K27 trimethylation mediates neurodegeneration in ataxia-telangiectasia. <span><span class="ref-journal">Nat Neurosci. </span>2013;<span class="ref-vol">16</span>:1745–1753.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3965909/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/24162653" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Neurosci&amp;title=EZH2-mediated+H3K27+trimethylation+mediates+neurodegeneration+in+ataxia-telangiectasia&amp;author=J.+Li&amp;author=R.P.+Hart&amp;author=E.M.+Mallimo&amp;author=M.R.+Swerdel&amp;author=A.W.+Kusnecov&amp;volume=16&amp;publication_year=2013&amp;pages=1745-1753&amp;pmid=24162653&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib130">130. <span class="element-citation" id="sref130">Hockly E., Richon V.M., Woodman B., Smith D.L., Zhou X., Rosa E. Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, ameliorates motor deficits in a mouse model of Huntington's disease. <span><span class="ref-journal">Proc Natl Acad Sci U S A. </span>2003;<span class="ref-vol">100</span>:2041–2046.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC149955/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/12576549" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Proc+Natl+Acad+Sci+U+S+A&amp;title=Suberoylanilide+hydroxamic+acid,+a+histone+deacetylase+inhibitor,+ameliorates+motor+deficits+in+a+mouse+model+of+Huntington's+disease&amp;author=E.+Hockly&amp;author=V.M.+Richon&amp;author=B.+Woodman&amp;author=D.L.+Smith&amp;author=X.+Zhou&amp;volume=100&amp;publication_year=2003&amp;pages=2041-2046&amp;pmid=12576549&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib131">131. <span class="element-citation" id="sref131">Steffan J.S., Bodai L., Pallos J., Poelman M., McCampbell A., Apostol B.L. Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in <em>Drosophila</em>. <span><span class="ref-journal">Nature. </span>2001;<span class="ref-vol">413</span>:739–743.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/11607033" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=Histone+deacetylase+inhibitors+arrest+polyglutamine-dependent+neurodegeneration+in+Drosophila&amp;author=J.S.+Steffan&amp;author=L.+Bodai&amp;author=J.+Pallos&amp;author=M.+Poelman&amp;author=A.+McCampbell&amp;volume=413&amp;publication_year=2001&amp;pages=739-743&amp;pmid=11607033&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib132">132. <span class="element-citation" id="sref132">Ferrante R.J., Kubilus J.K., Lee J., Ryu H., Beesen A., Zucker B. Histone deacetylase inhibition by sodium butyrate chemotherapy ameliorates the neurodegenerative phenotype in Huntington's disease mice. <span><span class="ref-journal">J Neurosci. </span>2003;<span class="ref-vol">23</span>:9418–9427.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC6740577/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/14561870" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Neurosci&amp;title=Histone+deacetylase+inhibition+by+sodium+butyrate+chemotherapy+ameliorates+the+neurodegenerative+phenotype+in+Huntington's+disease+mice&amp;author=R.J.+Ferrante&amp;author=J.K.+Kubilus&amp;author=J.+Lee&amp;author=H.+Ryu&amp;author=A.+Beesen&amp;volume=23&amp;publication_year=2003&amp;pages=9418-9427&amp;pmid=14561870&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib133">133. <span class="element-citation" id="sref133">Chen W., Dong G., Wu Y., Zhang W., Miao C., Sheng C. Dual NAMPT/HDAC inhibitors as a new strategy for multitargeting antitumor drug discovery. <span><span class="ref-journal">ACS Med Chem Lett. </span>2017;<span class="ref-vol">9</span>:34–38.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC5767891/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/29348808" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=ACS+Med+Chem+Lett&amp;title=Dual+NAMPT/HDAC+inhibitors+as+a+new+strategy+for+multitargeting+antitumor+drug+discovery&amp;author=W.+Chen&amp;author=G.+Dong&amp;author=Y.+Wu&amp;author=W.+Zhang&amp;author=C.+Miao&amp;volume=9&amp;publication_year=2017&amp;pages=34-38&amp;pmid=29348808&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib134">134. <span class="element-citation" id="sref134">Bustos F.J., Ampuero E., Jury N., Aguilar R., Falahi F., Toledo J. Epigenetic editing of the <em>Dlg4</em>/PSD95 gene improves cognition in aged and Alzheimer's disease mice. <span><span class="ref-journal">Brain. </span>2017;<span class="ref-vol">140</span>:3252–3268.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC5841035/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/29155979" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Brain&amp;title=Epigenetic+editing+of+the+Dlg4/PSD95+gene+improves+cognition+in+aged+and+Alzheimer's+disease+mice&amp;author=F.J.+Bustos&amp;author=E.+Ampuero&amp;author=N.+Jury&amp;author=R.+Aguilar&amp;author=F.+Falahi&amp;volume=140&amp;publication_year=2017&amp;pages=3252-3268&amp;pmid=29155979&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib135">135. <span class="element-citation" id="sref135">Kacher R., Lamazi&#x000e8;re A., Heck N., Kappes V., Mounier C., Despres G. <em>CYP46A1</em> gene therapy deciphers the role of brain cholesterol metabolism in Huntington's disease. <span><span class="ref-journal">Brain. </span>2019;<span class="ref-vol">142</span>:2432–2450.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/31286142" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Brain&amp;title=CYP46A1+gene+therapy+deciphers+the+role+of+brain+cholesterol+metabolism+in+Huntington's+disease&amp;author=R.+Kacher&amp;author=A.+Lamazi&#x000e8;re&amp;author=N.+Heck&amp;author=V.+Kappes&amp;author=C.+Mounier&amp;volume=142&amp;publication_year=2019&amp;pages=2432-2450&amp;pmid=31286142&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib136">136. <span class="element-citation" id="sref136">Scrivo A., Bourdenx M., Pampliega O., Cuervo A.M. Selective autophagy as a potential therapeutic target for neurodegenerative disorders. <span><span class="ref-journal">Lancet Neurol. </span>2018;<span class="ref-vol">17</span>:802–815.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC6359907/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/30129476" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Lancet+Neurol&amp;title=Selective+autophagy+as+a+potential+therapeutic+target+for+neurodegenerative+disorders&amp;author=A.+Scrivo&amp;author=M.+Bourdenx&amp;author=O.+Pampliega&amp;author=A.M.+Cuervo&amp;volume=17&amp;publication_year=2018&amp;pages=802-815&amp;pmid=30129476&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib137">137. <span class="element-citation" id="sref137">Xiang H.G., Zhang J.F., Lin C.C., Zhang L., Liu B., Ouyang L. Targeting autophagy-related protein kinases for potential therapeutic purpose. <span><span class="ref-journal">Acta Pharm Sin B. </span>2020;<span class="ref-vol">10</span>:569–581.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7161711/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/32322463" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Acta+Pharm+Sin+B&amp;title=Targeting+autophagy-related+protein+kinases+for+potential+therapeutic+purpose&amp;author=H.G.+Xiang&amp;author=J.F.+Zhang&amp;author=C.C.+Lin&amp;author=L.+Zhang&amp;author=B.+Liu&amp;volume=10&amp;publication_year=2020&amp;pages=569-581&amp;pmid=32322463&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib138">138. <span class="element-citation" id="sref138">Du F., Yu Q., Yan S., Hu G., Lue L.F., Walker D.G. PINK1 signalling rescues amyloid pathology and mitochondrial dysfunction in Alzheimer's disease. <span><span class="ref-journal">Brain. </span>2017;<span class="ref-vol">140</span>:3233–3251.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC5841141/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/29077793" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Brain&amp;title=PINK1+signalling+rescues+amyloid+pathology+and+mitochondrial+dysfunction+in+Alzheimer's+disease&amp;author=F.+Du&amp;author=Q.+Yu&amp;author=S.+Yan&amp;author=G.+Hu&amp;author=L.F.+Lue&amp;volume=140&amp;publication_year=2017&amp;pages=3233-3251&amp;pmid=29077793&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib139">139. <span class="element-citation" id="sref139">Xilouri M., Brekk O.R., Landeck N., Pitychoutis P.M., Papasilekas T., Papadopoulou-Daifoti Z. Boosting chaperone-mediated autophagy <em>in&#x000a0;vivo</em> mitigates <em>&#x003b1;</em>-synuclein-induced neurodegeneration. <span><span class="ref-journal">Brain. </span>2013;<span class="ref-vol">136</span>:2130–2146.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/23757764" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Brain&amp;title=Boosting+chaperone-mediated+autophagy+in&#x000a0;vivo+mitigates+&#x003b1;-synuclein-induced+neurodegeneration&amp;author=M.+Xilouri&amp;author=O.R.+Brekk&amp;author=N.+Landeck&amp;author=P.M.+Pitychoutis&amp;author=T.+Papasilekas&amp;volume=136&amp;publication_year=2013&amp;pages=2130-2146&amp;pmid=23757764&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib140">140. <span class="element-citation" id="sref140">Decressac M., Mattsson B., Weikop P., Lundblad M., Jakobsson J., Bj&#x000f6;rklund A. TFEB-mediated autophagy rescues midbrain dopamine neurons from <em>&#x003b1;</em>-synuclein toxicity. <span><span class="ref-journal">Proc Natl Acad Sci U S A. </span>2013;<span class="ref-vol">110</span>:E1817–E1826.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3651458/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/23610405" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Proc+Natl+Acad+Sci+U+S+A&amp;title=TFEB-mediated+autophagy+rescues+midbrain+dopamine+neurons+from+&#x003b1;-synuclein+toxicity&amp;author=M.+Decressac&amp;author=B.+Mattsson&amp;author=P.+Weikop&amp;author=M.+Lundblad&amp;author=J.+Jakobsson&amp;volume=110&amp;publication_year=2013&amp;pages=E1817-E1826&amp;pmid=23610405&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib141">141. <span class="element-citation" id="sref141">Xie Y., Zhou B., Lin M.Y., Wang S., Foust K.D., Sheng Z.H. Endolysosomal deficits augment mitochondria pathology in spinal motor neurons of asymptomatic fALS mice. <span><span class="ref-journal">Neuron. </span>2015;<span class="ref-vol">87</span>:355–370.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4511489/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/26182418" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Neuron&amp;title=Endolysosomal+deficits+augment+mitochondria+pathology+in+spinal+motor+neurons+of+asymptomatic+fALS+mice&amp;author=Y.+Xie&amp;author=B.+Zhou&amp;author=M.Y.+Lin&amp;author=S.+Wang&amp;author=K.D.+Foust&amp;volume=87&amp;publication_year=2015&amp;pages=355-370&amp;pmid=26182418&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib142">142. <span class="element-citation" id="sref142">Hickman S., Izzy S., Sen P., Morsett L., El Khoury J. Microglia in neurodegeneration. <span><span class="ref-journal">Nat Neurosci. </span>2018;<span class="ref-vol">21</span>:1359–1369.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC6817969/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/30258234" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Neurosci&amp;title=Microglia+in+neurodegeneration&amp;author=S.+Hickman&amp;author=S.+Izzy&amp;author=P.+Sen&amp;author=L.+Morsett&amp;author=J.+El+Khoury&amp;volume=21&amp;publication_year=2018&amp;pages=1359-1369&amp;pmid=30258234&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib143">143. <span class="element-citation" id="sref143">Jonsson T., Stefansson H., Steinberg S., Jonsdottir I., Jonsson P.V., Snaedal J. Variant of TREM2 associated with the risk of Alzheimer's disease. <span><span class="ref-journal">N Engl J Med. </span>2013;<span class="ref-vol">368</span>:107–116.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3677583/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/23150908" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=N+Engl+J+Med&amp;title=Variant+of+TREM2+associated+with+the+risk+of+Alzheimer's+disease&amp;author=T.+Jonsson&amp;author=H.+Stefansson&amp;author=S.+Steinberg&amp;author=I.+Jonsdottir&amp;author=P.V.+Jonsson&amp;volume=368&amp;publication_year=2013&amp;pages=107-116&amp;pmid=23150908&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib144">144. <span class="element-citation" id="sref144">Lambert J.C., Heath S., Even G., Campion D., Sleegers K., Hiltunen M. Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease. <span><span class="ref-journal">Nat Genet. </span>2009;<span class="ref-vol">41</span>:1094–1099.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/19734903" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Genet&amp;title=Genome-wide+association+study+identifies+variants+at+CLU+and+CR1+associated+with+Alzheimer's+disease&amp;author=J.C.+Lambert&amp;author=S.+Heath&amp;author=G.+Even&amp;author=D.+Campion&amp;author=K.+Sleegers&amp;volume=41&amp;publication_year=2009&amp;pages=1094-1099&amp;pmid=19734903&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib145">145. <span class="element-citation" id="sref145">Bertram L., Lange C., Mullin K., Parkinson M., Hsiao M., Hogan M.F. Genome-wide association analysis reveals putative Alzheimer's disease susceptibility loci in addition to APOE. <span><span class="ref-journal">Am J Hum Genet. </span>2008;<span class="ref-vol">83</span>:623–632.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2668052/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/18976728" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Hum+Genet&amp;title=Genome-wide+association+analysis+reveals+putative+Alzheimer's+disease+susceptibility+loci+in+addition+to+APOE&amp;author=L.+Bertram&amp;author=C.+Lange&amp;author=K.+Mullin&amp;author=M.+Parkinson&amp;author=M.+Hsiao&amp;volume=83&amp;publication_year=2008&amp;pages=623-632&amp;pmid=18976728&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib146">146. <span class="element-citation" id="sref146">Zhong L., Xu Y., Zhuo R., Wang T., Wang K., Huang R. Soluble TREM2 ameliorates pathological phenotypes by modulating microglial functions in an Alzheimer's disease model. <span><span class="ref-journal">Nat Commun. </span>2019;<span class="ref-vol">10</span>:1365.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC6433910/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/30911003" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Commun&amp;title=Soluble+TREM2+ameliorates+pathological+phenotypes+by+modulating+microglial+functions+in+an+Alzheimer's+disease+model&amp;author=L.+Zhong&amp;author=Y.+Xu&amp;author=R.+Zhuo&amp;author=T.+Wang&amp;author=K.+Wang&amp;volume=10&amp;publication_year=2019&amp;pages=1365&amp;pmid=30911003&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib147">147. <span class="element-citation" id="sref147">Minami S.S., Min S.W., Krabbe G., Wang C., Zhou Y., Asgarov R. Progranulin protects against amyloid <em>&#x003b2;</em> deposition and toxicity in Alzheimer's disease mouse models. <span><span class="ref-journal">Nat Med. </span>2014;<span class="ref-vol">20</span>:1157–1164.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4196723/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/25261995" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Med&amp;title=Progranulin+protects+against+amyloid+&#x003b2;+deposition+and+toxicity+in+Alzheimer's+disease+mouse+models&amp;author=S.S.+Minami&amp;author=S.W.+Min&amp;author=G.+Krabbe&amp;author=C.+Wang&amp;author=Y.+Zhou&amp;volume=20&amp;publication_year=2014&amp;pages=1157-1164&amp;pmid=25261995&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib148">148. <span class="element-citation" id="sref148">Allen N.J., Eroglu C. Cell biology of astrocytesynapse interactions. <span><span class="ref-journal">Neuron. </span>2017;<span class="ref-vol">96</span>:697–708.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC5687890/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/29096081" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Neuron&amp;title=Cell+biology+of+astrocytesynapse+interactions&amp;author=N.J.+Allen&amp;author=C.+Eroglu&amp;volume=96&amp;publication_year=2017&amp;pages=697-708&amp;pmid=29096081&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib149">149. <span class="element-citation" id="sref149">Valori C.F., Guidotti G., Brambilla L., Rossi D. Astrocytes: emerging therapeutic targets in neurological disorders. <span><span class="ref-journal">Trends Mol Med. </span>2019;<span class="ref-vol">25</span>:750–759.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/31122805" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Trends+Mol+Med&amp;title=Astrocytes:+emerging+therapeutic+targets+in+neurological+disorders&amp;author=C.F.+Valori&amp;author=G.+Guidotti&amp;author=L.+Brambilla&amp;author=D.+Rossi&amp;volume=25&amp;publication_year=2019&amp;pages=750-759&amp;pmid=31122805&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib150">150. <span class="element-citation" id="sref150">Kunze C., B&#x000f6;rner K., Kienle E., Orschmann T., Rusha E., Schneider M. Synthetic AAV/CRISPR vectors for blocking HIV-1 expression in persistently infected astrocytes. <span><span class="ref-journal">Glia. </span>2018;<span class="ref-vol">66</span>:413–427.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/29119608" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Glia&amp;title=Synthetic+AAV/CRISPR+vectors+for+blocking+HIV-1+expression+in+persistently+infected+astrocytes&amp;author=C.+Kunze&amp;author=K.+B&#x000f6;rner&amp;author=E.+Kienle&amp;author=T.+Orschmann&amp;author=E.+Rusha&amp;volume=66&amp;publication_year=2018&amp;pages=413-427&amp;pmid=29119608&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib151">151. <span class="element-citation" id="sref151">Cannon J.R., Sew T., Montero L., Burton E.A., Greenamyre J.T. Pseudotype-dependent lentiviral transduction of astrocytes or neurons in the rat substantia nigra. <span><span class="ref-journal">Exp Neurol. </span>2011;<span class="ref-vol">228</span>:41–52.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3038546/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/21056560" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Exp+Neurol&amp;title=Pseudotype-dependent+lentiviral+transduction+of+astrocytes+or+neurons+in+the+rat+substantia+nigra&amp;author=J.R.+Cannon&amp;author=T.+Sew&amp;author=L.+Montero&amp;author=E.A.+Burton&amp;author=J.T.+Greenamyre&amp;volume=228&amp;publication_year=2011&amp;pages=41-52&amp;pmid=21056560&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib152">152. <span class="element-citation" id="sref152">Gu J., Al-Bayati K., Ho E.A. Development of antibody-modified chitosan nanoparticles for the targeted delivery of siRNA across the blood&#x02013;brain barrier as a strategy for inhibiting HIV replication in astrocytes. <span><span class="ref-journal">Drug Deliv Transl Res. </span>2017;<span class="ref-vol">7</span>:497–506.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/28315051" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Drug+Deliv+Transl+Res&amp;title=Development+of+antibody-modified+chitosan+nanoparticles+for+the+targeted+delivery+of+siRNA+across+the+blood&#x02013;brain+barrier+as+a+strategy+for+inhibiting+HIV+replication+in+astrocytes&amp;author=J.+Gu&amp;author=K.+Al-Bayati&amp;author=E.A.+Ho&amp;volume=7&amp;publication_year=2017&amp;pages=497-506&amp;pmid=28315051&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib153">153. <span class="element-citation" id="sref153">Tanaka H., Nakatani T., Furihata T., Tange K., Nakai Y., Yoshioka H. <em>In&#x000a0;vivo</em> introduction of mRNA encapsulated in lipid nanoparticles to brain neuronal cells and astrocytes <em>via</em> intracerebroventricular administration. <span><span class="ref-journal">Mol Pharm. </span>2018;<span class="ref-vol">15</span>:2060–2067.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/29638135" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Mol+Pharm&amp;title=In&#x000a0;vivo+introduction+of+mRNA+encapsulated+in+lipid+nanoparticles+to+brain+neuronal+cells+and+astrocytes+via+intracerebroventricular+administration&amp;author=H.+Tanaka&amp;author=T.+Nakatani&amp;author=T.+Furihata&amp;author=K.+Tange&amp;author=Y.+Nakai&amp;volume=15&amp;publication_year=2018&amp;pages=2060-2067&amp;pmid=29638135&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib154">154. <span class="element-citation" id="sref154">Liu S., Gao Y., Zhou D., Zeng M., Alshehri F., Newland B. Highly branched poly(<em>&#x003b2;</em>-amino ester) delivery of minicircle DNA for transfection of neurodegenerative disease related cells. <span><span class="ref-journal">Nat Commun. </span>2019;<span class="ref-vol">10</span>:3307.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC6656726/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/31341171" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Commun&amp;title=Highly+branched+poly(&#x003b2;-amino+ester)+delivery+of+minicircle+DNA+for+transfection+of+neurodegenerative+disease+related+cells&amp;author=S.+Liu&amp;author=Y.+Gao&amp;author=D.+Zhou&amp;author=M.+Zeng&amp;author=F.+Alshehri&amp;volume=10&amp;publication_year=2019&amp;pages=3307&amp;pmid=31341171&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib155">155. <span class="element-citation" id="sref155">Andr&#x000e9; E.M., Passirani C., Seijo B., Sanchez A., Montero-Menei C.N. Nano and microcarriers to improve stem cell behaviour for neuroregenerative medicine strategies: application to Huntington's disease. <span><span class="ref-journal">Biomaterials. </span>2016;<span class="ref-vol">83</span>:347–362.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/26802487" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Biomaterials&amp;title=Nano+and+microcarriers+to+improve+stem+cell+behaviour+for+neuroregenerative+medicine+strategies:+application+to+Huntington's+disease&amp;author=E.M.+Andr&#x000e9;&amp;author=C.+Passirani&amp;author=B.+Seijo&amp;author=A.+Sanchez&amp;author=C.N.+Montero-Menei&amp;volume=83&amp;publication_year=2016&amp;pages=347-362&amp;pmid=26802487&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib156">156. <span class="element-citation" id="sref156">J&#x000f6;nsson M.E., Ludvik Brattas P., Gustafsson C., Petri R., Yudovich D., Pircs K. Activation of neuronal genes <em>via</em> LINE-1 elements upon global DNA demethylation in human neural progenitors. <span><span class="ref-journal">Nat Commun. </span>2019;<span class="ref-vol">10</span>:3182.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC6639357/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/31320637" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Commun&amp;title=Activation+of+neuronal+genes+via+LINE-1+elements+upon+global+DNA+demethylation+in+human+neural+progenitors&amp;author=M.E.+J&#x000f6;nsson&amp;author=P.+Ludvik+Brattas&amp;author=C.+Gustafsson&amp;author=R.+Petri&amp;author=D.+Yudovich&amp;volume=10&amp;publication_year=2019&amp;pages=3182&amp;pmid=31320637&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib157">157. <span class="element-citation" id="sref157">Biffi A., Montini E., Lorioli L., Cesani M., Fumagalli F., Plati T. Lentiviral hematopoietic stem cell gene therapy benefits metachromatic leukodystrophy. <span><span class="ref-journal">Science. </span>2013;<span class="ref-vol">341</span>:1233158.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/23845948" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Science&amp;title=Lentiviral+hematopoietic+stem+cell+gene+therapy+benefits+metachromatic+leukodystrophy&amp;author=A.+Biffi&amp;author=E.+Montini&amp;author=L.+Lorioli&amp;author=M.+Cesani&amp;author=F.+Fumagalli&amp;volume=341&amp;publication_year=2013&amp;pages=1233158&amp;pmid=23845948&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib158">158. <span class="element-citation" id="sref158">Foust K.D., Wang X., McGovern V.L., Braun L., Bevan A.K., Haidet A.M. Rescue of the spinal muscular atrophy phenotype in a mouse model by early postnatal delivery of SMN. <span><span class="ref-journal">Nat Biotechnol. </span>2010;<span class="ref-vol">28</span>:271–274.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2889698/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/20190738" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Biotechnol&amp;title=Rescue+of+the+spinal+muscular+atrophy+phenotype+in+a+mouse+model+by+early+postnatal+delivery+of+SMN&amp;author=K.D.+Foust&amp;author=X.+Wang&amp;author=V.L.+McGovern&amp;author=L.+Braun&amp;author=A.K.+Bevan&amp;volume=28&amp;publication_year=2010&amp;pages=271-274&amp;pmid=20190738&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span><link class="retraction-forward" pmcaccid="PMC9669147" /> <a class="red" href="/pmc/articles/PMC9669147/">Retracted</a></span></div><div class="ref-cit-blk half_rhythm" id="bib159">159. <span class="element-citation" id="sref159">Murrey D.A., Naughton B.J., Duncan F.J., Meadows A.S., Ware T.A., Campbell K.J. Feasibility and safety of systemic rAAV9-hNAGLU delivery for treating mucopolysaccharidosis IIIB: toxicology, biodistribution, and immunological assessments in primates. <span><span class="ref-journal">Hum Gene Ther Clin Dev. </span>2014;<span class="ref-vol">25</span>:72–84.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4124586/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/24720466" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Hum+Gene+Ther+Clin+Dev&amp;title=Feasibility+and+safety+of+systemic+rAAV9-hNAGLU+delivery+for+treating+mucopolysaccharidosis+IIIB:+toxicology,+biodistribution,+and+immunological+assessments+in+primates&amp;author=D.A.+Murrey&amp;author=B.J.+Naughton&amp;author=F.J.+Duncan&amp;author=A.S.+Meadows&amp;author=T.A.+Ware&amp;volume=25&amp;publication_year=2014&amp;pages=72-84&amp;pmid=24720466&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib160">160. <span class="element-citation" id="sref160">Mattar C.N., Waddington S.N., Biswas A., Johana N., Ng X.W., Fisk A.S. Systemic delivery of scAAV9 in fetal macaques facilitates neuronal transduction of the central and peripheral nervous systems. <span><span class="ref-journal">Gene Ther. </span>2013;<span class="ref-vol">20</span>:69–83.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/22278413" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Gene+Ther&amp;title=Systemic+delivery+of+scAAV9+in+fetal+macaques+facilitates+neuronal+transduction+of+the+central+and+peripheral+nervous+systems&amp;author=C.N.+Mattar&amp;author=S.N.+Waddington&amp;author=A.+Biswas&amp;author=N.+Johana&amp;author=X.W.+Ng&amp;volume=20&amp;publication_year=2013&amp;pages=69-83&amp;pmid=22278413&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib161">161. <span class="element-citation" id="sref161">Choudhury S.R., Fitzpatrick Z., Harris A.F., Maitland S.A., Ferreira J.S., Zhang Y. <em>In&#x000a0;vivo</em> selection yields AAV-B1 capsid for central nervous system and muscle gene therapy. <span><span class="ref-journal">Mol Ther. </span>2016;<span class="ref-vol">24</span>:1247–1257.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC5088762/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/27117222" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Mol+Ther&amp;title=In&#x000a0;vivo+selection+yields+AAV-B1+capsid+for+central+nervous+system+and+muscle+gene+therapy&amp;author=S.R.+Choudhury&amp;author=Z.+Fitzpatrick&amp;author=A.F.+Harris&amp;author=S.A.+Maitland&amp;author=J.S.+Ferreira&amp;volume=24&amp;publication_year=2016&amp;pages=1247-1257&amp;pmid=27117222&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib162">162. <span class="element-citation" id="sref162">Choudhury S.R., Harris A.F., Cabral D.J., Keeler A.M., Sapp E., Ferreira J.S. Widespread central nervous system gene transfer and silencing after systemic delivery of novel AAV-AS vector. <span><span class="ref-journal">Mol Ther. </span>2016;<span class="ref-vol">24</span>:726–735.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4886933/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/26708003" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Mol+Ther&amp;title=Widespread+central+nervous+system+gene+transfer+and+silencing+after+systemic+delivery+of+novel+AAV-AS+vector&amp;author=S.R.+Choudhury&amp;author=A.F.+Harris&amp;author=D.J.+Cabral&amp;author=A.M.+Keeler&amp;author=E.+Sapp&amp;volume=24&amp;publication_year=2016&amp;pages=726-735&amp;pmid=26708003&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib163">163. <span class="element-citation" id="sref163">Tardieu M., Z&#x000e9;rah M., Gougeon M.L., Ausseil J., de Bournonville S., Husson B. Intracerebral gene therapy in children with mucopolysaccharidosis type IIIB syndrome: an uncontrolled phase 1/2 clinical trial. <span><span class="ref-journal">Lancet Neurol. </span>2017;<span class="ref-vol">16</span>:712–720.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/28713035" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Lancet+Neurol&amp;title=Intracerebral+gene+therapy+in+children+with+mucopolysaccharidosis+type+IIIB+syndrome:+an+uncontrolled+phase+1/2+clinical+trial&amp;author=M.+Tardieu&amp;author=M.+Z&#x000e9;rah&amp;author=M.L.+Gougeon&amp;author=J.+Ausseil&amp;author=S.+de+Bournonville&amp;volume=16&amp;publication_year=2017&amp;pages=712-720&amp;pmid=28713035&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib164">164. <span class="element-citation" id="sref164">Cearley C.N., Wolfe J.H. A single injection of an adeno-associated virus vector into nuclei with divergent connections results in widespread vector distribution in the brain and global correction of a neurogenetic disease. <span><span class="ref-journal">J Neurosci. </span>2007;<span class="ref-vol">27</span>:9928–9940.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC6672652/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/17855607" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Neurosci&amp;title=A+single+injection+of+an+adeno-associated+virus+vector+into+nuclei+with+divergent+connections+results+in+widespread+vector+distribution+in+the+brain+and+global+correction+of+a+neurogenetic+disease&amp;author=C.N.+Cearley&amp;author=J.H.+Wolfe&amp;volume=27&amp;publication_year=2007&amp;pages=9928-9940&amp;pmid=17855607&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib165">165. <span class="element-citation" id="sref165">Hinderer C., Bell P., Katz N., Vite C.H., Louboutin J.P., Bote E. Evaluation of intrathecal routes of administration for adeno-associated viral vectors in large animals. <span><span class="ref-journal">Hum Gene Ther. </span>2018;<span class="ref-vol">29</span>:15–24.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC5770082/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/28806897" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Hum+Gene+Ther&amp;title=Evaluation+of+intrathecal+routes+of+administration+for+adeno-associated+viral+vectors+in+large+animals&amp;author=C.+Hinderer&amp;author=P.+Bell&amp;author=N.+Katz&amp;author=C.H.+Vite&amp;author=J.P.+Louboutin&amp;volume=29&amp;publication_year=2018&amp;pages=15-24&amp;pmid=28806897&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib166">166. <span class="element-citation" id="sref166">Hinderer C., Bell P., Gurda B.L., Wang Q., Louboutin J.P., Zhu Y. Intrathecal gene therapy corrects CNS pathology in a feline model of mucopolysaccharidosis I. <span><span class="ref-journal">Mol Ther. </span>2014;<span class="ref-vol">22</span>:2018–2027.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4429692/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/25027660" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Mol+Ther&amp;title=Intrathecal+gene+therapy+corrects+CNS+pathology+in+a+feline+model+of+mucopolysaccharidosis+I&amp;author=C.+Hinderer&amp;author=P.+Bell&amp;author=B.L.+Gurda&amp;author=Q.+Wang&amp;author=J.P.+Louboutin&amp;volume=22&amp;publication_year=2014&amp;pages=2018-2027&amp;pmid=25027660&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib167">167. <span class="element-citation" id="sref167">Samaranch L., Salegio E.A., San Sebastian W., Kells A.P., Foust K.D., Bringas J.R. Adeno-associated virus serotype 9 transduction in the central nervous system of nonhuman primates. <span><span class="ref-journal">Hum Gene Ther. </span>2012;<span class="ref-vol">23</span>:382–389.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3327605/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/22201473" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Hum+Gene+Ther&amp;title=Adeno-associated+virus+serotype+9+transduction+in+the+central+nervous+system+of+nonhuman+primates&amp;author=L.+Samaranch&amp;author=E.A.+Salegio&amp;author=W.+San+Sebastian&amp;author=A.P.+Kells&amp;author=K.D.+Foust&amp;volume=23&amp;publication_year=2012&amp;pages=382-389&amp;pmid=22201473&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib168">168. <span class="element-citation" id="sref168">Levites Y., Jansen K., Smithson L.A., Dakin R., Holloway V.M., Das P. Intracranial adeno-associated virus-mediated delivery of anti-pan amyloid <em>&#x003b2;</em>, amyloid <em>&#x003b2;</em>40, and amyloid <em>&#x003b2;</em>42 single-chain variable fragments attenuates plaque pathology in amyloid precursor protein mice. <span><span class="ref-journal">J Neurosci. </span>2006;<span class="ref-vol">26</span>:11923–11928.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC6674861/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/17108166" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Neurosci&amp;title=Intracranial+adeno-associated+virus-mediated+delivery+of+anti-pan+amyloid+&#x003b2;,+amyloid+&#x003b2;40,+and+amyloid+&#x003b2;42+single-chain+variable+fragments+attenuates+plaque+pathology+in+amyloid+precursor+protein+mice&amp;author=Y.+Levites&amp;author=K.+Jansen&amp;author=L.A.+Smithson&amp;author=R.+Dakin&amp;author=V.M.+Holloway&amp;volume=26&amp;publication_year=2006&amp;pages=11923-11928&amp;pmid=17108166&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib169">169. <span class="element-citation" id="sref169">Armbruster N., Lattanzi A., Jeavons M., Van Wittenberghe L., Gjata B., Marais T. Efficacy and biodistribution analysis of intracerebroventricular administration of an optimized scAAV9-SMN1 vector in a mouse model of spinal muscular atrophy. <span><span class="ref-journal">Mol Ther Methods Clin Dev. </span>2016;<span class="ref-vol">3</span>:16060.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC5022869/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/27652289" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Mol+Ther+Methods+Clin+Dev&amp;title=Efficacy+and+biodistribution+analysis+of+intracerebroventricular+administration+of+an+optimized+scAAV9-SMN1+vector+in+a+mouse+model+of+spinal+muscular+atrophy&amp;author=N.+Armbruster&amp;author=A.+Lattanzi&amp;author=M.+Jeavons&amp;author=L.+Van+Wittenberghe&amp;author=B.+Gjata&amp;volume=3&amp;publication_year=2016&amp;pages=16060&amp;pmid=27652289&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib170">170. <span class="element-citation" id="sref170">Dirren E., Aebischer J., Rochat C., Towne C., Schneider B.L., Aebischer P. SOD1 silencing in motoneurons or glia rescues neuromuscular function in ALS mice. <span><span class="ref-journal">Ann Clin Transl Neurol. </span>2015;<span class="ref-vol">2</span>:167–184.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4338957/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/25750921" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Ann+Clin+Transl+Neurol&amp;title=SOD1+silencing+in+motoneurons+or+glia+rescues+neuromuscular+function+in+ALS+mice&amp;author=E.+Dirren&amp;author=J.+Aebischer&amp;author=C.+Rochat&amp;author=C.+Towne&amp;author=B.L.+Schneider&amp;volume=2&amp;publication_year=2015&amp;pages=167-184&amp;pmid=25750921&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib171">171. <span class="element-citation" id="sref171">Ahmed S.G., Waddington S.N., Boza-Mor&#x000e1;n M.G., Y&#x000e1;&#x000f1;ez-Mu&#x000f1;oz R.J. High-efficiency transduction of spinal cord motor neurons by intrauterine delivery of integration-deficient lentiviral vectors. <span><span class="ref-journal">J Contr Release. </span>2018;<span class="ref-vol">273</span>:99–107.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC5845930/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/29289570" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Contr+Release&amp;title=High-efficiency+transduction+of+spinal+cord+motor+neurons+by+intrauterine+delivery+of+integration-deficient+lentiviral+vectors&amp;author=S.G.+Ahmed&amp;author=S.N.+Waddington&amp;author=M.G.+Boza-Mor&#x000e1;n&amp;author=R.J.+Y&#x000e1;&#x000f1;ez-Mu&#x000f1;oz&amp;volume=273&amp;publication_year=2018&amp;pages=99-107&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib172">172. <span class="element-citation" id="sref172">Russell S., Bennett J., Wellman J.A., Chung D.C., Yu Z.F., Tillman A. Efficacy and safety of voretigene neparvovec (AAV2-hRPE65v2) in patients with RPE65-mediated inherited retinal dystrophy: a randomised, controlled, open-label, phase 3 trial. <span><span class="ref-journal">Lancet. </span>2017;<span class="ref-vol">390</span>:849–860.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC5726391/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/28712537" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Lancet&amp;title=Efficacy+and+safety+of+voretigene+neparvovec+(AAV2-hRPE65v2)+in+patients+with+RPE65-mediated+inherited+retinal+dystrophy:+a+randomised,+controlled,+open-label,+phase+3+trial&amp;author=S.+Russell&amp;author=J.+Bennett&amp;author=J.A.+Wellman&amp;author=D.C.+Chung&amp;author=Z.F.+Yu&amp;volume=390&amp;publication_year=2017&amp;pages=849-860&amp;pmid=28712537&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib173">173. <span class="element-citation" id="sref173">Wang L., Xiao R., Andres-Mateos E., Vandenberghe L.H. Single stranded adeno-associated virus achieves efficient gene transfer to anterior segment in the mouse eye. <span><span class="ref-journal">PloS One. </span>2017;<span class="ref-vol">12</span></span> e0182473. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC5538712/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/28763501" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=PloS+One&amp;title=Single+stranded+adeno-associated+virus+achieves+efficient+gene+transfer+to+anterior+segment+in+the+mouse+eye&amp;author=L.+Wang&amp;author=R.+Xiao&amp;author=E.+Andres-Mateos&amp;author=L.H.+Vandenberghe&amp;volume=12&amp;publication_year=2017&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib174">174. <span class="element-citation" id="sref174">Vandenberghe L.H., Auricchio A. Novel adeno-associated viral vectors for retinal gene therapy. <span><span class="ref-journal">Gene Ther. </span>2012;<span class="ref-vol">19</span>:162–168.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/21993172" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Gene+Ther&amp;title=Novel+adeno-associated+viral+vectors+for+retinal+gene+therapy&amp;author=L.H.+Vandenberghe&amp;author=A.+Auricchio&amp;volume=19&amp;publication_year=2012&amp;pages=162-168&amp;pmid=21993172&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib175">175. <span class="element-citation" id="sref175">Trapani I., Auricchio A. Seeing the light after 25 years of retinal gene therapy. <span><span class="ref-journal">Trends Mol Med. </span>2018;<span class="ref-vol">24</span>:669–681.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/29983335" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Trends+Mol+Med&amp;title=Seeing+the+light+after+25+years+of+retinal+gene+therapy&amp;author=I.+Trapani&amp;author=A.+Auricchio&amp;volume=24&amp;publication_year=2018&amp;pages=669-681&amp;pmid=29983335&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib176">176. <span class="element-citation" id="sref176">Miller J.W., Vandenberghe L.H. Breaking and sealing barriers in retinal gene therapy. <span><span class="ref-journal">Mol Ther. </span>2018;<span class="ref-vol">26</span>:2081–2082.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC6127874/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/30107998" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Mol+Ther&amp;title=Breaking+and+sealing+barriers+in+retinal+gene+therapy&amp;author=J.W.+Miller&amp;author=L.H.+Vandenberghe&amp;volume=26&amp;publication_year=2018&amp;pages=2081-2082&amp;pmid=30107998&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib177">177. <span class="element-citation" id="sref177">Takahashi K., Igarashi T., Miyake K., Kobayashi M., Yaguchi C., Iijima O. Improved intravitreal AAV-mediated inner retinal gene transduction after surgical internal limiting membrane peeling in cynomolgus monkeys. <span><span class="ref-journal">Mol Ther. </span>2017;<span class="ref-vol">25</span>:296–302.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC5363307/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/28129123" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Mol+Ther&amp;title=Improved+intravitreal+AAV-mediated+inner+retinal+gene+transduction+after+surgical+internal+limiting+membrane+peeling+in+cynomolgus+monkeys&amp;author=K.+Takahashi&amp;author=T.+Igarashi&amp;author=K.+Miyake&amp;author=M.+Kobayashi&amp;author=C.+Yaguchi&amp;volume=25&amp;publication_year=2017&amp;pages=296-302&amp;pmid=28129123&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib178">178. <span class="element-citation" id="sref178">Biferi M.G., Cohen-Tannoudji M., Cappelletto A., Giroux B., Roda M., Astord S. A newAAV10-U7-mediated gene therapy prolongs survival and restores function in an ALS mouse model. <span><span class="ref-journal">Mol Ther. </span>2017;<span class="ref-vol">25</span>:2038–2052.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC5589057/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/28663100" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Mol+Ther&amp;title=A+newAAV10-U7-mediated+gene+therapy+prolongs+survival+and+restores+function+in+an+ALS+mouse+model&amp;author=M.G.+Biferi&amp;author=M.+Cohen-Tannoudji&amp;author=A.+Cappelletto&amp;author=B.+Giroux&amp;author=M.+Roda&amp;volume=25&amp;publication_year=2017&amp;pages=2038-2052&amp;pmid=28663100&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib179">179. <span class="element-citation" id="sref179">Hinderer C., Katz N., Buza E.L., Dyer C., Goode T., Bell P. Severe toxicity in nonhuman primates and piglets following high-dose intravenous administration of an adeno-associated virus vector expressing human SMN. <span><span class="ref-journal">Hum Gene Ther. </span>2018;<span class="ref-vol">29</span>:285–298.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC5865262/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/29378426" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Hum+Gene+Ther&amp;title=Severe+toxicity+in+nonhuman+primates+and+piglets+following+high-dose+intravenous+administration+of+an+adeno-associated+virus+vector+expressing+human+SMN&amp;author=C.+Hinderer&amp;author=N.+Katz&amp;author=E.L.+Buza&amp;author=C.+Dyer&amp;author=T.+Goode&amp;volume=29&amp;publication_year=2018&amp;pages=285-298&amp;pmid=29378426&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib180">180. <span class="element-citation" id="sref180">Amado D., Mingozzi F., Hui D., Bennicelli J.L., Wei Z., Chen Y. Safety and efficacy of subretinal readministration of a viral vector in large animals to treat congenital blindness. <span><span class="ref-journal">Sci Transl Med. </span>2010;<span class="ref-vol">2</span></span> 21ra16. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4169124/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/20374996" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Sci+Transl+Med&amp;title=Safety+and+efficacy+of+subretinal+readministration+of+a+viral+vector+in+large+animals+to+treat+congenital+blindness&amp;author=D.+Amado&amp;author=F.+Mingozzi&amp;author=D.+Hui&amp;author=J.L.+Bennicelli&amp;author=Z.+Wei&amp;volume=2&amp;publication_year=2010&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib181">181. <span class="element-citation" id="sref181">Vandamme C., Adjali O., Mingozzi F. Unraveling the complex story of immune responses to AAV vectors trial after trial. <span><span class="ref-journal">Hum Gene Ther. </span>2017;<span class="ref-vol">28</span>:1061–1074.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC5649404/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/28835127" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Hum+Gene+Ther&amp;title=Unraveling+the+complex+story+of+immune+responses+to+AAV+vectors+trial+after+trial&amp;author=C.+Vandamme&amp;author=O.+Adjali&amp;author=F.+Mingozzi&amp;volume=28&amp;publication_year=2017&amp;pages=1061-1074&amp;pmid=28835127&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib182">182. <span class="element-citation" id="sref182">Chandler R.J., Sands M.S., Venditti C.P. Recombinant adenoassociated viral integration and genotoxicity: insights from animal models. <span><span class="ref-journal">Hum Gene Ther. </span>2017;<span class="ref-vol">28</span>:314–322.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC5399742/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/28293963" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Hum+Gene+Ther&amp;title=Recombinant+adenoassociated+viral+integration+and+genotoxicity:+insights+from+animal+models&amp;author=R.J.+Chandler&amp;author=M.S.+Sands&amp;author=C.P.+Venditti&amp;volume=28&amp;publication_year=2017&amp;pages=314-322&amp;pmid=28293963&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib183">183. <span class="element-citation" id="sref183">Nault J.C., Datta S., Imbeaud S., Franconi A., Mallet M., Couchy G. Recurrent AAV2-related insertional mutagenesis in human hepatocellular carcinomas. <span><span class="ref-journal">Nat Genet. </span>2015;<span class="ref-vol">47</span>:1187–1193.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/26301494" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Genet&amp;title=Recurrent+AAV2-related+insertional+mutagenesis+in+human+hepatocellular+carcinomas&amp;author=J.C.+Nault&amp;author=S.+Datta&amp;author=S.+Imbeaud&amp;author=A.+Franconi&amp;author=M.+Mallet&amp;volume=47&amp;publication_year=2015&amp;pages=1187-1193&amp;pmid=26301494&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib184">184. <span class="element-citation" id="sref184">Gil-Farina I., Fronza R., Kaeppel C., Lopez-Franco E., Ferreira V., D'Avola D. Recombinant AAV integration is not associated with hepatic genotoxicity in nonhuman primates and patients. <span><span class="ref-journal">Mol Ther. </span>2016;<span class="ref-vol">24</span>:1100–1105.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4923321/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/26948440" ref="reftype=pubmed&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Mol+Ther&amp;title=Recombinant+AAV+integration+is+not+associated+with+hepatic+genotoxicity+in+nonhuman+primates+and+patients&amp;author=I.+Gil-Farina&amp;author=R.+Fronza&amp;author=C.+Kaeppel&amp;author=E.+Lopez-Franco&amp;author=V.+Ferreira&amp;volume=24&amp;publication_year=2016&amp;pages=1100-1105&amp;pmid=26948440&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7488363&amp;issue-id=365107&amp;journal-id=2814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div></div></div></div><!--post-content--><div class="courtesy-note whole_rhythm small"><hr /><div class="half_rhythm">Articles from <span class="acknowledgment-journal-title">Acta Pharmaceutica Sinica. B</span> are provided here courtesy of <strong>Elsevier</strong></div><hr /></div><div id="body-link-poppers"><span></span></div></div>
            
        </section>
    </article>
    <aside class="usa-width-one-fourth usa-layout-docs-sidenav pmc-sidebar">
         
  

<div class="scroller">

    
        <section>
                <h6>Other Formats</h6>
                <ul class="pmc-sidebar__formats">
                  <li class="pdf-link other_item"><a href="/pmc/articles/PMC7488363/pdf/main.pdf" class="int-view">PDF (1.0M)</a></li>
                </ul>
        </section>
    
    <section>
        <h6>Actions</h6>
        <ul class="pmc-sidebar__actions">
            <li>
                <button role="button" class="citation-button citation-dialog-trigger ctxp"
                        aria-label="Open dialog with citation text in different styles" data-ga-category="save_share" data-ga-action="cite" data-ga-label="open"
                        data-all-citations-url="/pmc/resources/citations/7488363/"
                        data-citation-style="nlm"
                        data-download-format-link="/pmc/resources/citations/7488363/export/"
                >
                    <span class="button-label">Cite</span>
                </button>
            </li>
            <li>
                
                    

<link type="text/css" href="ncbi-overlay-block/src/overlay-block.css">
<div class="collections-button-container" data-article-id="7488363" data-article-db="pmc">
  <button class="collections-button collections-dialog-trigger"
          aria-label="Save article in MyNCBI collections."
          data-ga-category="collections_button"
          data-ga-action="click"
          data-ga-label="collections_button"
          data-collections-open-dialog-enabled="false"
          data-collections-open-dialog-url="https://www.ncbi.nlm.nih.gov/account?back_url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7488363%2F%23open-collections-dialog"
          data-in-collections="false">
      <span class="button-label">Collections</span>
  </button>
  <div class="overlay" role="dialog">
  <div id="collections-action-dialog"
       class="dialog collections-dialog"
       aria-hidden="true">
    <div class="title">Add to Collections</div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/pmc/list-existing-collections/"
      data-add-to-existing-collection-url="/pmc/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/pmc/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

  <input type="hidden" name="csrfmiddlewaretoken" value="wRGGwkdqjTdJZ0IdWxpInHoMEdTTIL6ZpXMZ3quXvJTueZHBknczgrcZStlpcFOZ">

  

  <div class="choice-group" role="radiogroup">
    <ul class="radio-group-items">
      <li>
        <input type="radio"
               id="collections-action-dialog-new-aside "
               class="collections-new"
               name="collections"
               value="new"
               data-ga-category="collections_button"
               data-ga-action="click"
               data-ga-label="collections_radio_new">
        <label for="collections-action-dialog-new-aside ">Create a new collection</label>
      </li>
      <li>
        <input type="radio"
               id="collections-action-dialog-existing-aside "
               class="collections-existing"
               name="collections"
               value="existing"
               checked="true"
               data-ga-category="collections_button"
               data-ga-action="click"
               data-ga-label="collections_radio_existing">
        <label for="collections-action-dialog-existing-aside ">Add to an existing collection</label>
      </li>
    </ul>
  </div>

  <div class="controls-wrapper">
    <div class="action-panel-control-wrap new-collections-controls">
      <label for="collections-action-dialog-add-to-new" class="action-panel-label required-field-asterisk">
        Name your collection:
      </label>
      <input
        type="text"
        name="add-to-new-collection"
        id="collections-action-dialog-add-to-new"
        class="collections-action-add-to-new"
        pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
        maxlength=""
        data-ga-category="collections_button"
        data-ga-action="create_collection"
        data-ga-label="non_favorties_collection">
      <div class="collections-new-name-too-long usa-input-error-message selection-validation-message">
        Name must be less than  characters
      </div>
    </div>
    <div class="action-panel-control-wrap existing-collections-controls">
      <label for="collections-action-dialog-add-to-existing" class="action-panel-label">
        Choose a collection:
      </label>
      <select id="collections-action-dialog-add-to-existing"
              class="action-panel-selector collections-action-add-to-existing"
              data-ga-category="collections_button"
              data-ga-action="select_collection"
              data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
      </select>
      <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
        Unable to load your collection due to an error<br>
        <a href="#">Please try again</a>
      </div>
    </div>
  </div>

  <div class="action-panel-actions">
    <button class="action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
      Add
    </button>
    <button class="action-panel-cancel"
            aria-label="Close 'Add to Collections' panel"
            ref="linksrc=close_collections_panel"
            aria-controls="collections-action-panel"
            aria-expanded="false"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="cancel">
      Cancel
    </button>
  </div>
</form>
    </div>
  </div>
</div>
</div>
                
            </li>

        </ul>
    </section>
    
        <section class="social-sharing">
            <h6>Share</h6>
            <ul class="pmc-sidebar__share">
                <li><a class="fa-stack fa-lg" target="_blank" rel="noopener noreferrer" role="button" href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7488363%2F&amp;text=Gene%20therapy%20for%20neurodegenerative%20disorders%3A%20advances%2C%20insights%20and%20prospects" alt="Share on Twitter"><i class="fa fa-twitter fa-stack-1x">&#160;</i></a></li> 
<li><a class="fa-stack fa-lg" target="_blank" rel="noopener noreferrer" role="button" href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7488363%2F" alt="Share on Facebook"><i class="fa fa-facebook fa-stack-1x">&#160;</i></a></li>
                <li>
                    <div class="share-permalink">
                        <button class="trigger"  alt="Show article permalink" aria-expanded="false" aria-haspopup="true">
                            <i class="fa-stack fa-lg" >
                                <i class="fa fa-link fa-stack-1x">&nbsp;</i>
                            </i>
                        </button>
                        <div class="dropdown dropdown-container" hidden>
                              <div class="title">
                                Permalink
                              </div>
                              <div class="content">
                                  <input type="text" class="permalink-text" value="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7488363/" aria-label="Article permalink"><button class="permalink-copy-button usa-button-primary" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                                      <span class="button-title">Copy</span>
                                  </button>
                              </div>
                        </div>
                    </div>
                </li>
            </ul>
        </section>
    
    <section>
        <h6>RESOURCES</h6>
        <ul class="pmc-sidebar__resources">
        
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_similar_articles"
                            data-ga-label="/pmc/articles/PMC7488363/"
                            class="usa-accordion-button"
                            aria-controls="similar-articles-accordion-aside"
                            aria-expanded="false"
                            data-action-open="open_similar_articles"
                            data-action-close="close_similar_articles"
                    >
                        Similar articles
                    </button>
                    <div
                            
                                data-source-url="/pmc/resources/similar-article-links/32963936/"
                            

                         class="usa-accordion-content pmc-sidebar__resources--citations" id="similar-articles-accordion-aside" aria-hidden="true">
                        
                    </div>
                </div>
            </li>
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_cited_by"
                            data-ga-label="/pmc/articles/PMC7488363/"
                            class="usa-accordion-button"
                            aria-controls="cited-by-accordion-aside"
                            aria-expanded="false"
                            data-action-open="open_cited_by"
                            data-action-close="close_cited_by"
                    >
                        Cited by other articles
                    </button>
                    <div
                            
                                data-source-url="/pmc/resources/cited-by-links/32963936/"
                            
                            class="usa-accordion-content pmc-sidebar__resources--citations"
                            id="cited-by-accordion-aside"
                            aria-hidden="true"
                    >
                        
                    </div>
                </div>
            </li>
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/pmc/articles/PMC7488363/"
                            class="usa-accordion-button"
                            aria-controls="links-accordion-aside"
                            aria-expanded="false"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                    >
                        Links to NCBI Databases
                    </button>
                    <div data-source-url="/pmc/resources/db-links/7488363/" class="usa-accordion-content" id="links-accordion-aside" aria-hidden="true"></div>
                </div>
            </li>

            
        
        </ul>
    </section>

 </div>

    </aside>
</main>

    <div class="overlay" role="dialog" aria-label="Citation Dialog">
  <div class="dialog citation-dialog">
    <button class="close-overlay" tabindex="1">[x]</button>
    <div class="title">Cite</div>
    <div class="citation-text-block">
  <div class="citation-text"></div>
  <div class="citation-actions">
    <button
      class="copy-button dialog-focus"
      data-ga-category="save_share"
      data-ga-action="cite"
      data-ga-label="copy"
      tabindex="2">
      Copy
    </button>

      <a href="#"
              class="export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
          <span class="title">Download .nbib</span>
          <span class="title-mobile">.nbib</span>
      </a>


    

<div class="citation-style-selector-wrapper">
  <label class="selector-label">Format:</label>
  <select aria-label="Format" class="citation-style-selector" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
  </div>
</div>
  </div>
</div>

     <!-- ========== BEGIN FOOTER ========== -->
 <footer>
      <section class="icon-section">
        <div id="icon-section-header" class="icon-section_header">Follow NCBI</div>
        <div class="grid-container container">
          <div class="icon-section_container">
            <a class="footer-icon" id="footer_twitter" href="https://twitter.com/ncbi" aria-label="Twitter"><svg
                data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 300 300">
                <defs>
                  <style>
                    .cls-11 {
                      fill: #737373;
                    }
                  </style>
                </defs>
                <title>Twitter</title>
                <path class="cls-11"
                  d="M250.11,105.48c-7,3.14-13,3.25-19.27.14,8.12-4.86,8.49-8.27,11.43-17.46a78.8,78.8,0,0,1-25,9.55,39.35,39.35,0,0,0-67,35.85,111.6,111.6,0,0,1-81-41.08A39.37,39.37,0,0,0,81.47,145a39.08,39.08,0,0,1-17.8-4.92c0,.17,0,.33,0,.5a39.32,39.32,0,0,0,31.53,38.54,39.26,39.26,0,0,1-17.75.68,39.37,39.37,0,0,0,36.72,27.3A79.07,79.07,0,0,1,56,223.34,111.31,111.31,0,0,0,116.22,241c72.3,0,111.83-59.9,111.83-111.84,0-1.71,0-3.4-.1-5.09C235.62,118.54,244.84,113.37,250.11,105.48Z">
                </path>
              </svg></a>
            <a class="footer-icon" id="footer_facebook" href="https://www.facebook.com/ncbi.nlm" aria-label="Facebook"><svg
                data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 300 300">
                <title>Facebook</title>
                <path class="cls-11"
                  d="M210.5,115.12H171.74V97.82c0-8.14,5.39-10,9.19-10h27.14V52l-39.32-.12c-35.66,0-42.42,26.68-42.42,43.77v19.48H99.09v36.32h27.24v109h45.41v-109h35Z">
                </path>
              </svg></a>
            <a class="footer-icon" id="footer_linkedin"
              href="https://www.linkedin.com/company/ncbinlm"
              aria-label="LinkedIn"><svg data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 300 300">
                <title>LinkedIn</title>
                <path class="cls-11"
                  d="M101.64,243.37H57.79v-114h43.85Zm-22-131.54h-.26c-13.25,0-21.82-10.36-21.82-21.76,0-11.65,8.84-21.15,22.33-21.15S101.7,78.72,102,90.38C102,101.77,93.4,111.83,79.63,111.83Zm100.93,52.61A17.54,17.54,0,0,0,163,182v61.39H119.18s.51-105.23,0-114H163v13a54.33,54.33,0,0,1,34.54-12.66c26,0,44.39,18.8,44.39,55.29v58.35H198.1V182A17.54,17.54,0,0,0,180.56,164.44Z">
                </path>
              </svg></a>
            <a class="footer-icon" id="footer_github" href="https://github.com/ncbi" aria-label="GitHub"><svg
                data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 300 300">
                <defs>
                  <style>
                    .cls-11,
                    .cls-12 {
                      fill: #737373;
                    }

                    .cls-11 {
                      fill-rule: evenodd;
                    }
                  </style>
                </defs>
                <title>GitHub</title>
                <path class="cls-11"
                  d="M151.36,47.28a105.76,105.76,0,0,0-33.43,206.1c5.28,1,7.22-2.3,7.22-5.09,0-2.52-.09-10.85-.14-19.69-29.42,6.4-35.63-12.48-35.63-12.48-4.81-12.22-11.74-15.47-11.74-15.47-9.59-6.56.73-6.43.73-6.43,10.61.75,16.21,10.9,16.21,10.9,9.43,16.17,24.73,11.49,30.77,8.79,1-6.83,3.69-11.5,6.71-14.14C108.57,197.1,83.88,188,83.88,147.51a40.92,40.92,0,0,1,10.9-28.39c-1.1-2.66-4.72-13.42,1-28,0,0,8.88-2.84,29.09,10.84a100.26,100.26,0,0,1,53,0C198,88.3,206.9,91.14,206.9,91.14c5.76,14.56,2.14,25.32,1,28a40.87,40.87,0,0,1,10.89,28.39c0,40.62-24.74,49.56-48.29,52.18,3.79,3.28,7.17,9.71,7.17,19.58,0,14.15-.12,25.54-.12,29,0,2.82,1.9,6.11,7.26,5.07A105.76,105.76,0,0,0,151.36,47.28Z">
                </path>
                <path class="cls-12"
                  d="M85.66,199.12c-.23.52-1.06.68-1.81.32s-1.2-1.06-.95-1.59,1.06-.69,1.82-.33,1.21,1.07.94,1.6Zm-1.3-1">
                </path>
                <path class="cls-12"
                  d="M90,203.89c-.51.47-1.49.25-2.16-.49a1.61,1.61,0,0,1-.31-2.19c.52-.47,1.47-.25,2.17.49s.82,1.72.3,2.19Zm-1-1.08">
                </path>
                <path class="cls-12"
                  d="M94.12,210c-.65.46-1.71,0-2.37-.91s-.64-2.07,0-2.52,1.7,0,2.36.89.65,2.08,0,2.54Zm0,0"></path>
                <path class="cls-12"
                  d="M99.83,215.87c-.58.64-1.82.47-2.72-.41s-1.18-2.06-.6-2.7,1.83-.46,2.74.41,1.2,2.07.58,2.7Zm0,0">
                </path>
                <path class="cls-12"
                  d="M107.71,219.29c-.26.82-1.45,1.2-2.64.85s-2-1.34-1.74-2.17,1.44-1.23,2.65-.85,2,1.32,1.73,2.17Zm0,0">
                </path>
                <path class="cls-12"
                  d="M116.36,219.92c0,.87-1,1.59-2.24,1.61s-2.29-.68-2.3-1.54,1-1.59,2.26-1.61,2.28.67,2.28,1.54Zm0,0">
                </path>
                <path class="cls-12"
                  d="M124.42,218.55c.15.85-.73,1.72-2,1.95s-2.37-.3-2.52-1.14.73-1.75,2-2,2.37.29,2.53,1.16Zm0,0"></path>
              </svg></a>
            <a class="footer-icon" id="footer_blog" href="https://ncbiinsights.ncbi.nlm.nih.gov/" aria-label="Blog">
              <svg id="Layer_1" data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 40 40"><defs><style>.cls-1{fill:#737373;}</style></defs><path class="cls-1" d="M14,30a4,4,0,1,1-4-4,4,4,0,0,1,4,4Zm11,3A19,19,0,0,0,7.05,15a1,1,0,0,0-1,1v3a1,1,0,0,0,.93,1A14,14,0,0,1,20,33.07,1,1,0,0,0,21,34h3a1,1,0,0,0,1-1Zm9,0A28,28,0,0,0,7,6,1,1,0,0,0,6,7v3a1,1,0,0,0,1,1A23,23,0,0,1,29,33a1,1,0,0,0,1,1h3A1,1,0,0,0,34,33Z"/></svg>
            </a>
          </div>
        </div>
      </section>

      <section class="container-fluid bg-primary">
        <div class="container pt-5">
          <div class="row mt-3">
            <div class="col-lg-3 col-12">
              <p><a class="text-white" href="https://www.nlm.nih.gov/socialmedia/index.html">Connect with NLM</a></p>
              <ul class="list-inline social_media">
                <li class="list-inline-item"><a href="https://twitter.com/NLM_NIH" aria-label="Twitter"
                    target="_blank" rel="noopener noreferrer"><svg version="1.1" xmlns="http://www.w3.org/2000/svg"
                      xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 249 249"
                      style="enable-background:new 0 0 249 249;" xml:space="preserve">
                      <style type="text/css">
                        .st20 {
                          fill: #FFFFFF;
                        }

                        .st30 {
                          fill: none;
                          stroke: #FFFFFF;
                          stroke-width: 8;
                          stroke-miterlimit: 10;
                        }
                      </style>
                      <title>SM-Twitter</title>
                      <g>
                        <g>
                          <g>
                            <path class="st20" d="M192.9,88.1c-5,2.2-9.2,2.3-13.6,0.1c5.7-3.4,6-5.8,8.1-12.3c-5.4,3.2-11.4,5.5-17.6,6.7
                                                c-10.5-11.2-28.1-11.7-39.2-1.2c-7.2,6.8-10.2,16.9-8,26.5c-22.3-1.1-43.1-11.7-57.2-29C58,91.6,61.8,107.9,74,116
                                                c-4.4-0.1-8.7-1.3-12.6-3.4c0,0.1,0,0.2,0,0.4c0,13.2,9.3,24.6,22.3,27.2c-4.1,1.1-8.4,1.3-12.5,0.5c3.6,11.3,14,19,25.9,19.3
                                                c-11.6,9.1-26.4,13.2-41.1,11.5c12.7,8.1,27.4,12.5,42.5,12.5c51,0,78.9-42.2,78.9-78.9c0-1.2,0-2.4-0.1-3.6
                                                C182.7,97.4,189.2,93.7,192.9,88.1z"></path>
                          </g>
                        </g>
                        <circle class="st30" cx="124.4" cy="128.8" r="108.2"></circle>
                      </g>
                    </svg></a></li>
                <li class="list-inline-item"><a href="https://www.facebook.com/nationallibraryofmedicine"
                    aria-label="Facebook" rel="noopener noreferrer" target="_blank">
                    <svg version="1.1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" x="0px"
                      y="0px" viewBox="0 0 249 249" style="enable-background:new 0 0 249 249;" xml:space="preserve">
                      <style type="text/css">
                        .st10 {
                          fill: #FFFFFF;
                        }

                        .st110 {
                          fill: none;
                          stroke: #FFFFFF;
                          stroke-width: 8;
                          stroke-miterlimit: 10;
                        }
                      </style>
                      <title>SM-Facebook</title>
                      <g>
                        <g>
                          <path class="st10" d="M159,99.1h-24V88.4c0-5,3.3-6.2,5.7-6.2h16.8V60l-24.4-0.1c-22.1,0-26.2,16.5-26.2,27.1v12.1H90v22.5h16.9
                                                      v67.5H135v-67.5h21.7L159,99.1z"></path>
                        </g>
                      </g>
                      <circle class="st110" cx="123.6" cy="123.2" r="108.2"></circle>
                    </svg>
                  </a></li>
                <li class="list-inline-item"><a href="https://www.youtube.com/user/NLMNIH" aria-label="Youtube"
                    target="_blank" rel="noopener noreferrer"><svg version="1.1" xmlns="http://www.w3.org/2000/svg"
                      xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 249 249"
                      style="enable-background:new 0 0 249 249;" xml:space="preserve">
                      <title>SM-Youtube</title>
                      <style type="text/css">
                        .st4 {
                          fill: none;
                          stroke: #FFFFFF;
                          stroke-width: 8;
                          stroke-miterlimit: 10;
                        }

                        .st5 {
                          fill: #FFFFFF;
                        }
                      </style>
                      <circle class="st4" cx="124.2" cy="123.4" r="108.2"></circle>
                      <g transform="translate(0,-952.36218)">
                        <path class="st5"
                          d="M88.4,1037.4c-10.4,0-18.7,8.3-18.7,18.7v40.1c0,10.4,8.3,18.7,18.7,18.7h72.1c10.4,0,18.7-8.3,18.7-18.7
                                            v-40.1c0-10.4-8.3-18.7-18.7-18.7H88.4z M115.2,1058.8l29.4,17.4l-29.4,17.4V1058.8z"></path>
                      </g>
                    </svg></a></li>
              </ul>
            </div>
            <div class="col-lg-3 col-12">
              <p class="address_footer text-white">National Library of Medicine<br>
                <a href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/@38.9959508,-77.101021,17z/data=!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb:0x19156f88b27635b8!8m2!3d38.9959508!4d-77.0988323"
                  class="text-white" target="_blank" rel="noopener noreferrer">8600 Rockville Pike<br>
                  Bethesda, MD 20894</a></p>
            </div>
            <div class="col-lg-3 col-12 centered-lg">
              <p><a href="https://www.nlm.nih.gov/web_policies.html" class="text-white">Web Policies</a><br>
                <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office"
                  class="text-white">FOIA</a><br>
                <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="text-white" id="vdp">HHS Vulnerability Disclosure</a></p>
            </div>
            <div class="col-lg-3 col-12 centered-lg">
              <p><a class="supportLink text-white" href="https://support.nlm.nih.gov/">Help</a><br>
                <a href="https://www.nlm.nih.gov/accessibility.html" class="text-white">Accessibility</a><br>
                <a href="https://www.nlm.nih.gov/careers/careers.html" class="text-white">Careers</a></p>
            </div>
          </div>
          <div class="row">
            <div class="col-lg-12 centered-lg">
              <nav class="bottom-links">
                <ul class="mt-3">
                  <li>
                    <a class="text-white" href="//www.nlm.nih.gov/">NLM</a>
                  </li>
                  <li>
                    <a class="text-white"
                  href="https://www.nih.gov/">NIH</a>
                  </li>
                  <li>
                    <a class="text-white" href="https://www.hhs.gov/">HHS</a>
                  </li>
                  <li>
                    <a
                  class="text-white" href="https://www.usa.gov/">USA.gov</a>
                  </li>
                </ul>
              </nav>
            </div>
          </div>
        </div>
      </section>
    </footer>
 <!-- ========== END FOOTER ========== -->
  <!-- javascript to inject NWDS meta tags. Note: value of nwds_version is updated by "npm version" command -->
 
  <script type="text/javascript">
    var nwds_version = "1.1.9-2";

    var meta_nwds_ver = document.createElement('meta');
    meta_nwds_ver.name = 'ncbi_nwds_ver';
    meta_nwds_ver.content = nwds_version;
    document.getElementsByTagName('head')[0].appendChild(meta_nwds_ver);

    var meta_nwds = document.createElement('meta');
    meta_nwds.name = 'ncbi_nwds';
    meta_nwds.content = 'yes';
    document.getElementsByTagName('head')[0].appendChild(meta_nwds);

	var alertsUrl = "/core/alerts/alerts.js";
	if (typeof ncbiBaseUrl !== 'undefined') {
		alertsUrl = ncbiBaseUrl + alertsUrl;
	}
  </script>



  
    <!-- JavaScript -->
    <script src="/pmc/static/CACHE/js/output.0f72d6a64937.js"></script>
  
  
    <script src="https://code.jquery.com/jquery-3.5.0.min.js"
          integrity="sha256-xNzN2a4ltkB44Mc/Jz3pT4iU1cmeR0FkXs4pru/JxaQ="
          crossorigin="anonymous">
    </script>
    <script>
        var fallbackJquery = "/pmc/static/base/js/jquery-3.5.0.min.js";
        window.jQuery || document.write("<script src=" + fallbackJquery + ">\x3C/script>")
    </script>
  

  <script src="/pmc/static/CACHE/js/output.a212a9fcf845.js"></script>
<script src="/pmc/static/CACHE/js/output.7999321d1aac.js"></script>
<script src="/pmc/static/CACHE/js/output.7ca436b2ea51.js"></script>
<script src="/pmc/static/CACHE/js/output.f8422046fbe0.js"></script>
<script src="/pmc/static/CACHE/js/output.ff40c7d85ff8.js"></script>
<script src="/pmc/static/CACHE/js/output.a6a84a0ad361.js"></script>

<script type="text/javascript" src="/pmc/static/bundles/base/base.038d36e4e31104b40a19.js" ></script>

    <script type="text/javascript">
        if(typeof jQuery !=='undefined') {
            jQuery.migrateMute = true;
        }
    </script>
    <script type="text/javascript" src="https://code.jquery.com/jquery-migrate-1.4.1.js"></script>
    <script type="text/javascript" src="/core/jig/1.15.2/js/jig.nojquery.min.js">//</script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js?_=3.18">//</script><script type="text/javascript" src="/corehtml/pmc/js/NcbiTagServer.min.js?_=3.18">//</script><script type="text/javascript" src="/corehtml/pmc/js/crb.min.js?_=3.18">//</script><script type="text/javascript" src="/corehtml/pmc/js/jactions.min.js?_=3.18">//</script><script type="text/javascript">window.name="mainwindow";</script>

    <script type="text/javascript">var exports = {};</script>
    <script src="/pmc/static/CACHE/js/output.340a3b9cce7f.js"></script>
<script src="/pmc/static/CACHE/js/output.228f96f3298e.js"></script>
    <script type="text/javascript" src="/pmc/static/bundles/article/article.b7dd20e527283dd68f45.js" ></script>
    <script type="text/javascript">
        window.ncbi.pmc.articlePage.init({ pageURL: '/pmc/articles/PMC7488363/', citeCookieName: 'pmc-cf'});
    </script>


  
  
  <script  type="text/javascript" src="https://www.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


  
      
  

</body>
</html>
